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Abstract 
The metastatic spread of cancer cells is a major contributor to cancer patient 
deaths. In order to disseminate from one part of the body to another, invasive 
tumour cells must perform a complex cascade of steps. Common to several 
stages of the metastatic process is the ability of tumour cells to squeeze through 
narrow spaces. One adaptation that allows cancer cells to adjust to confined 
environments is a change in the cell mechanical properties, which results in 
diminished cell stiffness. Such an altered cellular physical property is thought to 
contribute to the invasive and metastatic properties of cancer cells. There is 
little currently known about the factors or signalling pathways that modulate 
cell stiffness; therefore, the identification of factors that modify tumour cell 
plasticity could identify potential drug targets for anti-metastasis chemotherapy. 
I hypothesized that within the distributions of parameters in tumour cell line 
populations, it would be possible to select for cells with an augmented ability to 
squeeze through narrow gaps, thus highlighting factors that contributed to cell 
deformability. To identify factors that help cancer cells migrate through 
confined spaces, MDA MB 231 human breast cancer cells and MDA MB 435 
melanoma cells underwent 3 rounds of selection, using tissue culture inserts 
with 3 µm pores. This selection approach allowed me to isolate cell populations 
with enhanced abilities to pass through physical constrictions, as well as 
augmented invasive abilities in vitro. Additionally, populations of small volume 
cells were selected from parental MD MB 231 cells by flow cytometry. By 
obtaining the matching cell size control, I found that increased pore invasion 
was not solely dependent on small cell or nuclei size. In fact, properties unique 
to the pore-selected invasive cells were: decreased actin cytoskeleton 
anisotropy and cell rigidity (Young’s modulus) as determined by Atomic Force 
Microscopy (AFM).  
To identify signalling pathways that were associated with observed cytoskeleton 
and elasticity changes, RNA sequencing was performed on parental, pore-
selected and flow-selected MDA MB 231 cells, and parental and pore-selected 
MDA MB 435 cells and a stringent comparison was performed. Such an approach 
allowed identification of common genes, which were used for further analysis by 
applying GSEA. The most common gene signature was found to associate with 
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increased signalling through the Ras-Raf-MEK-ERK mitogen-activated protein 
kinase (MAPK) pathway. Blocking the activity of the MAPK/ERK pathway with two 
pharmacologically distinct MEK inhibitors resulted in actin stress fibre 
restoration, increased cell stiffness and restrained cell invasion through collagen 
matrices. I was able to identify, for the first time that changes in cytoskeletal 
organisation mediated by increased signalling through the MAPK/ERK pathway 
resulted in cell plasticity alterations.  Therefore, drugs that block Ras-MAPK 
signalling would likely provide clinical benefit by reversing the effect of this 
signalling pathway on tumour cell plasticity and subsequently restraining 
migratory and invasive capabilities. 
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JNK c-Jun N-terminal kinases 
kg kilogram 
L Litre 
LIFA Lambert Instruments FLIM Attachment  
LILRB1  Leukocyte immunoglobulin-like receptor subfamily B member 1 
LIMK LIM domain kinase  
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M Molar 
MAPK Mitogen–activated protein kinase  
MAPKK Mitogen–activated protein kinase kinase 
MAPKKK Mitogen–activated protein kinase kinase kinase 
MBS Myosin-binding subunits  
MEK Mitogen-activated protein kinase  
MEM/EBSS  Minimum Essential Medium with Earle's Balanced Salts  
mg milligram 
ml millilitre 
MLC Myosin light chain 
MLCK Myosin light chain kinase 
MLCP Myosin light chain phosphatase 
mm millimetre 
mM  millimolar 
MMPs Matrix metalloproteinases  
mW milliwatt 
MXRA8 Matrix remodelling associated 8 
MYPT1 Myosin phosphatase target subunit 1 
NaN3 Sodium azide 
NBD 
(6-((N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl)sphingosyl 
phosphocholine) 
nm nanometre 
nM nanomolar 
nN  nanonewton 
PAGE Polyacrylamide gel electrophoresis  
PBS Phosphate-buffered saline 
PCA Principle Component Analysis  
PCR Polymerase chain reaction 
PFA Paraformaldehyde 
Pi inorganic phosphate  
PI Propidium iodide  
PLAT Tissue plasminogen activator 
PLAU Urokinase-type plasminogen activator 
PTPRU Receptor-type tyrosine-protein phosphatase PCP-2 
PyMT Polyoma middle T oncogene 
qPCR  quantitative PCR 
RIN RNA Integrity number   
RNA Ribonucleic acid 
ROCK Rho-associated coiled-coil containing kinase 
ROI Region of Interest 
rpm  Revolutions per minute  
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RTCA Real-Time Cell Analyzer  
Scar Suppressor of cAMP receptor 
SCC Squamous cell carcinoma  
SDS Sodium dodecyl sulfate  
Sel Selected 
SEM Scanning electron microscopy 
SEM Standard error of mean 
Ser Serine 
SRB Sulforhodamine B  
t1/2  half time 
TCA Trichloroacetic acid  
TEM Transmission electron microscopy  
TGFβ Transforming growth factor beta 
Thr Threonine 
TIRF Total Internal Reflection Fluorescent Microscopy 
TNF Tumour necrosis factor 
TNFSF15 TNF superfamily member 15 
U Unit 
µg microgram 
µm micrometre 
µM micromolar 
uPA  Urokinase 
v volume 
V Volts 
VEGF Vascular endothelial growth factor 
w weight 
WASP Wiskott–Aldrich syndrome protein 
WCS Whole Cell Stain 
ZEB 1/2 Zinc finger E-box-binding homeobox 1/2 
β-2-M Beta-2 microglobulin 
 
 
 
1 Introduction 
1.1 Cancer cell metastasis 
Cancer cell metastasis is a complex and multistep process in which malignant 
cells spread from primary tumour sites to distant organs (Gupta and Massague 
2006; Steeg 2006). Metastasis is one of the hallmarks of cancer, and it has been 
suggested that it is responsible of 90% of deaths among cancer patients. 
Therefore, it is very important to understand what factors drive cancer cell 
metastatic behaviours and to find therapeutic targets to block it (Hanahan and 
Weinberg 2011). In order to obtain invasive traits, cancer cells undergo many 
intrinsic genetic and epigenetic changes which occur in response to 
microenvironmental barriers (Chambers, Groom et al. 2002; Feinberg, Ohlsson et 
al. 2006; Bartek, Lukas et al. 2007). Such barriers can be divided into: chemical 
barriers, such as hypoxia, presence of reactive oxygen species, low pH; physical 
barriers, such as basement membrane, tensional forces; and biological barriers, 
such as immune surveillance and inhibitory cytokines (Chambers, Groom et al. 
2002; Harris 2002; Hussain, Hofseth et al. 2003; Paszek, Zahir et al. 2005; Gupta 
and Massague 2006). The main consequences of an acquired invasive phenotype 
are reduced adhesion, increased cell motility and an ability to invade 
surrounding tissues. Cells which acquire such properties in primary tumours, in 
order to migrate from one body part to the other, perform the following cascade 
of steps: invasion into the surrounding environment, intravasation into the blood 
or lymphatic microvasculature, survival in circulation, extravasation into distant 
tissue, survival in the foreign tissue, and adaptation to its conditions (Figure 1-1) 
(Chambers, Groom et al. 2002; Fidler 2003).  
1.1.1 Invasion into surrounding environment 
In the first step of the metastatic cascade, cancer cells invade into the 
surrounding tumour-associated stroma. In order to do this, epithelial tumour 
cells lose the tight organisation of epithelial tissue by turning on the epithelial-
to-mesenchymal transition (EMT) program (Thiery, Acloque et al. 2009). EMT 
leads to loss of cell polarity and disintegration of adherens and tight junctions. 
EMT can occur upon activation of transcription factors such as Slug, Snail, Twist, 
ZEB1, and ZEB2 (Thiery, Acloque et al. 2009). Some of these transcription 
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factors repress levels of E-Cadherin, which bond, epithelial cells together 
(Cavallaro and Christofori 2004). However, it has been reported that EMT is not 
necessary for metastasis to occur (Fischer, Durrans et al. 2015; Zheng, Carstens 
et al. 2015). Once tumour cells reduce their intracellular adhesiveness, they can 
disrupt the basement membrane (BM) which provides a specialized ECM structure 
underlying epithelial and endothelial cell layers, as well as a physical barrier for 
cancer cells (Bissell and Hines 2011). Some tumour cells are able to degrade the 
BM by production, secretion and activation of matrix metalloproteinases (MMPs) 
(Egeblad and Werb 2002; Kessenbrock, Plaks et al. 2010). In normal tissues, the 
expression of MMPs is tightly controlled, whereas cancer cells disturb this 
regulation and are able to proteolytically degrade the BM and enter the stroma 
(Kessenbrock, Plaks et al. 2010). Stromal tissue mainly consists of fibroblasts and 
myofibroblasts, endothelial cells, adipocytes, and immune cells (Grivennikov, 
Greten et al. 2010). Some of the components of stromal tissue have the 
potential to boost the metastatic capabilities of cancer cells. For example, 
interleukin-6 secreted by adipocytes enhance the invasiveness of breast cancer 
cells (Dirat, Bochet et al. 2011), while the production of chemokine CXCL12 by 
breast cancer associated fibroblasts increased the proliferation and migratory 
ability of cancer cells and promoted angiogenesis (Allinen, Beroukhim et al. 
2004; Orimo and Weinberg 2006).  
1.1.2 Intravasation into vasculature 
Highly motile cancer cells migrate towards blood vessels due to the presence of 
naturally occurring chemoattractant gradients (Bockhorn, Jain et al. 2007; 
Leung, Xue et al. 2016). The mechanism of intravasation - entering blood or 
lymphatic vessels, may be augmented by overexpression of vascular endothelial 
growth factors which stimulate the formation of new blood vessels (Carmeliet 
and Jain 2011). Endothelial cells which form the neovasculature are weaker in 
their adjacent organisation compared to the normal vasculature, moreover they 
lack pericyte coverage, which makes them leakier and more likely to facilitate 
intravasation (Gupta, Nguyen et al. 2007). Additionally, intravasation into the 
blood or lymphatic vessels can be facilitated by external factors including 
transforming growth factor-β (TGFβ) (Giampieri, Manning et al. 2009) or 
epidermal growth factor (EGF) (Wyckoff, Wang et al. 2007). 
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1.1.3 Survival in blood circulation 
Once cancer cells enter the circulation they become circulating tumour cells 
(CTCs) (Nagrath, Sequist et al. 2007; Pantel, Brakenhoff et al. 2008). Shedding 
of tumour cells into the circulation may occur in large numbers and from early 
stages of tumour formation, however only minority of these cells would be able 
to survive and form metastatic sites in distant organs (Lambert, Pattabiraman et 
al. 2017). In order to survive in the blood stream, CTCs must withstand many 
stresses related to loss of cell-matrix interaction as well as shear stress, 
compressive blood pressure, and immune surveillance. In the absence of 
adhesive supports, normal epithelial cells undergo anoikis – a form of cell death, 
whereas some CTCs have the ability to escape this process by triggering 
signalling pathways, such as the phosphatidylinositol-3-OH kinase/protein kinase 
B pathway (Kang and Pantel 2013). Additionally, cancer cells due to their large 
size (20-30 µm) may be trapped in the various capillaries (~8 µm diameter) 
within minutes after intravasation, therefore the time necessary to provoke 
anoikis process is short (Meng, Tripathy et al. 2004). Furthermore, in order to 
avoid being “eaten” by cells of the innate immune system, and to withstand 
physical hemodynamic forces, CTCs are able to become platelet-coated tumour 
cells called emboli. Platelets create a protective coat on the CTC surface, and in 
this way they increase the metastatic potential of CTCs (Nash, Turner et al. 
2002; Gupta, Nguyen et al. 2007; Joyce and Pollard 2009). 
1.1.4 Extravasation into distant tissue 
The extravasation process enables cancer cells to escape the circulation and 
enter distant tissues.  The vasculature at the distant site is not as leaky as the 
neovasculature created by tumour cells, therefore to overcome such physical 
barriers cancer cells secrete factors which induce vascular hyperpermeability as 
well as disrupting the tight endothelial organisation (Carmeliet and Jain 2011). 
For example, breast cancer cells secrete factors like MMP-1, MMP-2 and COX-2 
which help to disturb pulmonary endothelial cell junctions in order to 
extravasate into the lungs (Padua, Zhang et al. 2008; Carmeliet and Jain 2011). 
Moreover, some cancer cells in primary tumours are able to secrete 
premetastatic factors like MMP-3, VEGF and angiopoietin 2 (Angpt2), which help 
to induce pulmonary hyperpermeability prior to cancer cell arrival to the lungs 
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(Weis, Cui et al. 2004; Huang, Song et al. 2009). Furthermore, once trapped in 
the vasculature, cancer cells have the ability to grow up to the point where they 
rupture the walls of the surrounding vasculature and are placed directly in the 
foreign tissue parenchyma (Al-Mehdi, Tozawa et al. 2000).  
1.1.5 Survival and adaptation to the foreign tissue 
Due to the fact that foreign tissue environments are different from primary 
tumour environments, cancer cells are not necessarily well adapted to their new 
metastatic sites. In order to overcome this issue, it was proposed that some 
cancer cells may release pre-metastatic signals which prepare the sites of 
metastasis before tumour cells start disseminating (Psaila and Lyden 2009). Once 
tumour cells survive in the foreign tissue, some of them may stay in a state of 
long-term dormancy due to limited access to blood vessels or lack of 
biocompatibility between cancer cells and the foreign microenvironment 
(Chambers, Groom et al. 2002). To escape the dormancy state and colonize the 
new tissue, cancer cells must have the ability to interact with the new 
environment, and be able to release growth and survival factors. Different tissue 
present different requirements for the cancer cells to be able to proliferate and 
create new metastatic sites, therefore it has been proposed that cancer cells 
present organ-specific metastatic tropism, for example breast cancer spread to 
bones, lungs, brain and liver, prostate cancer mostly metastasise to the bones, 
while melanoma cancer cells spread to the brain and lungs (McAllister, Gifford et 
al. 2008; Hiratsuka, Goel et al. 2011). 
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Figure 1-1 Cancer cell metastatic cascade. 
The image illustrates cancer cell spread from a primary tumour to a distant site in the body. In the 
first step of the metastatic cascade – invasion, cancer cells lose their epithelial organisation and 
invade through the basement membrane into the stromal tissue and subsequently invade through 
its tight organisation. Stromal tissue is composed of collagen, fibroblasts, myofibroblasts, 
adipocytes and immune cells. In the next step, cancer cells intravasate into blood or lymphatic 
vessels. If cancer cells survive their journey through the circulation, they extravasate and colonize 
foreign tissue.  Image generated using Servier Medical Art. 
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1.2 Cancer cell migration in confinement 
The first crucial step of the metastatic cascade is invasion into the surrounding 
stroma. Abnormal cell migration plays a pivotal role in this step. Many 
mechanistic and regulatory studies of cells moving on two-dimensional (2D) 
substrates have been undertaken, however three dimensional (3D) cell motility 
is the key migration type in vivo. Depending on the size of spaces present in the 
ECM and cancer cell invasion abilities, cells can utilize different invasion modes 
(mesenchymal, amoeboid or collective). Cancer cells can move as individual 
cells or as a solid multicellular complex, or they can switch between migration 
types depending on the environmental properties. Such ability to change in 
response to varying conditions is referred to as cell plasticity. Some tracks/pores 
provide a path of least resistance for migrating cells, in which case cancer cells 
don’t need to remodel the surrounding matrix to widen the matrix pore. 
However, to move through spaces smaller than the migrating cells, cancer cells 
need to remodel the ECM by proteolysis mediated by enzymes such as matrix 
metalloproteinases (Stetler-Stevenson, Aznavoorian et al. 1993; Friedl 2004), 
and/or squeeze through the tight pore structures by deforming itself (Wolf, Mazo 
et al. 2003). 
1.2.1 Extracellular matrix confinement 
Cancer cells migrating through extracellular matrix (ECM) encounter varying 
degrees of confinement. Spaces present in the ECM form tunnel-like tracks or 
pores. The size of the tracks/pores present in the extracellular environment is 
comparable or smaller to the diameter of migrating cells; ranging from 0.1 to 30 
µm (Doerschuk, Beyers et al. 1993; Weigelin, Bakker et al. 2012). Tracks or 
pores exist naturally in healthy tissues, they can occur as spaces along or within 
blood vessels (Lugassy, Zadran et al. 2014), between muscle and nerve fibres 
(Weigelin, Bakker et al. 2012) or between collagen fibres (Gritsenko, Ilina et al. 
2012) (Figure 1-2), or they may be created by tumour-associated fibroblasts and 
macrophages. As an example, it was reported that fibroblasts can create tracks 
in collagen/matrigel matrices by proteolytic degradation and force-mediate 
remodeling, leading to enhanced collective invasion of squamous cell carcinoma 
(SCC) cells (Gaggioli, Hooper et al. 2007). Moreover, cancer-associated 
fibroblasts co-cultured with adenoid cystic carcinoma (ACC) cells in microfluidic 
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devices created proteolytically degraded tracks within matrigel, which promoted 
invasion of ACC cells (Li, Jia et al. 2016). Matrix remodeling can also occur at 
future pre-metastatic sites, leading to pre-metastatic site formation by bone-
marrow derived macrophages (Costa-Silva, Aiello et al. 2015). 
Tracks/pores present in the ECM may also facilitate cancer metastasis in vivo, as 
described in numerous studies in which cancer cell migration was imaged in 
primary tumours. For instance, using multiphoton microscopy, it was observed 
that highly metastatic CFP-expressing rat mammary adenocarcinoma MTLn3 cells 
injected into mammary glands moved more frequently along collagen fibres 
compared to low metastatic GFP-expressing MTLn3 cells (Sahai, Wyckoff et al. 
2005) and more importantly, metastatic MTLn3 cells were associated with higher 
extravasation into the lungs (Wang, Goswami et al. 2004).  Similar observations 
were made by imaging polyoma middle T oncogene (PyMT)-derived mammary 
tumours, where it was observed that GFP-labelled tumour cells migrated along 
collagen matrix fibres and around blood vessels. Moreover, human glioma cells 
injected into the brain migrated through perivascular space and white matter 
tracks (Cuddapah, Robel et al. 2014). Additionally, melanoma cells injected 
intra-arterially that successfully extravasated into the brain used cerebral 
microvessels as the main structures for migration and proliferation (Bentolila, 
Prakash et al. 2016).  Migration through pores present in stromal tissue also has 
clinical pertinence. As an example, Provenzano et al. showed that collagen 
aligned in the perpendicular orientation to the tumour boundary facilitated 
cancer cell invasion (Provenzano, Eliceiri et al. 2006) and such stromal collagen 
organization was associated with poor survival of breast cancer patients 
(Conklin, Eickhoff et al. 2011).  
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Figure 1-2 Microenvironments for confined migration in vivo. 
The image illustrates different confined migration paths present in vivo. Cancer cells may migrate in 
spaces present between muscle fibres, along and within blood vessels, between fibrillar collagen 
fibres and between neighbouring cells. Image adapted from (Paul, Mistriotis et al. 2017). Image 
generated using Servier Medical Art.  
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1.2.2 Modes of cancer cell migration / invasion 
The mesenchymal mode of invasion is one of the types of individual cell invasion 
(Figure 1-3). It occurs after completion of the epithelial to mesenchymal 
transition (EMT) program. It is characterized by elongated, fibroblast-like 
morphology with established cell polarity, and is dependent on proteolytic 
degradation of ECM (Friedl and Wolf 2003; Friedl 2004). Using this type of 
invasion, cells move relatively slowly, 0.1-1 µm/min. Such invasion mode has 
been detected in fibrosarcoma, glioblastoma and melanoma (Friedl and Wolf 
2003; Sanz-Moreno and Marshall 2009; Thomas, Monturo et al. 2011). 
Mesenchymal cells employ a five-step cycle in order to migrate: pseudopod 
protrusion, formation of focal contacts, proteolysis of ECM, acto-myosin 
contraction and detachment of the trailing edge (Friedl and Wolf 2003). 
Protrusion occurs upon activation of Rac1 and Cdc42 GTPases, which activates 
the Arp2/3 complex that drives actin polymerization at the front of the cell 
(Ridley, Schwartz et al. 2003), (O'Connor and Chen 2013). Cells utilizing this type 
of migration create tracks in the ECM by using proteases, such as MMPs and 
plasminogen activator (uPA) (Nabeshima, Inoue et al. 2002; Tang and Han 2013). 
Focal adhesions provide a contact between the actin cytoskeleton and the 
external environment through the interaction of transmembrane proteins, such 
as integrins, with their extracellular ligands, and intracellular protein complexes 
linked to the actin cytoskeleton. Focal adhesion formation is initiated upon the 
binding of adhesion receptors to extracellular matrix (ECM) ligands 
(e.g. fibronectin, vitronectin, collagen) along the cell periphery usually at the 
protruding edge of a cell. Attachment of the cell to the ECM components induces 
clustering of integrins on the cell surface. Clustered integrins act as a platform 
for the recruitment of cellular proteins, such as paxillin, talin, tensin, p130Cas 
which provide strong linkages to the actin cytoskeleton, thereby connect cells 
firmly to the ECM (Nagano, Hoshino et al. 2012; Burridge and Guilluy 2016). 
The amoeboid mode of invasion is the second type of individual cell invasion 
(Figure 1-3). It is characterized by rounded cell morphology and “a crawling” 
type of movement, with which cells are able to squeeze between spaces present 
in the ECM (Sabeh, Shimizu-Hirota et al. 2009). Cells utilizing this migration 
mode move at relatively high speeds, up to 4 µm/min (Friedl and Wolf 2003). 
Such invasion type has been observed in breast cancer, lymphoma, prostate 
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carcinoma, melanoma and sarcoma (Condeelis and Segall 2003; Friedl and Wolf 
2003; Belletti, Nicoloso et al. 2008; Sanz-Moreno and Marshall 2009). The main 
features of amoeboid migration are loss of cell polarity, loose attachment to the 
ECM, very little to no formation of stress fibres and MMP-independent 
movement. Amoeboid migration is driven by cortical actin polymerization which 
occurs through Rho-ROCK signalling where myosin activation promotes quick 
remodeling of cortical actin (Sahai and Marshall 2003). 
Collective modes of invasion are characterized by the migration of whole sheets, 
strand or tubes of cancer cells as whole structures or separated clusters (Friedl 
and Wolf 2008) (Figure 1-3). Such a mode of migration has been observed in 
breast, colorectal, melanoma cancers and other type of carcinomas (Nabeshima, 
Inoue et al. 1999; Hegerfeldt, Tusch et al. 2002; Wolf, Wu et al. 2007). From a 
mechanistic point of view, this type of migration is similar to the mesenchymal 
form where a leading cell degrades the ECM and creates a path for follower cells 
(Wolf, Wu et al. 2007). The main features of collective movement are 
degradation of the ECM by MMPs, maintenance of adherence junctions between 
cells, and coordinated action of actin cytoskeleton, acto-myosin contraction, 
cell polarity and cell surface receptors (Friedl and Wolf 2008).  
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Figure 1-3 Different modes of cancer cell invasion. 
The image represents three main types of cancer cell invasion: mesenchymal, amoeboid and 
collective. Image generated using Seriver Medical Art. 
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1.2.2.1 Actin cytoskeleton  
Cell motility is a complex and dynamic process involving many changes in cell 
cytoskeleton architecture and coordination of many signalling pathways. This 
multistep process is initiated by external stimuli, which can be signals from 
neighbouring cells, extracellular matrix or diffusible factors. The main engine of 
cellular migration are actin microfilaments which build the cell cytoskeleton 
(Olson and Sahai 2009). F-actin filaments are formed by polymerization of 
globular monomeric actin (G-actin) subunits. Each actin filament has a positive, 
“barbed” end where G-actin subunits are added, and a negative “pointed” end 
which undergoes depolymerization. The critical concentration (Cc) of free G 
actin subunits determines whether the actin filament ends grow or shrink. When 
the polymerization and depolymerization of actin filaments is in equilibrium, the 
subunit concentration at the plus end is higher than the Cc, while the subunits 
concentration at the minus end is lower than the Cc. The maintenance of pre-
existing actin filaments at equilibrium is called actin treadmilling. During this 
process, adenosine triphosphate (ATP)-loaded G-actin subunits associate with a 
positive end of the filament where over time the ATP is hydrolyzed to ADP and 
inorganic phosphate (Pi). The ADP-incorporated F-actin undergoes 
depolymerization at the “pointed” end. The ADP on released G-actin monomers 
is exchanged for ATP and the ATP-loaded G-actin can be re-incorporated into the 
positive end of F-actin (Pollard and Borisy 2003; Olson and Sahai 2009) (Figure 
1-4).  
There are many actin binding proteins that are associated with the assembly and 
disassembly of F-actin but the main players are summarized here. The Arp2/3 
complex is activated by WASP/Scar proteins (Van Troys, Huyck et al. 2008), 
leading to nucleation of actin filaments to create a branched filament network. 
Gelsolins belong to a family of capping proteins, which bind and block the 
barbed ends of actin filaments; moreover they have F-actin severing activity 
(Van Troys, Huyck et al. 2008). Formins bind to barbed ends of F-actin and 
prevent its blocking by capping proteins; moreover they are involved in F-actin 
elongation (Breitsprecher and Goode 2013). Profilin  is a G-actin binding protein 
that promotes polymerization and depolymerisation of F-actin (Nejedla, Sadi et 
al. 2016). ADF/Cofilin family proteins have the ability to sever F-actin filaments 
and to increase spontaneous polymerization (Bamburg and Bernstein 2010). 
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Figure 1-4 Actin filament polymerization and depolymerization. 
Image illustrates actin polymerization and depolymerization process. During this process, 
adenosine triphosphate (ATP)-loaded G-actin subunits associate with a positive end of the actin 
filament where over time the ATP is hydrolyzed to ADP and inorganic phosphate (Pi). The ADP-
incorporated F-actin undergoes depolymerization at the negative end. 
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There are many intracellular pathways that regulate the cell migration process, 
but Rho GTPases are known to be the key players (Figure 1-5) (Figure 1-6).  
The RhoA-like cluster of proteins consist of RhoA, RhoB and RhoC GTPases which 
share ~85% of sequence homology and has been well studied in cell migration 
(Michaelson, Silletti et al. 2001). During cell migration Rho activity is associated 
with cell body contraction and rear end retraction and mostly known to be 
involved in so called amoeboid type of migration (Ridley 2015; Carlier and 
Shekhar 2017). Important Rho effectors are the Ser/Thr ROCK1 and ROCK2 
kinases that phosphorylate myosin light chains (MLC) leading to bundling of actin 
fibres and clustering of integrins into focal adhesions (auf dem Keller, Huber et 
al. 2006; Burridge and Guilluy 2016). ROCK kinases also phosphorylate myosin-
binding subunits (MBS) of the myosin light chain phosphatase (MLCP) inhibiting 
its activity and enhancing MLC phosphorylation (Hartmann, Ridley et al. 2015). 
Myosin light chain phosphorylation is also regulated by the calcium-dependent 
myosin light chain kinase (MLCK).  ROCK kinases also phosphorylate and activate 
LIM kinases (LIMK1 and LIMK2) that in turn inactivate the actin-severing activity 
of cofilin leading to F-actin accumulation and stabilization (Oser and Condeelis 
2009).  
The Rac-like cluster of proteins consists of Rac1, Rac2 and Rac3 GTPases which 
share ~88% of homology (Jordan, Brazao et al. 1999). In cell migration, Rac 
GTPases are known to be involved in lamellipodia formation and membrane 
ruffles, and the mesenchymal type of migration characterized by elongated 
spindle-shaped cell morphology. A key role for Rac proteins is to induce actin 
polymerization in the front of migrating cells producing essential force in order 
to move cell forward (Eden, Rohatgi et al. 2002). Rac-dependent actin 
polymerization occurs via many effector proteins, which when leads to the 
initiation of actin polymerization. The actin-nucleating protein complex that can 
be indirectly triggered by Rac is the Arp2/3 complex, which is known to 
stimulate the formation of new actin branches, either de novo or at the barbed 
ends or sides of existing actin filaments (Goley and Welch 2006). Rac also 
induces the uncapping of barbed ends of actin filaments, thereby creating free 
ends necessary for actin assembly (Hanna and El-Sibai 2013). 
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The Cdc42 GTPase is known to be involved in the regulation of cell polarity and 
filopodia formation (Gupton and Gertler 2007). Filopodia are dynamic finger-like 
actin filament-bundled protrusions, which are thought to be responsible for 
extracellular sensing and transmitting signals back to the cell body to initiate 
actin polymerization. Cdc42 acts via Wiskott-Aldrich syndrome protein (WASP) 
leading to activation of the Arp2/3 complex (Hanna and El-Sibai 2013). 
Subsequently, it has been reported that mDia and IRSp53 are also downstream 
targets of Cdc42 and their activation leads to filopodia formation (Wu, 
Quondamatteo et al. 2006; Cory and Cullen 2007). 
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Figure 1-5 Rho GTPases and cell protrusion. 
The image represents filamentous actin structures and Rho GTPase protrusion control. MDA MB 
231 human breast cancer cells were fixed and stained for F-actin using phalloidin. The image was 
acquired on a Zeiss 880 microscope.  
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Figure 1-6 RhoGTPases and their role in organising actin cytoskeleton. 
The image illustrates the downstream effectors of Rho proteins and mechanisms affecting actin in 
a migrating cell. 
37 
 
1.3 Cell elasticity 
Changes in cell mechanical properties are often associated with health or 
disease states (Lee and Lim 2007). Diseases not only change cell biological 
properties, but also their physical and structural characteristics. In some  
diseases and pathologies, including sickle cell anaemia, spherocytosis and 
malaria; erythrocyte stiffening and increased viscosity have been observed and 
are believed to be causally linked with pathophysiological outcomes (Lee and 
Lim 2007). Additionally, cell mechanical changes have also been observed in 
cancer. For example, it was reported that cancer cells are softer compared to 
normal cells, and highly metastatic cancers are more easily deformed than less 
metastatic cancer cells (Doerschuk, Winn et al. 1990; Faria, Ma et al. 2008; Li, 
Lee et al. 2008). Such changes in the mechanical properties of cancer cells may 
play an important role in the metastatic cascade. An advantage of greater 
elasticity is thought to be increased cell deformability that enables passage 
through physical constraints to facilitate local tissue invasion and metastasis 
(Doerschuk, Winn et al. 1990; Cross, Jin et al. 2008). A change in cancer cell 
stiffness often is a result from changes in actin organisation (Li, Lee et al. 2008; 
Palmieri, Lucchetti et al. 2015).  
The cytoskeleton plays not only an important role in creating cell shape, 
directing migration and invasion, but also plays a major role in regulating cell 
mechanical properties. The main structural components of the three types of 
cytoskeleton (actin, microtubule and intermediate filament) exhibit unique 
viscoelastic properties when measured as purified cytoskeletal preparations 
(Gittes, Mickey et al. 1993; Janmey, Hvidt et al. 1994; Kojima, Ishijima et al. 
1994).  The main determinant of cellular mechanics is the actin cortex, a rich 
layer of actin meshwork which lies directly beneath the plasma membrane 
(Bordeleau, Alcoser et al. 2014; Tao, Li et al. 2017). The actin cortex is 
composed of filamentous actin, myosin motors and actin-binding proteins, which 
undergo continuous turnover of their components during polymerization and 
depolymerization, cell adhesion and acto-myosin contraction processes. This 
continuous reorganisation allows the cells to quickly respond and adapt to 
external cues and biochemical signalling (Kunda, Pelling et al. 2008; Stewart, 
Helenius et al. 2011). The involvement of cytoskeletal components in the 
regulation of cell mechanical properties was demonstrated using drugs which 
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disrupt cytoskeletal organisation, for example latrunculins or cytochalasins. 
Latrunculins are toxins produced by some marine sponges which prevent actin 
polymerization by binding to actin monomers and preventing their re-
incorporation into actin filaments (Morton, Ayscough et al. 2000). Cytochalasins 
are fungal metabolites which prevent actin polymerization and elongation 
(Goddette and Frieden 1986). Cells treated with actin-disrupting agents showed 
a decrease in their elastic modulus (Rotsch and Radmacher 2000; Vargas-Pinto, 
Gong et al. 2013). 
Additionally, as well as density and length of actin filaments, the ordering of the 
actin filaments determinate the cell cortical mechanics. Cells with more aligned 
actin fibres (also called nematic or anisotropic organisation) are characterized 
by increased cell stiffness, while cells with more disorganised actin structure 
(also called isotropic organisation) are characterized by decreased cell stiffness 
(Gupta, Sarangi et al. 2015). Although the actin cytoskeleton is a major 
determinant of cell elasticity, the mechanistic pathways responsible for cell 
stiffness changes in cancer have not yet been identified. 
There are many techniques available to study cell mechanical properties, 
including Atomic Force Microscopy (AFM), optical tweezers and micropipette 
aspiration (Addae-Mensah and Wikswo 2008).  
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1.4 Nuclei in confinement 
As described above, confinement highly influences cell movement. Small pores 
present in the ECM may become challenging for a cell to pass through. In fact, 
cell body components like the plasma membrane, cytoplasm, small organelles 
and cytoskeleton are sufficiently elastic to tailor their shape and fit through 
available spaces (Wolf, Te Lindert et al. 2013). However, distortion of the 
nucleus is much more challenging. The nucleus is the largest and most rigid 
organelle of the cell and consequently it can become an obstacle for migrating 
cancer cells (Lammerding 2011; Martins, Finan et al. 2012). There were many 
studies done showing the importance of nuclear properties in confined 
migration. Using microfabricated channels with varying degree of confinement, 
it was reported that cells migrated with higher speed through wider channels 
while migration through constrictions smaller than 5 µm resulted in decreased 
cell speed and required stronger nuclear deformation (Fu, Chin et al. 2012; 
Tong, Balzer et al. 2012; Davidson, Denais et al. 2014). 
1.4.1 Role of nuclear lamina in nuclear translocation 
The nuclear lamina is a dense protein network underlying the inner nuclear 
membrane. Mammalian cells express two types of lamin; lamin A-types (lamins A 
and C) and lamin B-types (lamins B1 and B2) (Shimi, Pfleghaar et al. 2008). Both 
lamin A and B-types contribute to the overlying protein mesh that, in addition to 
having an impact on chromatin organization, DNA damage repair and 
transcriptional regulation (Shimi, Pfleghaar et al. 2008; Ho and Lammerding 
2012; Solovei, Wang et al. 2013), also influences the physical properties and 
shape of the nucleus. The ratio of A-type lamin to B-type lamin in the nuclear 
lamina is proportional to tissue microelasticity. The lamina contains 
predominantly A-type lamins in stiff tissue, whereas B-type lamins are prevalent 
in the nuclear lamina in soft tissue. The nuclear mechanical response has been 
characterized as a combination of elastic and viscous properties with B-type 
lamins contributing primarily to the elastic response and A-type lamins 
contributing to the viscosity (Swift and Discher 2014; Swift et al. 2013).  Using 
cell-stretching and micropipette aspiration techniques, it was reported that A-
type lamins have greater influence on nuclear elasticity than B-type lamins. 
Mouse embryonic fibroblasts lacking lamin A and C had more deformed nuclei 
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and lower nuclear stiffness, while fibroblasts lacking lamin B1 had greater 
numbers of nuclear blebs but with physical properties that were not affected 
(Lammerding, Fong et al. 2006; Mitchell, Denais et al. 2015). In terms of 
confined cell migration, some studies reported that cells with decreased levels 
of lamin A/C migrated faster through constrictions smaller than the size of the 
nucleus (Harada, Swift et al. 2014). In contrast, increased expression of lamin 
A/C resulted in an opposite effect, it impaired the migration rate of neutrophils 
through micron-scale constrictions (Rowat, Jaalouk et al. 2013). Loss of lamin 
A/C expression did not affect nuclear size but rather nuclear translocations 
through small constrictions. Thus, nuclear stiffness may adjust to the structure 
of extracellular environment during cell migration through changes in lamin gene 
expression and contribute to cancer metastasis. Indeed, it has been observed 
that lamin gene expression was deregulated in many cancers (Hutchison 2014). 
1.4.2 Role of chromatin in nuclear translocation 
Besides lamins, the nuclear interior also plays a significant role in nuclear 
rigidity. Chromatin fibres occupy most of the nuclei space and, despite a major 
role in regulating genetic processes, such as transcription, there are also studies 
suggesting that it may affect the mechanical properties of the nucleus and 
subsequently alter cell migration. Chromatin fibres consist of DNA, proteins and 
RNA. DNA, in order to fit inside a small nucleus, is wrapped around histone 
octamers called nucleosomes, which are built of two copies of each histone 
protein: H2B, H2A, H3, and H4 and a linker DNA creating a “beads on a string”-
like structure (Dahl, Engler et al. 2005; Bhaumik, Smith et al. 2007; Pajerowski, 
Dahl et al. 2007). To create higher-order chromatin structure, nucleosomes can 
interact with linker histones like H1 and other non-histone proteins (Bustin, 
Catez et al. 2005). All histones have a positively charged N-tail which sticks out 
from the surface of the chromatin and provides many lysine and arginine 
residues which can undergo post-translational modifications, such as 
methylation, acetylation, phosphorylation, ubiquitination, sumoylation or ADP 
ribosylation. Such modifications can modify DNA-histone interactions and affect 
the level of chromatin compaction (Luger, Mader et al. 1997; Kouzarides 2007; 
Kusch and Workman 2007). During interphase, chromatin can be found in two 
states: euchromatin and heterochromatin. Euchromatin is lightly condensed and 
actively transcribed, while heterochromatin is a tightly packed, and 
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transcriptionally silent, usually found at the periphery of the nucleus, typically 
associated with the nuclear lamina (Guelen, Pagie et al. 2008). Heterochromatin 
is subdivided into two types: constitutive heterochromatin which contains non-
coding sequences and repetitive elements; and facultative form of 
heterochromatin which consists mainly of silenced genes, but which has the 
potential to be turned into transcribed euchromatin (Allis and Jenuwein 2016). 
Those two types of chromatin are discriminated by particular patterns of 
modification in the tail core of histones (Guelen, Pagie et al. 2008).  
Several studies identified that chromatin structure and the level of its 
condensation determine nuclear size and stiffness (Gruenbaum, Margalit et al. 
2005). Treatment of isolated nuclei with the chelating agent EDTA led to 
chromatin decondensation, nuclear swelling and decreased stiffness, while 
condensation of chromatin by addition of divalent cations led to nuclear 
shrinking and increased stiffness. (Dahl, Engler et al. 2005). Using the 
micropipette aspiration technique it was also reported that the nuclei of 
embryonic stem cells, which contained relatively lower levels of condensed 
chromatin, are softer compared to nuclei of differentiated cells which had more 
packed forms of chromatin, although nuclei of differentiated cells also 
expressed more lamin A and C (Pajerowski, Dahl et al. 2007; Rowat, Lammerding 
et al. 2008). In terms of cell migration, it was shown that directed cell migration 
required global chromatin condensation as it was observed by increased staining 
of heterochromatin marker trimethylation of Lys9 in H3 histone (H3K9me3) 
(Gerlitz, Livnat et al. 2007). Moreover, induction of cell migration increased the 
levels of two other heterochromatin markers trimethylation of Lys27 in histone 
H3 (H3K27me3) and mono-methylation on Lys10 in histone H4 (H4K20me1). 
However the level of euchromatin markers trimethylation of Lys4 in histone H3 
(H3K4me3) and acetylation of Lys9 in histone H3 (H3K9ac) were not changed 
(Gerlitz and Bustin 2010); suggesting that cell migration is contingent on global 
chromatin condensation. In addition, chromatin decompaction led to decreased 
rates of cell migration independent of changes in transcriptional level (Gerlitz 
and Bustin 2010). 
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1.5 MAPK signalling pathway  
The mitogen–activated protein kinase (MAPK) pathways control fundamental 
cellular processes such as proliferation, differentiation, migration and cell 
death. There are four distinct MAPK signalling cascades which are named 
according to their terminal serine/threonine kinases: ERK1/2, the c-Jun amino-
terminal kinases (JNK1/2/3), p38 kinases and ERK5 (Johnson and Lapadat 2002; 
Roberts and Der 2007). All of the four MAPK pathways are comprised of three 
protein kinases and are regulated by phosphorylation cascades; MAPK is 
activated upon phosphorylation by mitogen-activated protein kinase kinase 
(MAPKK) which in turn is phosphorylated by mitogen-activated protein kinase 
kinase kinase (MAPKKK) (Figure 1-7). The ERK pathway is typically activated by 
growth factors, whereas JNK, p38 and ERK5 pathways by growth factors, stress 
and cytokines. Activation of MAPK pathways leads to the activation of many 
transcription factors such as Elk-1, ATF-2, Ets-2, thereby leading to changes in 
gene expression profiles (Kyriakis and Avruch 2001; Dhillon, Hagan et al. 2007). 
The ERK pathway is the best studied MAPK signalling pathway and it is 
deregulated in one-third of all human cancers (Dhillon, Hagan et al. 2007). 
Various extracellular stimuli and internal processes activate the MAPK/ERK 
pathway. Ligand binding to receptor tyrosine kinases, for example epidermal 
growth factor receptors (EGFR), leads to receptor dimerization, 
autophosphorylation and the subsequent binding of receptor-bound protein 2 
(GBR2). Such interaction recruits binding of the nucleotide exchange factor SOS 
at the plasma membrane. Activated SOS promotes the displacement of GDP from 
Ras, allowing for GTP binding and activation of membrane associated Ras. GTP-
bound Ras combines with Raf and phosphorylates MEK1 and MEK2, which in turn 
activate ERK1 and 2 kinases. Activated ERK kinases translocate into the nucleus 
and activate transcription factors leading to expression of genes involved in the 
regulation of cell proliferation, migration, angiogenesis and survival (Chong, 
Vikis et al. 2003; Wellbrock, Karasarides et al. 2004; Meloche and Pouyssegur 
2007; Mebratu and Tesfaigzi 2009) (Figure 1-7). 
There are three human RAS genes designated as H-RAS, N-RAS and K-RAS. All of 
them belong to a class of proteins called small GTPases, which act as molecular 
switches and control the activity of many signalling pathways (Santarpia, 
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Lippman et al. 2012). Ras oncogenes are frequently mutated in many human 
cancers with the most common mutations occurring at the codons 12, 13 or 61. 
Such mutations lead to the formation of GTPase-activating protein (GAP)-
insensitive and constitutively active Ras proteins, and consequent continuous 
activation of downstream effectors (Hancock 2003; Dhillon, Hagan et al. 2007).  
RAF kinases are serine/threonine specific kinases. There are three members of 
this family, B-Raf, A-Raf and Raf1 (c-Raf) (Maurer, Tarkowski et al. 2011). Upon 
activation by GTP-loaded Ras proteins, Raf proteins are translocated from 
cytosol to the plasma membrane. The recruitment to the plasma membrane is an 
essential step in Raf activation (Lavoie and Therrien 2015). There is little data 
on A-Raf mutations in cancers. Although Raf-1 is known as a potent oncogene, B-
Raf is the major player in human carcinogenesis. B-Raf is frequently mutated in 
various human cancers, most frequently in melanoma, malignant thyroid and 
colon carcinomas (Maurer, Tarkowski et al. 2011). The most common B-Raf 
mutation occurs at codon 600, leading to valine (V) being substituted by 
glutamate (E) (Davies, Bignell et al. 2002).  
Due to the fact that MAPK/ERK pathway components (e.g. Ras and Raf) are 
frequently mutated or overexpressed (e.g. EGFR) in human cancers, this 
pathway has been the subject of intense research and several inhibitors have 
been developed. Some of them include EGFR inhibitors such as cetuximab or 
gefitinib (Harari 2004), Raf inhibitors such as Vemurafenib or Sorafenib which 
are V600E inhibitors (Santarpia, Lippman et al. 2012) or MEK1/2 inhibitors such 
as Trametinib and U0126 (Santarpia, Lippman et al. 2012). 
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Figure 1-7 The MAPK/ERK pathway. 
The MAPK/ERK pathway is the best-studied MAPK signalling pathway. The MAPK/ERK pathway 
involves sequential phosphorylation of three kinases: MAPK kinase kinase (MAPKKK), MAPK 
kinase (MAPKK) and MAPK (Kim and Bar-Sagi 2004). 
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1.5.1 MAPK/ERK pathway in cytoskeleton regulation 
Small GTPases can be divided into members of the Ras subfamily which control 
cell proliferation and differentiation, and the Rho subfamily (such as Rac1, 
Cdc42 and RhoA) which control actin cytoskeleton organisation. Such division of 
GTPase functions is not always accurate as there are many studies showing that 
Ras proteins also have a large impact on actin organisation and the formation of 
adherence and tight junctions (Pollock, Shirasawa et al. 2005; Wang, Li et al. 
2009). The best characterized Ras effectors are in the MAPK/ERK pathway. It has 
been demonstrated in many studies that the Raf/MEK/ERK pathway has profound 
effects on actin cytoskeleton organisation. Ras-transformed fibroblasts were 
characterised by the loss of stress fibres and focal adhesions, and the induction 
of membrane ruffling, which could be reversed by activation of RhoA (Pawlak 
and Helfman 2002). Furthermore, Sahai and Olson showed that sustained 
activation of the MAPK/ERK pathway achieved by oncogenic Ras induced 
transformation  led to the post-translational downregulation of ROCK1 and loss 
of stress fibres (Sahai, Olson et al. 2001). Moreover, metastatic breast cancer 
cells with high levels of K-Ras and enhanced phosphorylation of ERK were 
characterized with disrupted stress fibres organisation and focal adhesions, and 
this phenotype could be restored by MEK inhibition (Choi and Helfman 2014). 
1.6 Project aims 
The life-threatening characteristics of particularly deadly cancers, including 
breast cancer and melanoma, derive principally from their metastatic 
dissemination. It has become increasingly apparent that cancer cells are 
significantly softer than corresponding normal cells, with metastatic cells 
typically being softer than non-metastatic tumour cells. These changes in cell 
mechanical properties have been proposed to play important roles in several of 
the steps in the metastatic process. An advantage of reduced stiffness to 
invasive tumour cells is increased deformability that enables cells to pass 
through physical constrictions to facilitate invasion. Therefore, acquiring 
detailed understanding of the mechanisms that contribute to elasticity changes 
will help to identify potential drug targets to block tumour cell dissemination. 
Although the actin cytoskeleton is known to be a major determinant of cell 
elasticity, there is little currently known about the factors or signalling pathways 
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that modulate cell stiffness. Therefore, the aim of this project was, firstly, to 
isolate invasive cancer cells with enhanced deformability that enabled them to 
migrate through constrained environments, and secondly, to identify regulators 
of cell elasticity and assess their contributions to tumour cell invasion. 
 
 
2 Materials and methods 
2.1 Materials 
2.1.1 Antibodies 
Table 2-1 List of primary antibodies. 
 
 
Table 2-2 List of secondary antibodies. 
 
2.1.2 Plasmids 
Table 2-3 List of plasmids. 
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2.1.3 Primers 
Table 2-4 List of primers. 
 
 
2.1.4 Kits 
Table 2-5 List of kits. 
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2.1.5 Buffers and solutions 
Table 2-6 List of buffers and solutions. 
 
 
2.1.6 Reagents and chemicals 
Table 2-7 List of reagents and chemicals. 
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2.2 Cell culture techniques 
2.2.1 Origin, maintenance and storage of cell lines 
MDA MB 231 cells are an epithelial, adherent cell line. They were originally 
extracted from human breast cancer metastases. MDA MB 231-luc-D3H2LN cells 
are derived from a spontaneous lymph node metastasis from a MDA MB 231 
mammary fat pad tumour (Jenkins, Hornig et al. 2005). MDA MB 231-luc-D3H2LN 
cells stably express a firefly luciferase gene. 
MDA MB 435 cells are an adherent, epithelial cell line, originally derived from a 
pleural effusion of a female breast cancer patient. MDA MB 435 cells is a 
melanoma cell line, however they are often mistakenly used and described as 
breast cancer cells. Gene expression studies showed that MDA MB 435 cells are 
melanoma origin, not breast cancer (Prasad and Gopalan 2015).   
MDA MB 231-luc-D3H2NL and MDA MB 435 cell lines were grown in HyClone 
MEM/EBSS media, supplemented with 10% fetal bovine serum (FBS), 2 mM L-
glutamine, 10 U/ml penicillin and 10 µg/ml streptomycin, 1% MEM/NEAA (non-
essential amino acid), 1%  Sodium Pyruvate. Cells were kept at 37◦C with 5% CO2 
in a humidified incubator and passaged every 3-4 days as follows; culture media 
was aspirated and cells were washed once with PBS and subsequently incubated 
in 0.25% trypsin for a short time in standard tissue culture conditions. Cells were 
resuspended in medium and an aliquot was moved to a fresh tissue culture dish.  
Human fibroblasts were kindly provided by Max Nobis (Cancer Research UK 
Beatson Institute). They were grown in DMEM media supplemented with 10% FBS, 
2 mM L-glutamine, 10 U/ml penicillin and 10 µg/ml streptomycin. Fibroblasts 
were used for collagen matrix preparation for 3D cell invasion assay.  
 
For long-term storage, frozen cell stocks were prepared by resuspending healthy 
cell pellets in freezing media, which consisted of 90% FBS and 10% DMSO. 
Subsequently, 1 ml of aliquots were transferred to cryogenic vials and stored at -
80◦C for 24 hours and for long-term storage in liquid nitrogen vapour phase 
tanks. 
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2.2.2 Strategy for obtaining Selected and Flow sorted cell lines 
Three independent Selected (Sel) cell lines of MDA MB 231 or MDA MB 435 cells 
were generated as follows. Parental MDA MB 231 or MDA MB 435 cells were 
trypsinized and 1x106 of each cell line was resuspended in 10 ml of serum free 
medium. The cell suspension was seeded in 7.5 cm inserts with 3 µm pore 
membranes (Corning®). Subsequently, the inserts were placed in 10 cm dishes 
containing 10 ml of serum containing medium. The plates were left for 5 days in 
standard tissue culture conditions to allow cells to migrate through the pores 
and attach to the lower chamber compartment. Afterwards, the inserts were 
removed, the media was changed to fresh serum containing media and the plate 
was placed back in the incubator. The selection strategy was repeated 2 more 
times as described above. In brief, each of 3 independent Selected populations 
of MDA MB 231 and MDA MB 435 cells were selected through 3 µm pores in 3 
independent rounds of selection.  
Three independent Flow Sorted (FS) populations of MDA MB 231 cells were 
obtained as follows. Parental MDA MB 231 cells were trypsinized and 
resuspended in serum containing media and sorted for small size using a BD 
Fusion Sorter. Subsequently, the sorted cells were kept in standard tissue 
culture conditions to reach the desired concentrations. Once the cells expanded, 
the sorted cells were subjected to 2 more rounds of independent sorting as 
described above. In brief, each of 3 independent Flow sorted populations of 
MDAMB 231 cells were sorted for small size in 3 independent rounds of sorting.  
2.2.3 Tissue culture treatments 
2.2.3.1 Treatment of cells with Trametinib or U0126 inhibitors 
Treatment of MDA MB 231 and MDA MB 435 cells with Trametinib or U0126 
inhibitors were performed as follows. Cells were seeded in culture dishes and 
grown overnight. Next day, 0.5 µM Trametinib or 10 µM U0126 was added and 
incubated for 24 hours. After incubation, cells were processed depending on the 
experimental requirements. Both drugs were dissolved in DMSO to 10 mM stock 
concentrations.  
53 
 
2.2.3.2 Treatment of cells with Cytochalasin D 
Treatment of MDA MB 231 cells with Cytochalasin D was performed as follows. 
Cells were seeded in culture dishes and grown overnight. Next day, 0.5 µM 
Cytochalasin D was added and incubated for 2 hours. After incubation, cells 
were processed depending on the experimental requirements. Cytochalasin D 
was dissolved in DMSO to a 10 mM stock concentration.  
2.2.4 Transfection of DNA plasmids  
DNA plasmids, H2B-GFP, H2B-mCherry, were introduced into MDA MB 231 cells 
through electroporation using an Amaxa Cell Line Nucleofactor® Kit V. In brief, 
cells were trypsinized and 1x106 of cells were centrifuged at 90xg for 10 
minutes. Cell pellets were resuspended carefully in 100 µl of Nucleofactor® 
Solution/supplement mix (ratio 4.5:1) and subsequently 2 µg of DNA plasmid was 
added. The cell/DNA mix was transferred into supplied cuvettes and placed in 
the Nucleofactor® I Device where X-013 program for MDA MB 231 cells was 
applied. Thereafter, 500 µl of pre-warmed medium was added into the cuvettes 
and samples were gently transferred with a plastic Pasteur pipette into wells of 
6-well plate containing 1.5 ml of pre-warmed medium.  
2.2.5 Cell proliferation assay 
Cells were seeded in triplicate at 3x103 cells per well in 12-well plates.  Cell 
numbers were measured at 24, 48 and 72 hours. Cells were trypsinized and 
counted using a CASY® Cell Counter.  
2.2.6 Cell volume measurement 
Cell volumes were calculated using the formula for the volume of the sphere, V 
= ¾πr3. Mean diameter measurements were determined using a CASY® Cell 
Counter. 
2.2.7 Cell adhesion assay 
Cells were seeded in 96-well plate sat a density of 4x104 cells in 100 μl media 
per well. The plates were left for 3 hours at 37◦C in standard culture conditions 
to let cells adhere. After 3 hours of incubation, cells were washed 4 times with 
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PBS to remove non-adherent cells. Afterwards, 100 μl of culture medium was 
added to each well including control wells containing culture medium only. The 
number of adherent cells was measured using the CellTitre-Glo Luminescent Cell 
Viability Assay according to the manufacturer’s instructions. Briefly, CellTitre–
Glo reagent and cells were left at room temperature for 30 minutes to 
equilibrate. 100 μl of CellTitre-Glo reagent was added to each well. Next, plates 
were placed on an orbital shaker for 2 minutes and then incubated for 10 
minutes at room temperature. After incubation, the content of each well was 
transferred to Fisherbrand white 96-well plates. Luminescent readings were 
made on Glomax 96 Microplate Luminometer. 
2.2.8 Dispase-based cell detachment assay 
Cell were seeded at 3x105 cells per well in 12-well plates and left overnight in 
standard tissue culture conditions. Cells were washed once with PBS and 500 µl 
of 2 U/mg of dispase (in media) was added per well and subsequently left for 5 
minutes at 37◦C. 500 µl of the mix of dispase and medium was removed and cell 
numbers were measured. To measure the number of cells attached to the 
bottom of plates, 500 µl of the mix of 2 U/mg dispase and media was added and 
left until cells detached from the plates. The percentage of attached cells was 
normalized to the total number of cells. 
2.2.9 Cell spreading assay 
Cell spreading was measured using the xCelligence Real-Time Cell Analyzer 
(RTCA) system and E-plate 16. 50 μl of culture medium was added to each well 
and left to equilibrate for 1 hour in a standard tissue culture incubator. After 
incubation, the background measurement was taken before 1x104 cells in 100 μl 
of culture media were added to each well. The plates were placed back in the 
RTCA analyser and measurements were taken every 3 or 5 minutes for 12 or 3 
hours.  
2.2.10 Transwell cell migration assay 
The number of cells able to migrate through 3 µm or 8 µm pores was measured 
using a Transwell migration assay with 3 µm or 8 µm pore-membrane inserts. In 
brief, 1.2x105 cells for 3 µm pore membranes and 6x104 cells for 8 µm pore 
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membranes were resuspended in 300 µl of serum free medium. The cell 
suspension was added to the insert and placed in a well of 24-well plates 
containing 750 µl of serum full medium. The plates were left for 3 days in 
standard culture conditions to allow cells to migrate through the membrane and 
attach to the lower chamber compartment. 
The number of migrated cells at the bottom of 24 well–plates was quantified 
using a sulforhodamine B (SRB) colorimetric assay. Briefly, after removing the 
inserts, 10% (w/v) of trichloroacetic acid (TCA) was added to each well to reach 
a final concentration of 3.3%. The cells were fixed at 4◦C for 30 minutes. Cells 
were then washed 3 times with water, air-dried and 300 µl of 0.04% of SRB was 
added to each well and incubated for 30 minutes at room temperature. 
Afterwards, the SRB solution was removed; the wells were washed 3 times with 
1% (v/v) acetic acid and air-dried. Subsequently, 250 µl of 10 mM Tris (pH 10.5) 
was added into each well and the plates were placed on a shaker for 15 minutes. 
Afterwards, 200 µl of the well content was transferred to 96-well plates and 
absorbance was measured on a spectrophotometer at 490 nm.  
2.2.11 Individual cell migration assay 
Cells were seeded in 12-well plates at a density of 5x103 cells per well. Next 
day, the plates were placed in a Nikon TE 2000 Time Lapse Microscope set in an 
incubation chamber at 37◦C with 5% CO2. The plates were left for 1 hour to let 
cells adjust to the conditions of the chamber. Bright field images were taken 
every 15 minutes for 22 hours with a 10x objective. Migration velocity, 
accumulated distance and Euclidean distance were measured using Manual 
tracking and Chemotaxis plugins in ImageJ. Cells were tracked for 45 frames and 
dividing cells were not included. 
2.2.12 3D cell invasion assay  
3D collagen invasion assay was performed according to the protocol described by 
Timpson et al. (Timpson, Mcghee et al. 2011). 
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2.2.12.1 Preparation of collagen I from rat tails 
Collagen was prepared from approximately 12-14 adolescent rat tails. Rat tails 
were washed with 70% ethanol, the skin was removed and the tendons were 
detached from the core of the proximal region of the tail using toothed forceps. 
The tendons were kept in 70% ethanol in a petri dish to keep it hydrated. Next, 
the tendons were extracted for 48 hours in 1.5 L of 0.5 M acetic acid by stirring 
at 4◦C. Next day, the extract was centrifuged at 7500xg for 30 minutes and the 
supernatant was placed in a cooled 2 L beaker. Next, 10% (w/v) of NaCl was 
added to the supernatant and stirred for 30 – 60 minutes. The supernatant was 
centrifuged again at 10,000xg for 30 minutes. This time the supernatant was 
removed and the precipitate was dissolved in 0.25 M acetic acid and stirred for 
24 hours at 4◦C. In the next step, two dialysis tubes ~40 cm long were cut and 
microwaved for 1 min in dH2O. A knot was tied at the bottom of the tubes, the 
collagen was poured inside and the tubes were closed avoiding making air 
bubbles. Subsequently, the collagen was dialyzed against 6-8 changes of 6 L 
~17.5 mM acetic acid (changed twice daily, 1 ml of glacial acetic acid per litre of 
cold water). The dialyzed collagen was centrifuged at 30,000xg for 1.5 hours, 
the supernatant was removed and placed in the sterile bottle. The collagen 
solution was adjusted to 2 mg/ml concentration using 0.5 M acetic acid. The 
collagen was stored at 4◦C. 
2.2.12.2 Preparation of 3D matrix with embedded fibroblasts 
25 ml of ice-cold collagen (approximately 2 mg/ml) was mixed with 3 ml of 10x 
MEM media and approximately 3 ml of 0.22 M NaOH was added until the collagen 
turned orange (pH = 7.2). 1x106 fibroblasts were trypsinized and centrifuged at 
400xg for 5 minutes. Fibroblasts were resuspended in 3 ml of FBS and 
immediately added to 25 ml of ice-cold rat tail collagen then mixed and stirred. 
2.5 ml of collagen/fibroblast mix was plated per 35 mm dish as quickly as 
possible. The collagen/fibroblast mix was left to set in standard culture 
conditions for 30 minutes. Afterwards, 1 ml of fibroblast growth media was 
added and the collagen/fibroblast matrix was detached from the side of the dish 
using a pipet tip. Next day, fresh media was added and then changed every 
other day for approximately 8 days until the collagen matrix fitted in a well of 
24-well dish. Once the collagen disks reached the desired size, they were 
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incubated with culture media and puromycin at a final concentration of 5 µg/ml 
(2 ml per dish) for 2 days to remove the fibroblasts. Afterwards, the collagen 
disks were washed twice with PBS for 10 minutes each. 
2.2.12.3 Seeding cells on top of collagen matrix disks 
Contracted collagen plugs were placed in 24-well plates. 1.5x105 cells in 1 ml of 
culture media was seeded on top of the collagen disk and left for 2 days in 
standard culture conditions to let the cells adhere. After 2 days, matrix disks 
were moved onto grids.  
2.2.12.4 Transferring collagen disks onto grids for cell invasion 
Prior to use, stainless steel grids were cut to create a tripod and autoclaved. 
Each grid was placed in a 6 cm dish and growth media was added to reach the 
level above the grid. Collagen disks were placed on top of the grid and media 
was aspirated to create an air-liquid interface, to ensure that only the bottom of 
the matrix was in contact with the media. The media was replaced every other 
day for 8 days. After 8 days of invasion, the plugs were fixed in 4% PFA. 
2.2.12.5 Fixation of collagen disks 
The collagen disks were transferred onto a flat surface and cut in half. Two 
halves of the matrix were lifted with a scalpel and transferred to 4% PFA/PBS 
solution and fixed overnight. The fixed disks were horizontally paraffin-
embedded and 4 µm sections were cut and stained with haematoxylin and eosin 
(H&E) by the Beatson Histology Service. Stained collagen disks were imaged by 
Beatson Histology Service using the Leica Biosystem software. The invading 
distance of the cells was measured using ImageJ software.  
2.2.13 Plasma membrane fluidity determination using 
Fluorescence Recovery after Photobleaching (FRAP) 
2x105 cells were seeded on 35 mm glass bottom dishes and left overnight in 
standard tissue culture conditions. Next day, cells were washed twice with HBSS 
media followed by staining with NBD-sphingomyelin at 4 µM for 10 minutes in 
room temperature protected from light. Cells were then rinsed and observed in 
HBSS media.  
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Evaluation of membrane fluidity was obtained by measuring lateral diffusion of 
NBD-sphingomyelin by FRAP. All experiments were performed on a Zeiss 880 
confocal microscope. In all experiments, a 60x oil immersion objective was used. 
For the photobleaching, a 488 nm laser was used, set to 100% laser power. 
Images were set to 510 x 200 pixels and speed 12 for a sufficient speed scanning. 
The zoom factor was set to 2 to avoid bleach during acquisition. For bleaching a 
region of interest (ROI1), a circle of 24 pixels was defined on the apical cell body 
membrane. In order to perform quantification, two other regions of interests 
were drawn around the cell (ROI2) and a random non-fluorescent region, also 
referred to as background (ROI3). Mobile fraction and t1/2 were quantified using 
Easy FRAP software. The fluorescence intensity was normalized using a full scale 
normalization method. In order to extract quantitative information from the 
curves, double term fitting exponential equations were used. 
2.2.14 Nuclei volume measurement  
In order to quantify nuclei volumes, cells were fixed and stained with DAPI as 
described for the Immunofluorescence assay. In order to measure nuclei 
volumes, z-stack sections of DAPI-stained nuclei were taken on a Zeiss 710 
confocal microscope. The obtained z-stack sections were then fed into Volocity 
Software. The program allowed 3D image analysis based on the fluorescence 
signal obtained by the confocal microscope.  
2.2.15 Nuclei isolation 
Nuclei were isolated using Nuclei EZ Prep Nuclei Isolation kit. In brief, 1x106 
cells were seeded in 10 cm dishes and incubated overnight in standard tissue 
culture conditions. After incubation, cells were washed twice with 10 ml of ice 
cold PBS and harvested with 4 ml of lysis buffer provided with the kit using a 
bladed cell scraper. The entire cell lysates were transferred to 15 ml tubes, 
vortexed briefly and set on ice for 5 minutes. Next, the lysates were centrifuged 
for 5 minutes at 400xg at 4°C. The supernatants were aspirated and the nuclei 
pellets were resuspended in 500 µl of lysis buffer, vortexed, topped up with 3.5 
ml of lysis buffer and the washing step was repeated. After the final wash, the 
supernatants were aspirated and the isolated nuclei were processed for further 
experiments.  
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2.2.16 DNA cell cycle analysis with propidium iodide (PI) 
For the cell cycle analysis, cells were trypsinized and 1x106 cells were 
centrifuged at 1000 rpm for 5 minutes followed by a PBS wash. Subsequently, 
the cell pellets were resuspended in 300 µl of PBS and then 400 µl of 70% EtOH 
was added. The cell suspensions were vortexed, the volumes increased to 1.5 ml 
with 70% EtOH and stored at 4◦C for 24 hours. The samples were centrifuged at 
1000 rpm and washed twice with 2 ml of PBS each. The pellets were 
resuspended with 500 µl of PBS containing 50 µg/ml propidium iodide and 125 
µg/ml RNaseA followed by 1 hour incubation at room temperature in the dark. 
After the incubation, the samples were centrifuged at 1000 rpm for 3 minutes, 
resuspended in 300 µl of PBS and then transferred to flow cytometry tubes. The 
samples were analysed on a BD FACSCaliburTM machine.  
2.2.17 Cellular protein extraction 
2.2.17.1 Cell lysate preparation 
Cells were grown to the desired concentration and lysed to extract proteins. 
After placing cell culture dishes on ice, the medium was aspirated and cells were 
washed twice with ice-cold PBS. SDS lysis buffer (1% SDS in 50 mM Tris pH 7.5) 
was added to the culture dishes and the monolayer of cells were scraped using a 
cell lifter. Lysates were then transferred to a Qiagen Qiashredder column, which 
homogenized the samples, filtering out insoluble debris and reducing viscosity. 
The filtrates were centrifuged at 14,000 rpm for 1 minute and transferred to 1.5 
ml Eppendorf tubes and centrifuged at 14,000 rpm for 15 minutes at 4◦C to 
pellet any existing debris. The supernatants were transferred to fresh Eppendorf 
tubes and the protein concentrations were determined using the BCA assay. 
Samples were stored at -20◦C.   
2.2.17.2 Protein concentration determination 
Total protein concentration of cell lysates was determined using a bicinchoninic 
acid assay (BCA assay), also known as the Smith assay. Protein standards - 0.08, 
0.1, 0.2, 0.4, and 1 mg/ml - were prepared using 2 mg/ml bovine serum albumin 
stock solution by diluting it in the lysis buffer. To measure the concentration, 10 
μl of blank solution (in triplicate), standards and samples (in duplicate) were 
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added to Greiner Bio One 96-well plates. 200 μl of developing solution (50:1, 
bicinchoninic acid:copper sulphate solution) was added to each well, and the 
plates were incubated at 37◦C for 45-60 minutes. The absorbance of each well 
was measured using a Molecular Devices Microplate at 562 nm reader. Protein 
concentration was calculated from standard curves. 
2.2.17.3 SDS polyacrylamide gel electrophoresis 
SDS-polyacrylamide gel electrophoresis (PAGE) was used to separate proteins 
based on their molecular weight. NuPAGE Bis-Tris 4-12% gradient gels were used. 
Protein samples were diluted in SDS lysis buffer and 6x loading buffer added to 
reach the desired concentration. The samples were boiled for 5 minutes at 95◦C.  
After boiling, samples were centrifuged briefly, left to equilibrate to room 
temperature and then loaded onto the gel along with Precision Plus ProteinTM All 
Blue weight marker. Bis-Tris gels were run in tanks containing 1 x NuPAGE MES 
buffer at 160 V for approximately 1.5 hour. Subsequently, gels were used for 
western blotting. 
2.2.17.4 Western blotting 
Proteins were transferred to ProtranTM nitrocellulose membrane in a Bio-Rad Mini 
Trans-Blot® Cell. Proteins were transferred in tanks containing 1x NuPAGE 
Transfer Buffer with 20% methanol. Prior to transfer, nitrocellulose membranes 
were pre-wet in transfer buffer. Whatman papers and sponges were also pre-wet 
and stacked with the gel and membrane. All transfers were run at 100 V for 1 
hour using an ice pack in the apparatus. After transfer, the membranes were 
stained with Ponceau red solution to confirm equal loading of proteins. The stain 
was washed off with distilled water, and the membranes were blocked in 5% 
(w/v) milk powder or 3% BSA (depending on the antibody’s manufacturer 
instruction) in TBS-T for 1 hour at room temperature. Primary antibodies were 
diluted in blocking buffer to the desired concentration and incubated at 4◦C 
overnight. After incubation, the membranes were washed three times for 10 
minutes each in TBS-T and subsequently incubated with secondary antibody, 
which had been diluted 1:10000 in blocking buffer, for 60 minutes at room 
temperature. Once blots were washed in TBS-T three times, they were rinsed in 
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dH20 and protein bands were visualised using a LI-COR Odyssey® system. Protein 
bands were quantified using Image Studio Lite version 5.2. 
2.2.18 Gene expression studies 
2.2.18.1 RNA isolation and RT-qPCR 
RNA was isolated using the Qiagen RNasy Mini Kit according to manufacturer’s 
instructions. RNA concentration and purity was determined using a NanoDrop 
2000 spectrophotometer. To perform quantitative RT-qPCR, complementary DNA 
(cDNA) was prepared using the Quantitect Reverse Transcription kit.  In the first 
step, genomic DNA was eliminated by performing the following reaction; 2 µl of 
gDNA Wipeout Buffer was added to 1 µg of RNA and nuclease-free water to reach 
a total volume of 14 µl. The mixtures were incubated at 42◦C for 2 minutes in a 
water bath and in the next step kept on ice. Subsequently, reverse-transcription 
mix consisting of 1 µl of reverse transcriptase, 4 µl of RT buffer and 1 µl of RT 
primer mix was added and the solutions were incubated at 42◦C for 15 minutes in 
a water bath and then at 95◦C for 5 minutes in a thermal cycler.  
The cDNA samples were diluted 5 times with nuclease-free water and standards 
were prepared by pooling 10 µl of each sample and diluting to the following 
dilutions: 0.01, 0.04, 0.2, 1.  
To perform quantitative PCR (qPCR), SYBER Green based qPCR was performed in 
triplicate in 20 µl reaction mixtures containing 10 µl of master mix (master mix 
contains hot-start polymerase, SYBR green, PCR buffer, 5 mM MgCl2, and dNTP 
mix), 6.35 µl of nuclease-free water, 2 µl of primer, and 0.15 µl ROX passive 
reference dye per sample. The reaction mixtures were then distributed into 
MicroAmp® Fast Optical 96-well plates and 1.5 µl of cDNA sample or standard 
was added to each well. Reaction mixtures containing water instead of cDNA 
template were used as controls. The plates were covered with optically 
transparent sealing film and run on an Applied 7500 Fast Real-Time PCR system. 
A melting curve for each primer was established, which was used to identify the 
presence of single PCR products. Data were analysed on Applied Biosystem 7500 
Software 2.0.5 and the expression level of genes of interests were calculated 
using the ΔCt method and normalized to GAPDH.   
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2.2.18.2 RNA Sequencing 
1x106 cells were seeded into 6-well plates and grown overnight. Total RNA was 
extracted using the RNAeasy kit (Qiagen) according to manufacturer’s 
instructions. RNA was quantified using a Nanodrop spectrophotometer (Nanodrop 
Tech). The Agilent RNA ScreenTape assay and the Agilent 2200 TapeStation 
system were used to determine the RNA integrity number equivalent. This 
analysis indicated that the RNA integrity number (RIN) for all samples was ≥ 9.9. 
Total RNA was used to generate oligo dT-enriched libraries with the Illumina 
TruSeq RNA Library Preparation kit v2.0. The quality and quantity of DNA 
libraries were assessed using an Agilent 2100 Bioanalyzer and a Qubit (Thermo 
Fisher Scientific), respectively. The libraries were run on an Illumina NextSeq 
500 platform using High Output 75 cycles kit (2x36 cycles, paired-end reads, 
single index). Next-generation RNA sequencing was carried out by the Beatson 
Institute Molecular Technology Service. Data were analysed by the 
Computational Biology department (Cancer Research UK Beatson Institute). 
2.2.19 Microscopy 
2.2.19.1 Fluorescence Life Time Imaging Microscopy (FLIM) 
In order to obtain FLIM images, a Nikon TE 2000 inverted microscope fitted with 
a Lambert Instruments FLIM Attachment (LIFA) and a Yokogawa CSU22 spinning 
disk unit with 100x objective was used. The microscope was equipped with an 
incubation chamber suitable to maintain live cells and optics at constant 
temperature. The LIFA system was equipped with an Omicron 50 mW 445 nm 
laser for CFP lifetimes and a 60 mW 488 nm laser for GFP lifetimes. It is based 
on the frequency domain method for fluorescence lifetime imaging and allows 
the rapid acquisition and generation of lifetime images. Fluorescence lifetimes 
were measured using LI-FLIM software. 
2.2.19.1.1 Chromatin condensation determination 
For the chromatin condensation studies, 1x106 cells were transfected with H2B 
fused to eGFP via its carboxy terminus and H2B fused to mCherry via its amino 
terminus using Amaxa Cell Line Nucleofactor® Kit V. Transfected cells were 
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seeded on 35 mm glass bottom dishes and left for 72 hours in standard tissue 
culture conditions. After 3 days, cells were imaged using FLIM microscopy. 
For 2-deoxyglucose (2-DG) and sodium azide treatment experiments, cells were 
treated with 50 mM 2-deoxyglucose and 10 mM sodium azide 30 minutes before 
acquiring images. Control cells were treated with dH20. 
2.2.19.2 Total Internal Reflection Fluorescent Microscopy (TIRF)  
TIRF images were taken on a Nikon Eclipse TE2000-U microscope. A 100x 1.45 NA 
Plan Apochromat TIRF oil objective (Nikon) was used. The microscope was 
equipped with a Photometrics Evolve 512 camera, which allowed illumination of 
GFP and RFP at 473 nm and 561 nm, respectively. Red and green fluorescence 
signals can be separated using a DualView DV2 emission splitter. MetaMorph 
software was used to control the camera shutters and light source. Samples for 
the imaging were prepared as follows. 0.8x105 cells were seeded on 13 mm 
autoclaved cover slips placed in 24-well plates. The media was aspirated, cells 
were washed with PBS and then fixed with 4% PFA/PBS solution at room 
temperature for 15 minutes. Thereafter, cells were washed twice with PBS and 
permeabilized with 0.5% Triton X-100/PBS for 5 minutes at room temperature, 
washed twice with PBS and then incubated with Alexa Fluor 488 phalloidin 
(1:1000) for 1 hour at room temperature. After incubation, cover slips were 
washed twice with PBS and inverted on 7 µl of ProLong® Diamond Antifade 
Mountant with DAPI on glass slides. In order to quantify actin anisotropy, an 
ImageJ plugin called Fibril Tool was used.  
2.2.19.3 Operetta High Content Imaging System 
In order to determine cell morphological features, an Operetta High-Content 
Imaging System was used. Prior to cell imaging, cells were seeded in black 96-
well plates at 2x104 cells per well. The next day, media was removed and cells 
were fixed with 4% PFA/PBS for 15 minutes at room temperature. Cells were 
washed twice with PBS, permeabilized with 0.5% Triton X-100 for 5 minutes at 
room temperature and then washed twice with PBS. Cells were incubated with 
0.15 µg/ml of DAPI for 20 minutes in room temperature followed by two PBS 
washes. 50 µl of 1:5000 dilution of Cellomics® Whole Cell Stain (WCS) was added 
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per well and incubated at room temperature for 30 minutes and subsequently 
washed three times with PBS. The plates were imaged on an Operetta High-
Content Imaging System and the data was analysed on Columbus™ Image Data 
Storage and Analysis System. Cell shapes were analysed using Columbus™ Image 
Data Storage and Analysis System, and an enhanced set of algorithms known 
collectively as STAR system. The software was trained to recognise different 
populations of cell shapes by selecting examples of each class. 
2.2.19.4 Immunofluorescence 
0.8x105 cells were seeded on 13 mm autoclaved cover slips placed in 24-well 
plates and grown overnight. The media was aspirated, cells were washed with 
PBS and then fixed with 4% PFA/PBS solution at room temperature for 15 
minutes. Cells were washed twice with PBS and permeabilized with 0.5% Triton 
X-100/PBS for 5 minutes at room temperature, washed twice with PBS and 
blocked with 1% BSA/PBS for 30 minutes. All primary antibodies were used at a 
1:200 dilution and incubated for 2 hours at room temperature. The coverslips 
were washed twice with PBS before being incubated with secondary antibody for 
1 hour at a 1:1000 dilution. After incubation, coverslips were washed twice with 
PBS, once with distilled water and inverted on 6 µl of ProLong® Diamond 
Antifade Mountant with DAPI on glass slides. Cells were imaged on a Zeiss 710 
upright confocal microscope or Zeiss 880 confocal using a 63x oil immersion 
objective. 
2.2.19.5 Electron Microscopy 
Scanning electron microscopy (SEM) was used to visualise nuclei. Briefly, isolated 
nuclei were seeded on autoclaved 10 mm coverslips placed in 24-well plates and 
cultured overnight. The next day, media was aspirated and cells were fixed with 
3% glutaraldehyde in 0.1 M phosphate buffer for 2 hours at room temperature. 
After fixation, cells were washed 3 times with 0.1 M phosphate buffer for 10 
minutes each.  
Transmission electron microscopy (TEM) was used to visualise chromatin 
structures. Cells were pelleted and resuspended in 3% glutaraldehyde in 0.1 M 
phosphate buffer for 1 hour at room temperature for fixation. After fixation, the 
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cells were washed 3 times with sodium cacodylate buffer for 5 minutes each. 
Samples were kept at 4◦C until ready for processing.  
All samples were processed by the Electron Microscopy Facility at University of 
Glasgow. Images were taken at different magnifications. 
2.2.19.6 Atomic Force Microscopy (AFM) 
The Atomic Force Microscopy studies were performed in collaboration with the 
Engineering department at Glasgow University. Cells were seeded in 3 cm petri 
dishes and incubated for 24 hours in standard tissue culture conditions. During 
the experiment, cells were kept in standard tissue culture conditions and 1% 
HEPES was added to the media to maintain the pH level. Cells were probed with 
a 4.74 µm diameter spherical bead and force of 3 nN. Indentations were 
performed with a constant speed of 2.5 µm/s and a z length of 3 µm. Cells were 
measured on the nucleus area at 5 points disposed in a square configuration of 1 
µm and an average of Young’s modulus value was determined per cell. 
For the nuclei elasticity measurements, prior to the experiment nuclei were 
isolated using the Nuclei EZ Prep Nuclei Isolation kit. Isolated nuclei were 
seeded in 3 cm petri dishes in the lysis buffer provided with the kit. Once nuclei 
had attached onto the dish, AFM was performed. Nuclei were probed with a 4.74 
µm diameter spherical bead and force of 3 nN. One measurement was taken per 
nucleus.  
2.2.20 In vivo work 
The in vivo work was carried out in collaboration with the Transgenic Models 
Advanced Technology service (Cancer Research UK Beatson Institute). All animal 
work was carried out under project licence (PPL70/8645) authority and with 
ethical approval (University of Glasgow) in line with the Animals (Scientific 
Procedures) Act and EU Directive. 
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2.2.20.1 Orthotopic injection of breast cancer cells into mammary fat 
pads of nude mice 
Orthotopic injection of MDA MB 231 breast cancer cells into mammary fat pads 
of nude mice was performed as follows. Nude female CD1 mice were obtained 
from Charles River. Seven week old mice were injected with 1x106 cells in 50 µl 
of 1:1 (Matrigel:PBS) into the fourth abdominal fat pad. Tumour growth was 
monitored over the course of study and animals were sacrificed when tumour 
size reached 15 mm. Mice were injected intraperitoneally with 250 µl BrdU two 
hours prior to sacrifice. Animals were euthanized by a Schedule 1 method using 
carbon dioxide inhalation. Primary tumour and organs were harvested, paraffin 
embedded and stained with hematoxylin and eosin (H&E) or antibodies against 
Human Leukocyte Antigen (HLA). Histology sample processing was performed by 
the Beatson Histology Service. Slides were analysed using Leica Biosystems 
software.  
2.2.20.2 MDA MB 231 and MDA MB 435 cell injection into nude mouse 
tail veins 
For the experimental metastasis assay, MDA MB 231 or MDA MB 435 cell lines 
were injected into the tail veins of nude female CD1 mice. Seven-week old mice 
were injected with 1x106 cells in 100 µl of PBS into lateral tail veins. Mice were 
monitored over the course of the study. Mice were sacrificed 6.5 weeks after 
injection and lungs were harvested. Animals were euthanized by a Schedule 1 
method using carbon dioxide inhalation. Lungs were paraffin embedded and 
H&E-stained by the Beatson Histology Service. Slides were analysed using Leica 
Biosystems software. 
2.2.20.3 Histology 
Paraffin-embedded tissue sections were cut and routinely stained with 
haematoxylin and eosin (H&E) by the Beatson Histology Service. Other standard 
stains performed by the Histology Service include BrdU and HLA. Serial lung 
sections of 4 µm thickness were cut at 50 µm intervals.  
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2.2.21 Statistical analysis 
Statistical significance (p<0.05) of differential findings between experimental 
groups was determined by performing appropriate test using GraphPad 7.03 
software. The test used in analysis is stated in the corresponding figure legends.  
2.2.21.1 Principal component analysis (PCA) 
Principal component analysis (PCA) is a mathematical procedure that transforms 
a number of (possibly) correlated variables into a (smaller) number of 
uncorrelated variables called principal components. It uses an orthogonal 
transformation to reduce a large set of variables to a small set that still contains 
most of the information in the large set. PCA is a technique used to identify 
outliers, batch effects and clusters. It's often used to make data easy to explore 
and visualize. PCA was quantified using R package, prcomp 
(https://stat.ethz.ch/R-manual/R-patched/library/stats/html/prcomp.html). 
The calculation is done by a singular value decomposition of the centered data 
matrix not by using eigen on the covariance matrix. This is generally the 
preferred method for numerical accuracy. Data were analysed by the 
Computational Biology department (Cancer Research UK Beatson Institute). 
  
 
 
 
 
3 In vitro selection of cancer cells through 3 µm 
pores using cell culture inserts 
3.1 Rationale 
Tumour cell invasion and subsequent cancer metastasis are the most difficult 
problems faced by cancer patients; moreover they remain one of the most 
poorly understood processes in cancer biology (Hanahan and Weinberg 2011). 
Within primary tumours, some cancer cells acquire invasive and metastatic traits 
that enable them to survive the complex journey from the primary site to 
distant organs and to colonise a foreign tissue. In the first and last steps (local 
invasion, intravasation, extravasation) of the metastatic cascade, cancer cells 
must invade into the surrounding associated stromal tissue and migrate through 
its dense composition (Gupta and Massague 2006). The ECM architecture 
provides complex scaffoldings, and many obstacles in the form of pores and 
narrow channels for migrating cancer cells. Therefore, acquiring detailed 
understanding of the mechanisms that contribute to constrained invasive 
adaptations will help to identify potential drug targets to block tumour cell 
dissemination and improve patient outcomes.  
I hypothesized that within the dispersed distributions of parameters in tumour 
cell lines, it would be possible to select cells that were better able to squeeze 
through narrow gaps, thus highlighting factors that contributed to increased cell 
deformability. Therefore, I set up an in vitro selection strategy in which cancer 
cells were selected based on their ability to pass through narrow diameter 
constrictions (3 µm) that mimic the gaps in the ECM or between cells. In order to 
enrich for cells with enhanced abilities to pass through physical constrictions, 
cells were seeded on 3 µm pore-membranes in 10 cm Transwell inserts and 
allowed to migrate towards medium containing 10% fetal bovine serum (FBS). 
After 5 days, cells were collected and re-plated on the inserts twice more 
(Figure 3-1). In brief, each of three independent Selected populations were 
selected through 3 µm pores in three independent rounds of selection. In further 
parts of the thesis, I will refer to the original populations of cells as Parental 
cells and to the sub-population as Selected (Sel) cells. The study was performed 
on MDA MB 231-luc-D3H2LN breast cancer cells and some experiments were 
carried out on MDA MB 435 melanoma cancer cells. 
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3.2 Results 
3.2.1 Selected MDA MB 231 cells are more migratory through 3 
µm pores compared to Parental MDA MB 231 cells 
In order to assess 3 µm pore migration capability of Parental and independent 
Selected MDA MB 231 cells, 6.5 mm diameter Transwell inserts with 3 µm pore 
membranes were used. Briefly, cells were resuspended in serum free media, 
seeded in Transwell inserts and subsequently incubated in standard tissue 
culture conditions for 3 days to allow cells to migrate towards medium 
containing 10% fetal bovine serum (FBS). Following incubation for 72 hours, the 
inserts were removed and cells that migrated through the membrane and 
attached to the lower-chamber compartment were fixed and stained with 
sulforhodamine B (SRB) to quantify migrated cells. The SRB assay is a 
colorimetric assay used for cell density determination based on the 
measurement of cellular protein content. The analysis revealed a significant 
increase in 3 µm pore migration of Selected MDA MB 231 cells relative to 
Parental MDA MB 231 cells (Figure 3-2).  
3.2.2 Small size does not determine 3 µm pore migration ability of 
Selected MDA MB 231 cells 
After discovering that Selected MDA MB 231 cells were significantly more 
migratory through 3 µm pores, I wanted to know if these changes were cell size 
dependent. To measure the size of Parental and independent Selected cell 
populations, the Operetta High Content Imaging System was utilised for high 
throughput quantification of cell morphological features, such as cell area. In 
brief, cells were seeded in black 96-well plates and following incubation for 24 
hours, cells were fixed and stained with DAPI and Whole Cell Stain (WCS). The 
results showed that the majority of Selected MDA MB 231 cells had significantly 
smaller cell area compared to Parental MDA MB 231 cells (Figure 3-3A). 
Given the possibility that cell size was a major determinant responsible for the 
enhanced 3 µm pore migration of Selected MDA MB 231 cells, one additional 
selection strategy that enabled testing of this parameter was adopted. I 
enriched Parental cells for small cell size by flow cytometry using a BD Cell 
Sorter. In brief, Parental MDA MB 231 cells were enriched for small size using 
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flow cytometry and subsequently seeded in serum full media and kept in 
standard tissue culture conditions until they reached the desired concentration. 
Next, flow cytometry sorting was repeated twice more for each independent 
Flow sorted (FS) cell population. Cell areas and cell volumes were determined 
for Parental, Selected and Flow sorted populations. The analysis revealed that 
Selected and Flow sorted cells were associated with 2D smaller cell area and 3D 
cell volume relative to Parental cells (Figure 3-3B,C). Cell areas were assessed 
using the Operetta High Content Imaging System and cell volumes were 
calculated from measured cell diameters.  
To determine whether small size was a significant contributor to the enhanced 
constrained cell migration of Selected MDA MB 231 cells, 3 µm migration ability 
was assessed on Parental, independent Selected and independent Flow sorted 
MDA MB 231 cell populations using a Transwell migration assay with 6.5 mm 
Transwell inserts. I found that independent Selected cells were significantly 
more migratory through 3 µm pores compared to equivalently small Flow sorted 
cells and to Parental cells, but all of the cell sub-populations were equally 
invasive through 8 µm pores (Figure 3-3D). These results indicated that small 
size did not solely determine constrained cell migration ability of Selected MDA 
MB 231 cells. 
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Figure 3-1 Selection strategy of cancer cells through 3 µm pore membranes. 
Schematic diagram of selection strategy. Cancer cells were plated in serum-free medium in well 
inserts with 3 µm pores. Cells that moved towards medium containing 10% fetal bovine serum 
(FBS) to the bottom of the well were collected after 5 days and re-plated in the well inserts twice 
more to establish the selected cell populations. 
72 
 
 
Figure 3-2 Selected MDA MB 231 cells are more migratory through 3 µm pores. 
Graph represents mean (± SEM) 3 µm relative migration for Parental and independent Selected 
cell populations. Each dot represents an average value from n = 3 wells. Data pooled from n > 3 
independent experiments. Statistical significance determined by Mann - Whitney test. 
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Figure 3-3 Small cell size does not determine enhanced constrained migration of Selected 
MDA MB 231 cells. 
A) Relative frequency of cell area for Parental and independent Selected cell populations. Cell 
areas were determined using Operetta High Content Imaging System. B) Graph represents mean 
cell area (± SEM) for Parental, independent Selected and independent Flow sorted cell populations 
pooled from n > 3 independent experiments. Each dot represents an average value from n = 6 
fields per well, from at least 200 cells per field. Cell area was determined using Operetta High 
Content Imaging system. C) Graph represents mean cell volume (± SEM) for Parental, 
independent Selected and independent Flow sorted cell populations. Cell volumes were 
determined by measuring cell diameter. Each dot represents an average value from n ≥ 4 
measurements. Data pooled from n > 3 independent experiments. D) Left graph depicts mean (± 
SEM) 3 µm relative migration for Parental, independent Selected and independent Flow sorted cell 
populations. Right graph depicts mean (± SEM) 8 µm relative migration for Parental, independent 
Selected and independent Flow sorted cell populations. Each dot represents an average value 
from n = 3 wells. Data pooled from n ≥ 3 independent experiments. Statistical significance 
determined by Kruskal - Wallis followed by Dunn’s multiple comparison test. 
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3.2.1 No difference in proliferation between Parental, Selected 
and Flow sorted MDA MB 231 cells in vitro 
Before undertaking any further experiments, proliferation rates of Parental, 
Selected and Flow sorted MDA MB 231 cells, were checked. To assess cell 
proliferation rates, 30,000 cells per well were seeded in 12-well plates in 
triplicates. Cell number was measured after 24, 48 and 72 hours using a CASY® 
Cell Counter. From this, I was able to determine that there was no difference in 
the proliferation rates between Parental, Selected and Flow sorted MDA MB 231 
cells (Figure 3-4). 
3.2.2 Selected MDA MB 231 invade to a greater depth in fibroblast 
conditioned collagen matrix compared to Parental and Flow 
sorted MDA MB 231 
Having determined that 3 µm pore selection enriched for cells with enhanced 
constrained migration properties, and that such a property was not solely 
dependent on cell size, the invasion of Parental, Selected and Flow sorted cells 
were studied in a more physiologically relevant environment. To address this, a 
collagen matrix invasion assay in which tumour cells moved through a dense 
fibroblast-conditioned collagen gel, was used. Human primary fibroblasts were 
mixed with rat tail collagen1 and left for a week to allow conditioning and 
contraction of the collagen “plug”. The fibroblasts were then removed by 
treating the collagen disks with puromycin for 48 hours and subsequently washed 
twice with PBS. Once the matrices were prepared, cells were seeded on top and 
allowed to invade the collagen for 8 days. After this time, the collagen disks 
were fixed, paraffin-embedded and stained with H&E, and invasion distances 
were quantified using ImageJ. From this, I discovered that independent Selected 
MDA MB 231 cells invaded to a greater depth into the collagen relative to 
Parental and independent Flow sorted MDA MB 231 cells, indicating that Selected 
MDA MB 231 cells were more invasive in vitro (Figure 3-5). 
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Figure 3-4 No differences in proliferation rates between Parental, Selected and Flow sorted 
MDA MB 231 cells. 
Graph depicts mean (± SEM) cell number for Parental, Selected and Flow sorted MDA MB 231 
cells measured at 24, 48 and 72 hours. Data pooled from n = 4 independent experiments. 
Statistical significance determined by Kruskal - Wallis followed by Dunn’s multiple comparison test. 
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Figure 3-5 Selected MDA MB 231 cells invade to a greater depth into the collagen matrix. 
Representative images of invading cells into the collagen matrix showed for Parental, Selected and 
Flow sorted cells. Scale bar = 100 µm. Left graph depicts box and whiskers plot (1-99 percentile) 
representing the distance travelled by individual cells for Parental, independent Selected and 
independent Flow sorted populations. Data pooled from n = 3 independent experiments. Statistical 
significance determined by Kruskal - Wallis followed by Dunn’s multiple comparison test (**** = 
p<0.0001). Right graph depicts mean (± SEM) travelled distance for Parental, independent 
Selected and independent Flow sorted cell populations. Data pooled from n = 3 independent 
experiments. Statistical significance determined by Kruskal - Wallis followed by Dunn’s multiple 
comparison test. 
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3.2.3 Nuclear properties in constrained cell migration 
3.2.3.1 Rationale 
Due to the presence of narrow pores and channels in the complex architecture 
of the stromal tissue surrounding tumours, migration may become challenging 
for cancer cells. One of the biggest and stiffest cellular components, the nuclei, 
may become an obstacle in this process. Nuclear deformability is necessary for 
cells to be able to squeeze through the tight organization of the ECM (Khatau, 
Bloom et al. 2012). There are many factors that may dictate nuclear rigidity, 
such as lamin A/C, chromatin content and condensation (Lammerding 2011). The 
ratio of A-type lamin to B-type lamin in the nuclear lamina is proportional to 
tissue microelasticity. The lamina contains predominantly A-type lamins in stiff 
tissue, whereas B-type lamins are prevalent in the nuclear lamina in soft tissue 
(Swift and Discher 2014; Swift et al. 2013). Due to the strong influence that 
nuclear mechanical properties have been shown to have on migration through 
small gaps, as detailed in the introduction, I investigated several nuclear 
properties, including size, elasticity, lamin A/C expression, DNA content and 
chromatin condensation, to determine whether the nucleus was likely to be an 
important contributor to the invasive ability of Selected cells. All experiments 
described below were performed on MDA MB 231-D3H2LN cells. 
3.2.3.2 Results 
3.2.3.2.1 Nuclear size does not determine constrained cell migration ability 
of Selected MDA MB 231 cells 
Having identified that small cell size did not determine the increased confined 
migration ability of Selected cells, nuclei size was investigated next. To measure 
nuclei volume, z-stack sections of DAPI-stained nuclei were taken on a Zeiss 710 
confocal microscope, followed by quantification using the Volocity image 
analysis program. The program allowed me to fill in the fluorescent signal 
obtained by confocal microscopy and to determine nuclear volumes. Nuclei size 
measurements revealed comparable volumes for independent Selected and Flow 
sorted cell populations (Figure 3-6A). These results indicated that nuclear 
volume was not associated with differences in invasive ability of Parental, 
Selected and Flow sorted cells. 
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Moreover, isolated nuclei from each population of MDA MB 231 cells were also 
visualized using Scanning Electron Microscopy (SEM). The SEM images supported 
the previously obtained results. The results revealed smaller nuclei size of 
Selected and Flow sorted cells compared to Parental cells. Representative SEM 
images are shown in Figure 3-6B. 
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Figure 3-6 Selected and Flow sorted cells have smaller nuclear size relative to Parental 
cells. 
A) Graph represents mean nuclear volume (± SD) for Parental, independent Selected and 
independent Flow sorted cell populations. Data represent individual nuclei pooled from n = 3 
independent experiments. Images of DAPI-stained nuclei were taken on a Zeiss 710 confocal 
microscopy followed by nuclei volume determination using Volocity program. B) SEM 
representative images of isolated nuclei showing smaller nuclear size of Selected and Flow sorted 
cells compared to Parental cells. Scale bar = 5 µm. Statistical significance determined by Kruskal - 
Wallis followed by Dunn’s multiple comparison test. 
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3.2.3.2.2 Selected and Flow Sorted cells have increased nuclear stiffness but 
the expression of nuclear lamins is diminished 
After finding that nuclei volume did not determine the invasive ability of 
Selected cells, in the next step nuclei mechanical properties were investigated. 
In order to measure nuclei elasticity, a collaboration was established with the 
Engineering Department at Glasgow University. In the first step, nuclei were 
isolated using a Nuclei Isolation kit and subsequently seeded on glass bottom 3 
cm petri dishes in the lysis buffer provided with the kit. Once the nuclei had 
settled and attached on the dish, Young’s modulus values were obtained using 
Atomic Force Microscopy (AFM). Nuclei were probed with a 4.74 µm diameter 
spherical bead with a force of 3 nN and one measurement was taken per nuclei. 
These results revealed that Selected and Flow sorted cells had increased nuclear 
stiffness compared to Parental cells (Figure 3-7A).  
As it was reported that nuclear deformability may depend on lamin A/C 
expression level as detailed in the introduction, a western blot was performed. 
The membrane was probed with anti lamin A/C antibody and GAPDH (Figure 
3-7B). The blot showed decreased expression of lamin A/C in Selected and Flow 
sorted cells relative to Parental cells. The expression of Lamin B was not 
investigated.  
3.2.3.2.1 DNA content does not determine constrained migration ability of 
Selected cells 
As it was reported that nuclei may be a hindrance during compressive 
deformation using the micropipette aspiration technique (Rowat, Lammerding et 
al. 2006; Rowat, Lammerding et al. 2008), I wanted to investigate DNA content 
and its possible implication in enhanced constrained invasion of Selected cells. 
Firstly, DNA content was assessed by propidium iodide (PI) staining of fixed cells. 
PI is a commonly used dye to determine cell content/cycle. It intercalates into 
double-stranded DNA in proportion to DNA content. Cell cycle graphs of PI-
stained cells revealed an unusual cell cycle profile for Parental cells. It 
suggested that Parental cells contained more DNA compared to Selected and 
Flow sorted cells (Figure 3-8A).  
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Having identified increased DNA content in Parental cells, more detailed analysis 
of DNA content was performed. In order to quantify chromosome number, a 
collaboration was established with the Welcome Trust Centre for Human 
Genetics in Oxford and cytogenetic analyses of Parental, independent Selected 
and independent Flow sorted cell populations were performed. The experiment 
revealed that Parental cells are largely sub-tetraploid with an average 
chromosome number near 70, while Selected and Flow sorted cells were near 
diploid (Figure 3-8B,C). This confirmed that differences in constrained cell 
migration ability did not depend on chromosome number or DNA content. 
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Figure 3-7 Selected and Flow sorted cells have increased nuclear stiffness but Lamin A/C 
expression is diminished. 
A) Graph represents mean (± SD) of Young’s modulus (nuclear elasticity) showing an increase of 
nuclear stiffness of Selected and Flow sorted cells compared to Parental. Data represent individual 
nuclei pooled from n = 2 independent experiments. B) Lamin A/C and GAPDH expression levels 
showed for Parental, two independent Selected and two independent Flow sorted cell populations. 
Statistical significance determined by Kruskal - Wallis followed by Dunn’s multiple comparison test. 
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Figure 3-8 Parental cells have more DNA compared to Selected and Flow sorted cells. 
A) FACS analysis showing cell cycle distribution in Parental, Selected and Flow sorted cells. B) 
Representative relative frequencies of chromosomes numbers for Parental, Selected and Flow 
sorted cell populations. C) Mean chromosome number (± SEM) determined for independent 
Parental, independent Selected and independent Flow sorted cell populations. Each dot represents 
an average value from n = 20 cells. Data pooled from n = 3 independent experiments. Statistical 
significance determined by Kruskal - Wallis followed by Dunn’s multiple comparison test. 
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3.2.3.2.2 Selected and Flow sorted cells have more condensed chromatin 
compared to Parental cells 
As discussed in the introduction, chromatin condensation plays an important role 
in directed cell migration. Condensation of chromatin may influence physical 
properties of the nucleus and its ability to pass through small pores. The 
organization of chromatin is determined by post-translational modification of 
histones tails. One of the histone modifications which is involved in repression of 
transcription and known to be associated with condensed forms of chromatin is a 
trimethylation of histone H3 at lysine 27 (H3K27me3) (Kouzarides 2007). To 
assess chromatin condensation, cells were fixed and immunostained for the 
heterochromatin marker H3K27me3. Immunofluorescence of H3K27me3 showed a 
punctate pattern of staining in Selected and Flow sorted cells, while H3K27me3-
immunostained nuclei of Parental cells were characterized by more diffuse 
staining. These results suggested that Selected and Flow sorted cells might have 
had more condensed chromatin. Representative images of cells stained with 
H3K27me3 antibody are shown in Figure 3-9A. 
Given the possibility that chromatin compaction was a determinant of enhanced 
invasion of Selected cells, after finding that Selected and Flow sorted cells had 
increased staining of heterochromatin marker H3K27me3, chromatin 
condensation levels were determined by applying a Förster resonance energy 
transfer (FRET)-based assay using Fluorescence Lifetime Imaging Microscopy 
(FLIM) previously described by Lleres et al. (Lleres, James et al. 2009). FRET can 
be used to detect protein-protein interactions in live cells and it is highly 
distance dependent, two proteins need to be within ~1-10 nm distance. Briefly, 
FLIM was used to measure FRET between histone proteins H2B fused to either 
GFP (donor fluorophore) or mCherry (acceptor fluorophore) in interphase nuclei. 
If chromatin is in a more compacted state, FRET decreases the donor 
fluorescence and increases the acceptor fluorescence, and by using FLIM the 
decreased donor fluorescence life time (time difference between fluorophore 
excitation and photon emission) can be measured. Fluorescence lifetimes were 
measured using LI-FLIM software. 
In order to evaluate if changes in chromatin compaction in MDA MB 231 cells 
could be detected using this FLIM-FRET approach, the experiment was 
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performed by treating cells with 2-deoxyglucose (2-DG) and sodium azide (NaN3). 
2-DG and sodium azide treatment induces ATP depletion and leads to extensive 
chromatin compaction. After transfection with H2B-GFP and H2B-mCherry 
plasmids using Amaxa Nucleofactor Kit V, cells were incubated in standard tissue 
culture conditions for 72 hours to let histones incorporate into chromatin. 30 
minutes before acquiring images on the FLIM microscope, cells were treated 
with 50 mM 2-DG plus 10 mM sodium azide or control cells with dH2O. As a 
result, extensive chromatin compaction was observed, which was indicated by 
decreased life time of the donor fluorophore in Parental and Selected cells 
compared to control cells, independent of differences in DNA content (Figure 
3-9B). 
After validation that changes in chromatin condensation could be detected in 
MDA MB 231 cells, the experiment was continued to determine chromatin 
compaction in Parental, Selected and Flow sorted cells. Cells were transected 
with H2B-GFP and H2B-mCherry plasmids and left for 72 hours at standard tissue 
culture conditions. After 72 hours images were obtained on the FLIM microscope. 
The results showed that Selected and Flow sorted cells had decreased life time 
of donor fluorophore GFP relative to Parental cells, meaning that chromatin in 
those cell lines was more compacted (Figure 3-9C).  
The chromatin was also visualized by transmission electron microscopy (TEM). 
TEM images showed more condensed material in Selected cells, which likely was 
more condensed heterochromatin (Figure 3-9D). These results indicated that 
chromatin compaction alone does not determine the invasive phenotype of 
Selected cells. Instead, the level of chromatin condensation correlated with 
small nuclei volume and chromatin content. 
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Figure 3-9 Selected and Flow sorted cells have more condensed chromatin compared to 
Parental cells. 
A) Representative images of H3K27me
3
-immunostained nuclei of Parental, Selected and Flow 
sorted MDA MB 231 cells. Scale bar = 5 µm. B) Left graph represents the range of changes in the 
fluorescence life time in Parental MDA MB 231 cells upon treatment with 2-DG and sodium azide. 
Right graph represents the range of changes in the fluorescence life time in Selected MDA MB 231 
cells upon treatment with 2-DG and sodium azide. Data depicts individual cells pooled from n = 2 
independent experiments, with mean (± SD) indicated. Statistical significance determined by Mann 
- Whitney test. C) Graph depicts the range of changes in the fluorescence life time in Parental, 
Selected and Flow sorted MDA MB 231 cells. Data depicts individual cells pooled from n = 2 
independent experiments, with mean (± SD) indicated. Statistical significance determined by 
Kruskal - Wallis followed by Dunn’s multiple comparison test. D) Representative TEM images of 
isolated nuclei. White arrows indicate heterochromatin. Scale bar = 1 µm.  
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Table 3-1 Summary of nuclear properties. 
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3.2.4 In vitro selection of MDA MB 435 cells using cell culture 
inserts  
Having showed that there were cells with augmented constrained invasion 
capacities within MDA MB 231 Parental cell populations, I next wanted to explore 
this finding using another cancer cell line. For this reason, MDA MB 435 
melanoma cancer cells were chosen. MDA MB 435 Parental cells were subjected 
to the same 3 µm selection strategy as described for MDA MB 231 cells. Three 
independent Selected MDA MB 435 cell populations were obtained. In order to 
validate Parental and Selected MDA MB 435 cells constrained migration ability, 
6.5 mm Transwell inserts with 3 µm and 8 µm pore membranes were used and 
the Transwell migration assay was conducted. The results revealed that 
independent Selected MDA MB 435 cells were significantly more migratory 
through 3 µm and 8 µm pores, respectively compared to Parental MDA MB 435 
cells (Figure 3-10). 
3.2.5  No difference in proliferation between Parental and 
Selected MDA MB 435 cells in vitro 
Before undertaking any further experiments, proliferation rates of Parental and 
Selected MDA MB 435 cells, were checked. To assess cell proliferation rates, 
30,000 cells per well were seeded in 12-well plates in triplicates. Cell number 
was measured after 24, 48 and 72 hours using a CASY® Cell Counter. From this, I 
was able to determine that there was no difference in the proliferation rates 
between Parental and Selected MDA MB 435 cells (Figure 3-11). 
3.2.6 Selected MDA MB 435 cells have smaller cell area and 
invade to a greater depth in fibroblast conditioned collagen 
matrix compared to Parental MDA MB 435 cells 
After discovering that 3 µm pore selection of MDA MB 231 cells enriched for cells 
with smaller cell area and volume, I wanted to find out whether it was also 
similar for MDA MB 435 cells. In order to evaluate these possible differences, I 
measured cell areas and volumes of Parental and independent Selected MDA MB 
435 cell populations as described for MDA MB 231 cells. The results revealed that 
independent Selected MDA MB 435 cells had significantly smaller 2D cell areas 
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(Figure 3-12A) and 3D cell volumes (Figure 3-12B), respectively, relative to 
Parental MDA MB 435 cells.  
To evaluate the invasive behaviour of Parental and independent Selected MDA 
MB 435 cell populations in a more physiologically relevant environment, 
fibroblast conditioned collagen matrices were utilized as described for MDA MB 
231 cells. Invading distances were quantified with ImageJ. The results revealed 
that independent Selected MDA MB 435 cells invaded to a greater depth into the 
collagen compared to Parental MDA MB 435 cells (Figure 3-13). These results 
indicated that within the Parental population of MDA MB 435 cells, there were 
cells with greater constrained invasive behaviours. 
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Figure 3-10 Selected MDA MB 435 cells are more migratory through 3 and 8 µm pores 
relative to Parental MDA MB 435 cells. 
Left graph depicts mean (± SEM) relative 3 µm migration for Parental and independent Selected 
MDA MB 435 cell populations. Right graph depicts mean (± SEM) relative 8 µm migration for 
Parental and independent Selected MDA MB 435 cell populations. Each dot represents an average 
value from n = 3 wells. Data pooled from n ≥ 3 independent experiments. Statistical significance   
determined by Mann - Whitney test. 
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Figure 3-11 No differences in proliferation rates between Parental and Selected MDA MB 435 
cells. 
Graph depicts mean (± SEM) cell number for Parental and Selected MDA MB 435 cells measured 
at 24, 48 and 72 hours. Data pooled from n = 3 independent experiments. Statistical significance 
determined by Kruskal - Wallis followed by Dunn’s multiple comparison test. 
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Figure 3-12 Selected MDA MB 435 cells have smaller cell size relative to Parental MDA MB 
435 cells. 
A) Graph depicts mean (± SEM) cell area for Parental and independent Selected MDA MB 435 cell 
populations. Each dot represents an average from n = 6 fields per well, from at least 200 cells per 
field. Data pooled from n = 3 independent experiments. Right graph depicts relative frequency of 
cell area for Parental and independent Selected MDA MB 435 cell populations. Cell area was 
determined by using Operetta High Content Imaging System. B) Graph represents mean (± SEM) 
cell volume for Parental and independent Selected MDA MB 435 cell populations. Cell volume was 
determined by measuring cell diameter. Each dot represents an average value from n = 3 
measurements. Data pooled from n = 4 independent experiments. Statistical significance   
determined by Mann - Whitney test. 
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Figure 3-13 Selected MDA MB 435 cells invade to a greater depth into collagen matrix. 
Representative images of invading cells into the collagen matrix showed for Parental and Selected 
MDA MB 435 cells. Scale bar = 100 µm. Left graph depicts box and whiskers plot (1-99 percentile) 
representing the distance travelled by individual cells for Parental and independent Selected MDA 
MB 435 cell populations pooled from n = 3 independent experiments. Statistical significance 
determined by Kruskal - Wallis followed by Dunn’s multiple comparison test (**** = p<0.0001). 
Right graph depicts mean (± SEM) travelled distance for Parental and independent Selected MDA 
MB 435 cell populations pooled from n = 3 independent experiments. Statistical significance 
determined by Mann - Whitney test. 
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3.3 Conclusions 
To reveal invasive traits of cancer cells, I adopted an in vitro selection strategy 
with a successful outcome. As shown in this chapter, I have presented results 
indicating that the in vitro 3 µm pore selection strategy can be used to enrich 
for cells with enhanced invasive properties, as shown for MDA MB 231 and MDA 
MB 435 cells. By applying the 3 µm pore migration and 3D collagen invasion 
assays, I found that Selected cells are characterized by greater constrained 
invasion capacities. Additionally, to test the possibility that cell size was a major 
determinant for the enhanced constrained invasion of Selected cells, I adopted 
an additional selection strategy that allowed me to directly study this 
parameter. I revealed that the invasive properties by Selected MDA MB 231 cells 
were not solely a reflection of small cell size.  
Furthermore, I have presented data showing that nuclear size did not determine 
the greater invasive capabilities of Selected MDA MB 231 cells. By studying 
nuclear mechanical properties, I showed that Selected and Flow sorted MDA MB 
231 cells had increased nuclear stiffness relative to Parental cells; however this 
was not associated with relatively higher Lamin A/C expression. Moreover, the 
expression of Lamin B was not investigated. Investigation of nuclear content and 
chromatin condensation revealed that both of these properties also did not 
determine the invasive phenotype of Selected MDA MB 231 cells. However, the 
reduction in chromosome number correlated with decreased nuclear and cell 
volume; additionally the decreased chromosome number correlated with more 
condensed chromatin (Table 3-1). 
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4 In vivo cell properties 
4.1 Rationale 
Having identified enhanced invasion properties of Selected MDA MB 231 and MDA 
MB 435 cells in vitro, I next wanted to investigate their metastatic potential in 
vivo. In order to perform these experiments, a collaboration was established 
with the Transgenic Models Advanced Technology Service (Cancer Research UK 
Beatson Institute). In order to assess the aspects of cancer growth and spread of 
Parental, Selected and Flow sorted MDA MB 231 cells, cells were orthotopically 
injected into the mammary fat pads of immune-compromised mice. In addition, 
all isolated cell populations from both cell lines, MDA MB 231 and MDA MB 435, 
were injected into the tail veins of immune-compromised mice. 
In order to assess in vivo metastatic and growth properties, there are numerous 
in vivo models available. In xenograft transplantation, human cells are 
inoculated into immune-compromised mice under the skin or into the organ 
corresponding to that from which the cancer cells were derived (orthotopic) 
(Khanna and Hunter 2005). A major advantage of these models is the possibility 
to study metastasis of human cancer cells in an in vivo context. Moreover, it 
resembles the human situation, with changes in tumour-associated vascularity, 
tumour-stroma interactions, gene expression patterns and metastases. On the 
other hand, due to the lack of a fully functional immune system, the input of the 
immune system to metastatic progression cannot be evaluated (Jonkers and 
Derksen 2007).  
To study breast cancer progression, orthotropic injection of cancer cells into 
mammary fad pads can be utilised. This in vivo model allows for the assessment 
of tumour growth, and the metastatic progression process, from primary sites to 
metastasis formation. Such a transplantation model of metastatic dissemination 
is referred to as spontaneous metastasis (Kocaturk and Versteeg 2015). In the 
experimental metastasis assay, tumour cells are injected directly into the 
systemic circulation. Cancer cells can be injected via various routes such as 
lateral tail vein, intra-portal, intra-cardiac etc. Depending on the injection route 
and tropism of the tumour cells, distant metastatic sites may be manifested in 
different organs throughout the body (Khanna and Hunter 2005). The most 
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commonly used experimental metastasis assay is the injection of cancer cells 
into the tail vein. Such a route of cancer cell injection mostly leads to 
development of metastatic foci in lungs (Khanna and Hunter 2005). This 
transplantation model reproduces the later steps of the metastatic cascade, 
extravasation and organ colonisation. 
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4.2 Results 
4.2.1 Selected MDA MB 231 cells show a trend towards enhanced 
tumourigenicity in vivo relative to Parental and Flow sorted 
MDA MB 231 cells 
To investigate the in vivo properties of MDA MB 231 cells, 1x106 of Parental, 
Selected and Flow sorted  MDA MB 231 cells were injected in 50 µl PBS:matrigel 
(1:1) into fourth abdominal fat pads of female CD1 nude mice. Tumour 
measurements were taken over the course of the study, starting at the day when 
tumours became palpable (day 0). Tumour volumes were quantified using the 
formula 1/2(Length × Width2). When one of the tumours reached 15 mm in 
diameter, animals were sacrificed, the primary tumours and the lungs were 
harvested and weighed. Moreover, in order to visualise tumour growth, mice 
were injected with 150 mg/kg of D-luciferin in PBS prior to sacrifice. 
Bioluminescence images were acquired 5 min after injections in order to allow 
for the distribution of D-luciferin within the entire body of the animal. Images 
were acquired using the IVIS Spectrum Imaging System. One mouse injected with 
Selected MDA MB 231 cells developed a palpable tumour at day 14 and it was 
excluded from further analysis.  
Analysis of tumour volumes and weights revealed that Selected MDA MB 231  
cells injected into the mammary fat pads of immune-compromised mice showed 
a trend towards a slight increase of tumourigenic potential relative to Parental 
and Flow sorted MDA MB 231 cells (Figure 4-1) (Figure 4-2). 
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Figure 4-1 IVIS images of tumours derived from Parental, Selected and Flow sorted cells 
injected into the mammary fat pads of immuno-compromised mice. 
Bioluminescent Parental, Selected and Flow sorted MDA MB 231 cells were injected into the 
mammary fat pads of nude mice and tumours size was monitored by imaging them with the IVIS 
Spectrum Imaging System. Images represent tumours size at day 17.  
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Figure 4-2 Selected MDA MB 231 cells show a trend towards an enhanced tumourigenicity in 
vivo relative to Parental and Flow sorted MDA MB 231 cells. 
A) Growth curves of primary tumour volume (± SD) for tumours derived from Parental, Selected 
and Flow sorted MDA MB 231 cells injected into mammary fat pads. B) Graphs represent mean (± 
SD) tumour volume for tumour derived from Parental, Selected and Flow sorted mammary fat pad-
injected cells at days 10, 12, 14, 17. C) Graph depicts mean (± SD) tumour weight for tumour 
derived from Parental, Selected and Flow sorted MDA MB 231 mammary fat pads-injected cells. 
Each dot represents data obtained from n = 1 mouse. Statistical significance determined by 
Kruskal - Wallis followed by Dunn’s multiple comparison test. 
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4.2.1.1 Selected MDA MB 231 cells show a trend towards increased 
proliferation in vivo relative to Parental and Flow sorted MDA MB 231 
cells 
Proliferation of cells in primary tumours from mice injected with Parental, 
Selected or Flow sorted MDA MB 231 were determined by staining for anti-BrdU 
(5-bromo-2’-deoxyuridine) incorporation. Mice were injected intraperitoneally 
two hours prior to sacrifice, and paraffin embedded tumour section were stained 
with BrdU antibody. The number of BrdU-positive cells was quantified per total 
cell number (excluding necrotic areas) using Leica Biosystems software. Analysis 
of BrdU-stained tumour sections revealed that Selected MDA MB 231 cells 
showed a trend towards increased proliferation relative to Parental and Flow 
sorted MDA MB 231 cells (Figure 4-3).  
Necrotic foci were quantified on H&E-stained tumour sections. Large areas of 
necrotic foci were seen in all tumour sections obtained from all Parental, 
Selected and Flow sorted cell-injected mice. The necrotic areas were quantified 
as a percentage necrotic area relative to total tumour area using Leica 
Biosystems software. The analysis revealed that there were no differences in 
necrotic foci between Parental, Selected and Flow sorted MDA MB 231 cells 
(Figure 4-3). 
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Figure 4-3 Selected MDA MB 231 cells show a trend towards increased proliferation in vivo 
relative to Parental MDA MB 231 cells. 
Representative images of BrdU-stained tumour sections of Parental, Selected and Flow sorted 
MDA MB 231 cells. Scale bar = 100 µm. Left graph depicts mean (± SD) of BrdU-positive cells / 
total cells in tumour sections for Parental, Selected and Flow sorted MDA MB 231 cells. Right 
graph depicts mean (± SD) percent of necrotic area in tumour sections for Parental, Selected and 
Flow sorted MDA MB 231 cells. Each dot represents data obtained from n = 1 mouse. Statistical 
significance determined by Kruskal - Wallis followed by Dunn’s multiple comparison test. 
 
105 
 
4.2.1.2 No visible lung metastatic sites in mice injected with Parental, 
Selected and Flow sorted MDA MB 231 cells 
In order to detect micrometastasis in the harvested lungs of mice injected with 
Parental, Selected and Flow sorted MDA MB 231 cells, H&E- and Human 
Leukocyte Antigen (HLA)-stained sections were analysed. Analysis of H&E 
sections revealed no detectable micrometastasis in the lung sections. 
Anti-HLA staining was used as a specific marker to detect human cells within 
murine lung tissue. HLA is present on most nucleated human cells. Five serial 
sections were prepared per mouse lung and stained with anti-HLA antibody. The 
staining revealed no detectable HLA-positive micrometastatic sites in the 
harvested lungs. 
Furthermore, in order to detect human cells in murine lungs, RT-qPCR was 
performed. RNA was extracted from harvested lungs. Specific primers for human 
GAPDH were used and Mouse Beta-2-microglobulin (β-2-M) as a housekeeping 
reference gene. The analysis revealed no detectable tumour cell specific mRNA 
present in the lung tissues.  
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4.2.2 Parental MDA MB 231 cells show a trend towards an 
increase in metastatic potential in vivo in the experimental 
metastasis assay 
In order to assess the metastatic potential of MDA MB 231 cells, Parental, 
Selected and Flow sorted cells were injected into the tail vein of immune-
compromised mice. In brief, 1x106 Parental and Selected cells in 100 µl of PBS 
were injected into the lateral tail vein of female CD1 nude mice (8 mice per 
condition). After 6.5 weeks, mice were sacrificed and lungs were harvested. H&E 
staining was performed on paraffin-embedded lung sections and lung metastasis 
was assessed. 5 serial sections were made per harvested lung. Analysis of H&E 
sections showed the presence of metastatic nodules and thickening of the 
alveolar septa. Analysis of metastatic score revealed that six out of eight mice 
injected with Parental MDA MB 231 cells developed metastatic nodules. Four out 
of eight mice injected with Selected MDA MB 231 cells developed metastatic 
foci, while three out of eight mice injected with Flow sorted MDA MB 231 cells 
developed metastases (Figure 4-4).  
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Figure 4-4 Parental MDA MB 231 cells show a trend towards an increase in metastatic 
potential in vivo in the experimental metastasis assay. 
Representative H&E-stained lung sections from mice injected with Parental, Selected and Flow 
sorted MDA MB 231 cells showing more tumour foci in mice injected with Parental cells. Black 
arrows indicate metastatic nodules and green arrows indicate thickening of the alveolar septa. 
Scale bar 100 µm. Left graph depict mean (± SD) lung metastasis score in lungs harvested from 
mice injected with Parental, Selected and Flow sorted MDA MB 231 cells. Right graph depicts 
mean (± SD) lung weight harvested from mice injected with Parental, Selected and Flow sorted 
MDA MB 231 cells. Each dot represents data obtained from n = 1 mouse. Statistical significance 
determined by Kruskal - Wallis followed by Dunn’s multiple comparison test. 
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4.2.3 Selected MDA MB 435 cells show a trend towards an 
increase in metastatic potential in vivo in the experimental 
metastasis assay 
In order to assess the metastatic potential of MDA MB 435 cells, Parental and 
Selected cells were injected into the tail veins of immune-compromised mice. In 
brief, 1x106 Parental and Selected cells in 100 µl of PBS were injected into the 
lateral tail vein of female CD1 nude mice (7 mice per condition). After 6.5 
weeks, mice were sacrificed and lungs were harvested. H&E staining was 
performed on paraffin-embedded lung sections and lung metastasis was 
assessed. Analysis of H&E sections showed the presence of metastatic nodules 
and thickening of the alveolar septa. 5 serial sections were made per each 
harvested lung. Analysis of metastatic score revealed that five out of seven mice 
injected with Selected MDA MB 435 cells developed metastatic nodules. Three 
mice had 1, 2 or 3 visible tumour foci in their lungs, whereas the other two 
developed high numbers of metastatic foci, 16 or 18 (Figure 4-5). Furthermore, 
two out of seven mice developed a tumour at a lumbar region. Histopathological 
analysis of H&E-stained tumours revealed that the lumbar tumours consisted of 
injected Selected cells and that the tumour cells invaded into the muscle region 
(Figure 4-6). Two mice out of seven injected with Parental MDA MB 435 cells 
developed 3 metastatic lesions each in the lung.  
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Figure 4-5 Selected MDA MB 435 cells show a trend towards an increase in metastatic 
potential in vivo in the experimental metastasis assay. 
Representative H&E-stained lung sections from mice injected with Parental or Selected MDA MB 
435 cells showing more tumour foci in mice injected with Selected cells. Black arrows indicate 
metastatic nodules and green arrows indicate thickening of the alveolar septa. Scale bar = 100 µm. 
Left graph depicts mean (± SD) lung metastasis score in lungs harvested from mice injected with 
Parental and Selected MDA MB 435 cells. Right graph depicts mean (± SD) lung weight harvested 
from mice injected with Parental and Selected MDA MB 435 cells. Each dot represents data 
obtained from n = 1 mouse. Statistical significance determined by Mann - Whitney test. 
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Figure 4-6 Two mice injected with Selected MDA MB 435 cells develop tumour at a lumbar 
region. 
A) Photo showing a developed tumour at the lumbar region in mice injected with Selected MDA MB 
435 cells. B) H&E staining of tumour developed at the lumbar region in mice injected with Selected 
MDA MB 435 cells. The image shows that the tumour consists of Selected MDA MB 435 cells and 
invasion of Selected cells into the muscle region.  
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4.3 Conclusions 
In this chapter I have presented data describing the metastatic and growth 
potential of Parental, Selected and Flow sorted MDA MB 231, and Parental and 
Selected MDA MB 435 cell lines. Taking advantage of MDA MB 231 cells being 
breast cancer cells, their in vivo metastatic and growth abilities were assessed 
by injecting them into the mammary fat pads of immune-compromised mice and 
monitoring their growth over the course of the study. From this experiment, I 
found that Selected MDA MB 231 cells showed a trend towards increased 
tumourigenic potential in comparison to Parental and Flow sorted MDA MB 231 
cells. Due to the short duration of the experiment, there were no metastatic 
foci found in the lungs in any of the injected mouse.  
In order to assess the metastatic potential of Parental, Selected and Flow sorted 
MDA MB 231 cells, cells were injected into the tails of immune-compromised 
mice. The analysis of H&E-stained lung sections revealed a trend towards 
increased number of metastatic sites in lungs of mice injected with Parental 
cells. Such results are not surprising since Parental MDA MB 231-luc-D3N2LN cells 
are derived from spontaneous lymph node metastasis of MDA MB 231 cells and 
possess enhanced growth and widespread metastasis in mice (Jenkins, Hornig et 
al. 2005). Additionally, Parental cells due to their bigger size may lodge in 
pulmonary capillaries, where they formed tumours, while the smaller size of 
Selected and Flow Sorted cells might have reduced the number getting stuck, 
therefore leading to fewer tumours.  
In order to assess the metastatic potential of Parental and Selected MDA MB 435 
cells, cells were injected into the tail veins of immune-compromised mice. The 
analysis of H&E-stained lungs revealed a trend towards increased number of 
metastatic sites in lungs of mice injected with Selected MDA MB 435 cells. 
Additionally, two mice injected with Selected MDA MB 435 cells developed 
tumours at a lumbar region.  
In conclusion, these results revealed that there were no significant differences 
in the metastatic or tumourigenic potential between Parental, Selected and 
Flow sorted MDA MB 231 cell lines and between Parental and Selected MDA MB 
435 cells. Such lack of differences could be explained by the limitations of the 
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experimental metastatic in vivo model used, such as it only reproduces the later 
steps of the metastatic cascade, extravasation and organ colonisation, therefore 
the stages of the metastasis cascade might be irrelevant for this assay. 
Furthermore, tumours which were derived from Selected MDA MB 231 or MDA MB 
435 cells may revert back to parental-like phenotype. 
 
 
 
5 Determination of cell mechanical properties and 
behaviour 
5.1 Rationale 
A number of cellular changes occur that enable cancer cells to become invasive 
and metastatic; however many of the metastatic cascade steps require 
enhanced cell motility which is driven by a cycle of actin polymerisation, cell 
adhesion and acto-myosin contraction (Olson and Sahai 2009). The cell 
cytoskeleton plays not only a dominant role in driving cell migration and 
invasion, but also by creating a network of actin filaments, it shapes and 
provides a structural support that subsequently contributes to cell mechanical 
rigidity (Blanchoin, Boujemaa-Paterski et al. 2014; Grady, Composto et al. 
2016). From a mechanical perspective, a cell can be considered as an elastic 
material that will deform if subjected to an applied external force, and which 
will recover its shape when the force is removed (Kuznetsova, Starodubtseva et 
al. 2007).  As the stiffness of a material increases, more force is necessary to 
deform its shape, which is a reflection of the material’s elasticity and can be 
quantitatively represented as its Young’s modulus (Polacheck and Chen 2016). 
 Multiple studies have reported that malignant cancer cells are more easily 
deformed than normal cells (Cross, Jin et al. 2008; Swaminathan, Mythreye et 
al. 2011) and such biological adaptations of cell mechanical rigidity may 
facilitate cancer cell invasion and metastasis. Although the actin cytoskeleton is 
known to be the major determinant of cell elasticity (McPhee, Dalby et al. 2010; 
Ketene, Schmelz et al. 2012), the mechanistic signalling pathways and potential 
contributors have not been identified yet. Besides the cytoskeleton being a 
known cell elasticity determinant, it has been shown that lipid bilayers also 
possess bending and compression elasticity (Espinosa, Lopez-Montero et al. 
2011). In order to investigate cell mechanical properties, Atomic Force 
Microscopy (AFM) was utilised. Potential contributors of mechanical properties, 
cytoskeleton structures and membrane fluidity, were studied as described 
below. Furthermore, dysregulation in cancer cell adhesiveness has been shown 
to facilitate cancer cell migration and invasion (Cavallaro and Christofori 2001; 
Yoshimura, Hamada et al. 2016). Therefore, to address the questions whether 
there were differences in migration, spreading and adhesion properties between 
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Parental, Selected and Flow sorted MDA MB 231, and Parental and Selected MBA 
435 cells, a set of experiments to explore these phenotypes was performed as 
described below. 
5.2 Results 
5.2.1 Selected MDA MB 231 have reduced stiffness compared to 
Parental and Flow sorted MDA MB 231 cells as measured by 
Atomic Force Microscopy (AFM) 
Given the possibility that cell mechanical properties may play an important role 
in enabling Selected MDA MB 231 cells to squeeze through constraining 
environments, the elasticity of Parental, Selected and Flow sorted MDA MB 231 
cells were investigated. In order to measure cell mechanical properties, Atomic 
Force Microscopy was utilised in collaboration with the Engineering Department 
at Glasgow University. In order to perform the experiment, cells were seeded in 
3 cm petri dishes and incubated 24 hours in standard tissue culture conditions 
prior the experiment. During the experimental procedure, cells were kept in 
standard tissue culture conditions and 1% HEPES was added to the media to 
maintain the pH level. Cells were probed with a 4.74 µm diameter spherical 
bead and force of 3 nN. Five measurements were taken on the nuclear area and 
an average of Young’s modulus value was determined per cell. The results 
revealed that Selected MDA MB 231 cells had significantly decreased Young’s 
modulus values relative to Parental and Flow sorted MDA MB 231 cells (Figure 
5-1), suggesting that Selected MDA MB 231 cells were more easily deformed than 
Parental and Flow sorted MDA MB 231 cells. 
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Figure 5-1 Selected MDA MB 231 cells have decreased Young’s modulus relative to Parental 
and Flow sorted MDA MB 231 cells. 
The graph depicts mean (± SD) Young’s modulus measured for Parental, Selected and Flow sorted 
cells. Young’s modulus was determined by applying AFM. Data represent individual cells pooled 
from n = 4 independent experiments. Statistical significance determined by Kruskal - Wallis 
followed by Dunn’s multiple comparison test. 
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5.2.2 Selected MDA MB 231 cells have more isotropic actin 
alignment compared to Parental and Flow sorted MDA MB 
231 cells 
Having identified decreased stiffness of Selected MDA MB 231 cells, the 
organisation of the cytoskeleton, was investigated as a potential contributor of 
elasticity. As it has been reported that transitions from isotropic to anisotropic 
fibrillary actin ordering have been associated with increased cell stiffness 
(Gupta, Sarangi et al. 2015), actin cytoskeleton structures were visualised using 
a Zeiss 880 high resolution confocal microscopy. Phalloidin staining revealed that 
Selected MDA MB 231 cells had more ruffled-like F-actin with short actin 
filaments, while Parental and Flow sorted MDA MB 231 cells had longer and more 
aligned actin stress fibre organisation (Figure 5-2A). 
In order to quantify actin alignment, an ImageJ plug-in Fibril Tool was utilised. 
Fibril Tool allowed quantification of fibre anisotropy. In order to be consistent 
with a z-plane image of stained F-actin taken for the anisotropy analysis, Total 
Internal Reflection Fluorescence microscopy (TIRF) images were used. TIRF 
microscopy allowed visualisation of fluorescent molecules within 200 nm from 
the cell-coverslip interface. Such location corresponded to the cortical actin 
position. TIRF images revealed organised long actin filaments in Parental and 
Flow sorted MDA MB 231 cells, while phalloidin-stained Selected MDA MB 231 
cells had more diffused cortical actin staining (Figure 5-2A). Analysis of actin 
anisotropy showed that Selected MDA MB 231 cells had significantly decreased 
actin anisotropy compared to Parental and Flow sorted MDA MB 231 cells, 
suggesting that Selected cells had more disorganised actin organisation (Figure 
5-2B). 
5.2.2.1 Cytochalasin D disrupts actin structure and reduces cell stiffness 
In order to determine whether the changes in cell stiffness of Parental, Selected 
and Flow sorted MDA MB 231 cells might have depended on difference in actin 
organisation, a control experiment with Cytochalasin D (CytoD) treatment was 
performed. CytoD is a cell permeable inhibitor that blocks actin polymerisation 
and elongation. First, the effect of CytoD was validated by microscopy 
visualisation. Cells were treated with 0.5 µM CytoD or vehicle control DMSO for 2 
hours and incubated in standard tissue culture conditions. After incubation, cells 
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were fixed, stained with phalloidin and subsequently actin was visualised on a 
Zeiss 710 confocal microscopy. The images revealed that CytoD-treated cells had 
disrupted actin stress fibre organisation compared to vehicle-treated cells 
(Figure 5-3A). 
After validation that CytoD disorganised actin structure, AFM measurements 
were performed on CytoD-treated Parental MDA MB 231 cells. Prior to the AFM 
measurements, cells were incubated with 0.5 µM CytoD for 2 hours, and control 
cells were treated with DMSO. The results revealed a reduction in Young’s 
modulus upon CytoD treatment compared to DMSO-treated cells (Figure 5-3B).  
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Figure 5-2 Selected MDA MB 231 cells have more isotropic actin alignment relative to 
Parental and Flow sorted MDA MB 231 cells. 
A) Left column shows maximal projection images of phalloidin-stained cells showing F-actin 
structures. The images were taken on a Zeiss 880 confocal microscope. Scale bar 10 µm. Right 
column shows representative images of phalloidin-stained cells showing cortical actin structure. 
Images were taken by TIRF microscopy. Scale bar 10 µm. B) Graph depicts mean (± SD) F-actin 
anisotropy for Parental, independent Selected and independent Flow sorted cell populations. Data 
represent individual cells pooled from n = 3 experiments. Statistical significance determined by 
Kruskal - Wallis followed by Dunn’s multiple comparison test.  
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Figure 5-3 CytochalasinD treatment of Parental MDA MB 231 cells disrupts actin 
organisation and leads to decreased cell stiffness.  
A) Representative images of phalloidin-stained Parental, Selected and Flow sorted MDA MB 231 
cells treated with Cytochalasin D or DMSO. Images were taken on a Zeiss 710 confocal 
microscope. Scale bar 10 µm. B) Graph depicts mean (± SD) Young’s modulus measured for 
Parental cells treated with DMSO or Cytochalasin D. Data represent individual cells from n = 1 
experiment. Statistical significance determined by Kruskal - Wallis followed by Dunn’s multiple 
comparison test.  
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5.2.3 Selected MDA MB 231 cells have fewer focal adhesions 
compared to Parental and Flow Sorted MDA MB 231 cells 
Having identified a disorganised actin organisation in Selected MDA MB 231 cells 
and more aligned actin fibres in Parental and Flow sorted MDA MB 231 cells, the 
assembly of focal adhesion (FA) complexes was investigated next. Focal 
adhesions provide a contact between the actin cytoskeleton and the external 
environment through the interaction of transmembrane proteins, such as 
integrins, with their extracellular ligands, and intracellular protein complexes 
linked to the actin cytoskeleton (Burridge and Guilluy 2016). In order to visualise 
focal adhesions, cells were fixed and stained with pFAK antibody and 
subsequently visualized on a Zeiss 710 confocal microscope. The images revealed 
that Selected MDA MB 231 cells had fewer and less pronounced focal complexes 
relative to Parental and Flow sorted MDA MB 231 cells, which were characterized 
by more mature and larger focal assemblies (Figure 5-4A). The number of focal 
adhesions complexes were counted using ImageJ. Number of FA was counted per 
cell. The average number of focal adhesions per group was counted per cell and 
then normalized to the cell area, which was determined from Operetta High 
Content Imaging System. This revealed that Selected MDA MB 231 cells had 
significantly fewer focal adhesions per cell and per cell area compared to 
Parental and Flow sorted MDA MB 231 cells (Figure 5-4B). In terms of anti-pFAK 
staining, it is predominantly used for detection of tension differences. In order 
to reveal more differences in number of focal adhesions, antibodies against 
paxilin or talin could be used.   
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Figure 5-4 Selected MDA MB 231 cells have fewer focal adhesions relative to Parental and 
Flow sorted MDA MB 231 cells. 
A) Representative images of pFAK-stained focal adhesions and phalloidin-stained F-actin for 
Parental, Selected and Flow sorted MDA MB 231 cells. Scale bar 10 µm. B) Top panel – left graph 
depicts focal adhesions per individual cell for Parental, independent Selected and independent 
Flow sorted MDA MB 231 cells. Data depicts individual cells pooled from n = 3 independent 
experiments, with mean (± SD) indicated. Right graph depicts mean (± SEM) focal adhesions per 
cell (n = 12 – 15 cells per experiment) for Parental, independent Selected and independent Flow 
sorted MDA MB 231 cells. Data from n = 3 independent experiments.  Bottom panel – mean (± 
SEM) focal adhesions per cell per mean cell area (n = 12 – 15 cells per experiment) for Parental, 
independent Selected and independent Flow sorted MDA MB 231 cells. Data pooled from n = 3 
independent experiments. Statistical significance determined by Kruskal - Wallis followed by 
Dunn’s multiple comparison test. 
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5.2.4 No difference in membrane fluidity between Parental, 
Selected and Flow sorted MDA MB 231 cells 
Given the possibility that the decreased cell stiffness of Selected MDA MB 231 
cells could be due to changes in membrane fluidity, the lateral membrane 
diffusion of NBD-C6-sphingomyelin in cells was measured using the Fluorescence 
Recovery after Photobleaching method (FRAP). NBD-C6-sphingomyelin is a probe 
that fluorescently labels membrane fatty acid phospholipids, with excitation of 
the NBD group at 460 nm and emission at 534 nm (Klein, Pillot et al. 2003). In 
brief, a small portion of fluorescently labelled cell membrane is photobleached 
and then the recovery of fluorescence is imaged over time. Based on the 
normalized recovery curves, three parameters can be obtained: the half time 
(t1/2), which is the time it takes for the fluorescence intensity to recover to half 
of the plateau level; immobile fraction, which is a fraction of molecules that 
cannot exchange between bleached and nonbleached regions; and mobile 
fraction, which is the fraction of recovered fluorescence.  
In order to perform the experiment, cells were seeded in the glass bottom dishes 
and incubated for 24 hours, the next day they were stained with 4 µM NBD-C6-
sphingomyelin for 10 minutes at room temperature, subsequently washed twice 
with HBSS medium and then imaged on the fluorescent microscopy (Zeiss 880 
confocal microscopy). Bleaching was performed on a cell apical membrane 
(Figure 5-5A). Cells were imaged for 10 scans prior to bleaching, and then the 
bleaching was performed for five successive scans and then imaging of the cells 
for 105 scans. Data analysis was performed using Easy FRAP software. The results 
revealed that there were no differences in t1/2 and mobile fraction between 
Parental, independent Selected and independent Flow sorted MDA MB 231 cells 
(Figure 5-5B,C) suggesting that there were no difference in membrane fluidity 
between the cell lines. 
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Figure 5-5 No difference in membrane fluidity between Parental, Selected and Flow sorted 
MDA MB 231 cells. 
A) Representative images of a FRAP experiment. Cell before (0 seconds) and just after bleaching 
(11 and 16 seconds). White arrow indicates a bleached area on the apex of the cell. Scale bar 5 
µm. B) Example of FRAP analyses curves from Parental, Selected and Flow sorted cells. C) Left 
graph represents mean (± SD) mobile fraction for Parental, independent Selected and independent 
Flow sorted cell populations. Right graph represents mean half time (± SD) for Parental, 
independent Selected and independent Flow sorted cell populations. Data represent individual cells 
pooled from n = 3 independent experiments. Statistical significance determined by Kruskal - Wallis 
followed by Dunn’s multiple comparison test. 
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5.2.5 Selected MDA MB 435 cells have reduced cell stiffness, 
more isotropic cytoskeleton alignment and fewer focal 
adhesions compared to Parental MDA MB 435 cells 
After finding that Selected MDA MB 231 cells had reduced cell rigidity, next, the 
stiffness of MDA MB 435 cells was investigated. The experiment was performed 
as described for MDA MB 231 cells. The results revealed that Selected MDA MB 
435 cells had significantly reduced Young’s modulus relative to Parental MDA MB 
435 cells, suggesting that Selected MDA MB 435 cells were more elastic (Figure 
5-6A).  
In order to determine whether cell stiffness differences could be an effect of 
cytoskeleton disorganisation, phalloidin-stained cells were visualised by Zeiss 
880 confocal microscopy and actin alignment was measured using an ImageJ 
plug-in Firbil Tool. The experiments were performed as detailed for MDA MB 231 
cells. Imaging F-actin revealed cytoplasmic fibrillary structures in Parental MDA 
MB 435 cells while Selected MDA MB 435 cells primarily had cortical F-actin 
(Figure 5-6B). Using Fibril Tool to quantify F-actin anisotropy revealed that 
Selected MDA MB 435 cells had significantly decreased actin anisotropy relative 
to Parental MDA MB 435 cells (Figure 5-6C). 
Having shown changes in actin organisation between Parental and Selected MDA 
MB 435 cells, focal adhesion complexes were also visualized and counted as 
described for MDA MB 231 cells. From this, I found that Selected MDA MB 435 
cells had also fewer mature and smaller focal complexes relative to Parental 
MDA MB 435 cells (Figure 5-7). Moreover, by quantifying the number of focal 
complexes, I found that Selected MDA MB 435 cells had significantly fewer focal 
adhesions per cell and per cell area compared to Parental MDA MB 435 cells 
(Figure 5-7).  
5.2.6 No difference in membrane fluidity between Parental and 
Selected MDA MB 435 cells 
Membrane fluidity measurements for Parental and independent Selected MDA MB 
435 cells were performed as described for MDA MB 231 cells. The results showed 
that there were no differences in half time and mobile fraction between 
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Parental and independent Selected MDA MB 435 cells indicating that there were 
no differences in membrane fluidity between the cell lines (Figure 5-8). 
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Figure 5-6 Selected MDA MB 435 cells have decreased cell stiffness and F-actin anisotropy 
relative to Parental MDA MB 435 cells. 
A) Graph depicts mean (± SD) Young’s modulus measured for Parental and Selected MDA MB 435 
cells. Young’s modulus was determined by AFM. Data represent individual cells pooled from n = 2 
independent experiments. B) Top panel - representative maximum projection images of phalloidin-
stained cells showing F-actin structure for Parental and Selected MDA MB 435 cells. The images 
were taken on a Zeiss 880 confocal microscope. Scale bar 10 µm. Bottom panel - representative 
images of phalloidin-stained cells showing cortical actin structure for Parental and Selected MDA 
MB 435 cells. The images were taken by TIRF microscopy. C) Graph depicts mean (± SD) F-actin 
anisotropy for Parental and independent Selected MDA MB 435 cell populations. Data represent 
individual cells pooled from n = 3 independent experiments. Statistical significance determined by 
Mann - Whitney test. 
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Figure 5-7 Selected MDA MB 435 cells have fewer focal adhesions relative to Parental MDA 
MB 435 cells. 
Representative images of pFAK-stained focal adhesions and phalloidin-stained F-actin for Parental 
and Selected MDA MB 435 cells. Scale bar 10 µm. A) Focal adhesions per individual cell for 
Parental and independent Selected MDA MB 435 cells. Data depicts individual cells pooled from n 
= 3 independent experiments, with mean (± SD) indicated. B) Mean (± SEM) focal adhesions per 
cell (n = 12 – 15 cells per experiment) for Parental and independent Selected MDA MB 435 cells. 
Data from n = 3 independent experiments.  C) Mean (± SEM) focal adhesions per cell per cell area 
(n = 12 – 15 cells per experiment) for Parental and independent Selected MDA MB 231 cells. Data 
pooled from n = 3 independent experiments. Statistical significance determined by Mann - Whitney 
test. 
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Figure 5-8 No difference in membrane fluidity between Parental and Selected MDA MB 435 
cells. 
A) Examples of FRAP analyses curves from Parental and Selected MDA MB 435 cells. B) Left 
graph represents mean (± SEM) mobile fraction for Parental and independent Selected cell 
populations. Right graph represents mean (± SD) half time for Parental and independent Selected 
MDA MB 435 cell populations. Data represent individual cells pooled from n = 3 independent 
experiments. Statistical significance determined by Mann - Whitney test. 
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5.2.7 Selected and Flow sorted MDA MB 231 cells are 
characterized by more elongated and less irregular cell 
shapes relative to Parental MDA MB 231 cells 
Human cells adopt many different cell shapes which closely relate to their tissue 
specific functions; for example, nerve cells have many thin extensions 
(dendrites, axons) which allow them to send and receive electrical signals, while 
red blood cells have biconcave shapes that maximise oxygen absorption. In 
addition, embryonic non-migratory epithelial cells have the potential to convert 
into motile mesenchymal cells needed for tissue organisation; hence cell 
morphological plasticity plays an important role in organism development 
(Alizadeh, Lyons et al. 2016). Additionally, changes in cell shapes have been 
associated with disease states; for example, it has been shown that during the 
progression from non-invasive to invasive phenotypes, cancer cells undergo a 
transition from tightly packed to spindle-like cell morphology, a process known 
as epithelial to mesenchymal transition (EMT) (Ding, Zhang et al. 2013). The 
cytoskeleton is known to be the main determinant of cell shape. Due to the 
forces generated during actin polymerisation, acto-myosin contractility and 
adhesion, it generates hydraulic pressure which contributes to cell shape 
determination (Pellegrin and Mellor 2007; Gauthier, Fardin et al. 2011). Due to 
observed alterations in actin organisation and cell elasticity in Selected MDA MB 
231 and Selected MDA MB 435 cells, I decided to undertake detailed analysis of 
cellular morphology, hence Operetta High Content Imaging System was utilised. 
Cellular morphology characteristics were assessed using the Operetta High 
Content Imaging System. 10,000 cells were seeded in each well of black 96-well 
plates. Following 24-hour incubation, cells were fixed and stained with DAPI and 
Whole Cell Stain (WCS). Cell shapes were analysed using Columbus™ Image Data 
Storage and Analysis System, and an enhanced set of algorithms known 
collectively as STAR system. The software was trained to recognise different 
populations of cell shapes by selecting examples of each class. Three different 
cell shapes were assessed: regular, characterized by a rounded morphology; 
irregular, characterized by many protrusions extending at different directions; 
elongated cells, characterized with spindle-like shapes (Figure 5-9). The cell 
morphology analysis revealed that Selected and Flow sorted MDA MB 231 cells 
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had more elongated and regular shaped cells, and fewer irregular cell shapes 
relative to Parental MDA MB 231 cells (Figure 5-9B). 
5.2.8 Selected MDA MB 231 cells migrated with increased speed 
and further distance compared to Parental and Flow sorted 
MDA MB 231 cells  
In order to examine single cell motility parameters such as velocity, 
accumulated and Euclidean distances, an individual cell migration assay was 
utilised. To perform the assay, 5,000 cells were seeded on a 12-well plate per 
well. Next day, the plate was placed in Nikon TE 2000 Time Lapse Microscope 
and images were acquired every 15 minutes for 22 hours. Individual cells from 
each Parental, independent Selected and independent Flow sorted MDA MB 231 
cell population were tracked for 45 frames excluding dividing cells using the 
Manual tracking tool in ImageJ. Migration velocity, accumulated distance and 
Euclidean distance were measured using the Chemotaxis plug-in in ImageJ. From 
this experiment, I discovered that Selected MDA MB 231 cells migrated with 
increased velocity, migrated with further accumulated and Euclidean distances 
as individual cells compared to Parental and independent Flow sorted MDA MB 
231 cells (Figure 5-10).  
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Figure 5-9 Cell shape analysis reveals that Selected and Flow sorted MDA MB 231 cells 
characterize with more regular and elongated, and fewer iregular cell shapes relative to 
Parental MDA MB 231 cells. 
A) Cell morphological profiling, a) image shows Whole Cell Stain (WSC)-stained cells which were 
recognised by  Columbus™ Image Data Storage and Analysis System, b) image depicts software 
training step where three cell shapes (irregular, regular and elongated) were chosen, c) image 
depicts three different cell shapes which were recognised by the software. B) Top panel - graph 
represents a mean percentage (± SEM) of elongated, regular and irregular cell shapes within 
Parental, Selected and Flow sorted MDA MB 231 cell populations. Bottom panel - graphs represent 
a mean (± SEM) percentage of regular, irregular and elongated cell shape for Parental, 
independent Selected and independent Flow sorted MDA MB 231 cell populations. Each dot 
represents an average from n = 6 fields per well, from at least 200 cells per field. Data pooled from 
n = 3 independent experiments. Statistical significance determined by Kruskal - Wallis followed by 
Dunn’s multiple comparison test (* = p=0.0275, ** = p=0.0042).  
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Figure 5-10 Selected MDA MB 231 cells migrate with increased velocity and travel further 
distances relative to Parental and Flow sorted MDA MB 231 cells when measured as 
individual cells. 
A) Representative tracked plots for Parental, Selected and Flow sorted MDA MB 231 cells. Each 
track represents one cell. B) Top panel - left graph depicts mean velocity (± SEM) for Parental, 
independent Selected and independent Flow sorted MDA MB 231 cells. Right graph depicts mean 
(± SEM) accumulated distance for Parental, independent Selected and independent Flow sorted 
MDA MB 231 cells. Bottom panel - graph depicts mean (± SEM) Euclidean distance for Parental, 
independent Selected and independent Flow sorted MDA MB 231 cells. Each dot represents a 
mean of n ≥ 8 tracked cells. Data pooled from n ≥ 3 independent experiments. Statistical 
significance determined by Kruskal - Wallis followed by Dunn’s multiple comparison test. 
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5.2.9 Selected MDA MB 231 cells have reduced cell spreading 
compared to Parental and Flow sorted MDA MB 231 
In the next experiment, spreading properties of Parental Selected and Flow 
sorted cell populations using the xCelligence Real-Time Cell Analyzer (RTCA) 
system was investigated. The RTCA system is impendence-based and allows 
monitoring of cell spreading in real-time. Special plates called E-plates used in 
this assay have micro-electrodes integrated at the bottom of the plate that 
allow measurement of changes in electrical impendence across the plate due to 
cell spreading and a read out of this called cell index is reported. In order to 
perform the experiment, 10,000 cells were seeded per well and measurements 
were taken every 3 minutes for 12 hours. From this experiment, I found that 
Selected MDA MB 231 cells had significantly decreased cell spreading abilities 
compared to equivalently smaller Flow sorted cells and Parental MDA MB 231 
cells. Due to significantly bigger size of Parental MDA MB 231 cells compared to 
Selected and Flow sorted MDA MB 231 cells, the measured spreading for Parental 
cells was much larger (Figure 5-11). 
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Figure 5-11 Selected MDA MB 231 cells spread less relative to Parental and Flow sorted 
MDA MB 231 cells. 
Top graph depicts cell spreading for Parental, Selected and Flow sorted MDA MB 231 cells. The 
spreading was measured with the RTCA system. Bottom panel - graph depicts mean (± SEM) cell 
spreading at 12 hrs for Parental, Selected and Flow sorted MDA MB 231 cells. Data pooled from n 
= 2 independent experiments. Statistical significance determined by Kruskal - Wallis followed by 
Dunn’s multiple comparison test. 
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5.2.10 Selected MDA MB 231 cells have reduced adhesion 
compared to Parental and Flow sorted MDA MB 231 cells 
Having revealed decreased spreading properties of Selected MDA MB 231 cells, 
adhesion properties were explored next. Adhesion properties were investigated 
in two different experiments. In the first experiment, 40,000 cells per well of 
Parental, independent Selected and independent Flow sorted cells lines were 
seeded in 96-well plate and left to adhere for three hours in standard tissue 
culture conditions. Thereafter, non-adherent cells were washed away with PBS 
and cells that remained attached to the plate were measured using the 
CellTitre–Glo® Luminescent Cell Viability assay. The CellTitre-Glo method 
allowed determination of viable cells based on their ATP levels. From this 
experiment, decreased adhesive properties of Selected and Flow sorted MDA MB 
231 compared to Parental MDA MB 231 cells were observed (Figure 5-12).  
In the second experiment, dispase-based solution was used as a mild reagent for 
cell detachment. 300,000 cells of Parental, independent Selected and 
independent Flow sorted cells were seeded per well in a 12-well plate and left 
overnight in standard tissue culture conditions. Next, 500 µl of dispase solution 
was added to the plate and left for 5 minutes in the tissue culture incubator. 
Thereafter, 500 µl of cell suspension was removed and the number of detached 
cells was counted. 500 µl of disapse was added again to the plate followed by 15 
minutes incubation at 37◦C and subsequently the number of attached cells was 
counted. The percentage of attached cells was normalized to the total number 
of cells. From this experiment, I found that Selected and Flow sorted MDA MB 
231 cells had decreased adhesion properties compared to Parental MDA MB 231 
cells (Figure 5-12). 
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Figure 5-12 Selected and Flow sorted MDA MB 231 cells have reduced adhesion compared 
to Parental MDA MB 231 cells. 
Left graph depicts mean (± SEM) percent of relative cell adhesion measured with CellTitre-Glo 
method for Parental, independent Selected and independent Flow sorted MDA MB 231 cell 
populations. Each dot represents an average value from n = 3 wells. Data pooled from n = 3 
independent experiments. Right graph depicts mean (± SEM) percent of relative number of 
adherent cells measured with dispase detachment assay for Parental, independent Selected and 
independent Flow sorted MDA MB 231 cell populations. Each dot represents an average value 
from n = 3 wells. Data pooled from n = 3 independent experiments. Statistical significance 
determined by Kruskal - Wallis followed by Dunn’s multiple comparison test. 
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5.2.11 Selected MDA MB 435 cells are characterized by more 
irregular and elongated, and fewer regular cell shapes 
relative to Parental MDA MB 435 cells 
Cellular morphology characteristics were assessed by applying Operetta High 
Content Imaging System as described in detail for MDA MB 231 cells. The cell 
morphology analysis revealed that Selected MDA MB 435 cells were characterized 
by more irregular and elongated, and fewer regular cell shapes relative to 
Parental MDA MB 435 cells (Figure 5-13).  
5.2.12 Selected MDA MB 435 cells migrate with increased 
speed and migrate further distance compared to Parental 
MDA MB 435 cells 
After discovering that Selected MDA MB 231 cells migrated with increased speed 
and further distance compared to Parental and Flow sorted MDA MB 231 cells, 
individual migration assay was undertaken for MDA MB 435 cells. From this 
experiment, I discovered that Selected MDA MB 435 cells migrated with 
significantly increased velocity and further distance relative to Parental MDA MB 
435 cells (Figure 5-14).  
5.2.13 Selected MDA MB 435 have reduced spreading 
compared to Parental MDA MB 435 cells measured by the 
xCelligence system 
In order to study cell spreading properties of MDA MB 435 cells, an RTCA system 
was used as described for MDA MB 231 cells. The results demonstrated that 
Selected MDA MB 435 cells had significantly diminished spreading properties 
relative to Parental MDA MB 435 cells (Figure 5-15).  
5.2.14 Selected MDA MB 435 cells have reduced adhesion 
compared to Parental MDA MB 435 cells 
After establishing that Selected MDA MB 435 cells had reduced spreading abilities 
compared to Parental MDA MB 435 cells, further experiments to investigate cells 
adhesiveness were undertaken. Cell adhesion assay and dispase-based assay 
were utilised as described in details for MDA MB 231 cells. The results from both 
experiments revealed that Selected MDA MB 435 cells had significantly reduced 
adhesiveness compared to Parental MDA MB 435 cells (Figure 5-16).  
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Figure 5-13 Cell shape analysis reveals that Selected MDA MB 435 cells were characterized 
by more irregular and elongated, and fewer regular cell shapes compared to Parental MDA 
MB 435 cells. 
Top panel - graph represents a mean percentage (± SEM) of elongated, regular and irregular cell 
shapes for Parental and Selected MDA MB 435 cell populations. Bottom panel - graphs represent a 
mean (± SEM) percentage of regular, irregular and elongated cell shape for Parental and 
independent Selected MDA MB 435 cells. Each dot represents an average from n = 6 fields per 
well, from at least 200 cells per field. Data pooled from n = 3 independent experiments. Statistical 
significance determined by Mann - Whitney test (* = p=0.0238). 
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Figure 5-14 Selected MDA MB 435 cells migrate with increased velocity and further distance 
relative to Parental MDA MB 435  cells measured as individual cells. 
A) Representative tracked plots for Parental and Selected MDA MB 435 cells. Each track 
represents one cell. B) Top panel – left graph depicts mean velocity (± SEM) for Parental and 
independent Selected MDA MB 435 cells. Right graph depicts mean (± SEM) accumulated 
distance for Parental and independent Selected MDA MB 435 cells. Bottom panel - graph depicts 
mean (± SEM) Euclidean distance for Parental and independent Selected MDA MB 435 cells. Each 
dot represents a mean of n ≥ 8 tracked cells. Data pooled from n = 3 independent experiments. 
Statistical significance determined by Mann - Whitney test. 
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Figure 5-15 Selected MDA MB 435 cells spread less relative to Parental MDA MB 435 cells. 
Top graph depicts cell spreading for Parental and Selected MDA MB 435 cells. The spreading was 
measured with RTCA system. Bottom graph depicts mean (± SEM) cell spreading at 3 hours for 
Parental and Selected MDA MB 435 cells. Data for n = 2 independent experiments. Statistical 
significance determined by Mann - Whitney test. 
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Figure 5-16 Selected MDA MB 435 cells have reduced adhesion compared to Parental MDA 
MB 435 cells. 
Left graph depicts mean (± SEM) percent of relative cell adhesion measured with CellTitre-Glo 
method showed for Parental and independent Selected MDA MB 435 cells. Each dot represents an 
average value from n = 3 wells. Data pooled from n = 3 independent experiments. Right graph 
depicts mean (± SEM) percent of relative number of adherent cells measured with dispase 
detachment assay for Parental and independent Selected MDA MB 435 cells. Each dot represents 
an average value from n = 3 wells. Data pooled from n = 3 independent experiments. Statistical 
significance determined by Mann - Whitney test. 
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5.3 Conclusions 
In this chapter I have investigated cell mechanical properties and two possible 
cell mechanical determinants – the cytoskeleton and the cell membrane. I 
revealed that properties unique to the pore-selected invasive cells were 
decreased actin cytoskeleton anisotropy and cell rigidity (Young’s modulus) as 
determined by Atomic Force Microscopy (AFM). Additionally, changes in cell 
cytoskeleton organisation reflected changes in focal adhesion assembly in both 
pore-selected sub-populations. Observed changes in focal adhesion densities 
could reflect the changes in adhesion tension due to observed differences in the 
anti-pFAK staining applied. In order to get more insights into organisation or 
number of focal adhesions, staining for paxillin or talin could be utilised. 
Moreover, by applying FRAP and studying cell membrane fluidity, I revealed that 
there were no differences in membrane elasticity between MDA MB 231 and MDA 
MB 435 sub-populations.  
Additionally, I have presented data describing in vitro cell properties such as cell 
morphology, migration, spreading and adhesion. By analysing cell shapes, I found 
that Selected and Flow sorted MDA MB 231 cells are characterized by increased 
regular and elongated, and fewer irregular cell shapes relative to Parental MDA 
MB 231 cells, while Selected MDA MB 435 cells have more irregular and 
elongated, and fewer regular cell shapes compared to Parental MDA MB 435 
cells. Additionally, both pore-selected cell populations exhibited enhanced cell 
velocity and migrated further distance as measured with individual cell 
migration assays. Moreover, by studying cell spreading and adhesion properties, I 
revealed that Selected and Flow sorted MDA MB 231, and Selected MDA MB 435 
cells spread less and have decreased cell adhesion compared to Parental cell 
lines. 
 
 
 
6 RNA Sequencing reveals a Ras “signature” 
associated with pore-selection 
6.1 Rationale 
As described in previous chapters, I showed that 3 µm pore selection enriched 
for cells with enhanced constrained migration properties. I revealed that pore-
selected MDA MB 231 and MDA MB 435 cells were more migratory through 3 µm 
pores, and invaded to a greater depth into collagen matrices in vitro. In vivo 
studies showed that Selected MDA MB 231 cells injected into the mammary fat 
pads of immune-compromised mice were more tumourigenic relative to Parental 
and Flow sorted MDA MB 231 cells. Selected MDA MB 435 cells injected into tail 
veins of immune-compromised mice were more invasive and metastatic relative 
to Parental MDA MB 435 cells. Additionally, the properties unique to the pore-
selected invasive cells were decreased cell rigidity (Young’s modulus) and actin 
cytoskeleton anisotropy. To identify signalling pathways associated with these 
cytoskeleton and elasticity changes that contributed to the invasive behaviour of 
pore-selected cells in vitro and in vivo, RNA Sequencing was performed on 
Parental, pore-selected and flow-selected MDA MB 231 cells, and Parental and 
pore-selected MDA MB 435 cells. RNA Sequencing analysis was performed in 
collaboration with the Beatson Institute Molecular Technology Service and 
obtained data were analysed by the Computational Biology department. The 
most common gene signature was found to associate with increased signalling 
through the Ras-Raf-MEK-ERK mitogen-activated protein kinase (MAPK) pathway. 
In order to validate whether the MAPK pathway was involved in the regulation of 
actin organisation and cell rigidity in Selected MDA MB 231 and MDA MB 435 
cells, treatments of pore-selected invasive cells with pharmacological MEK 
inhibitors, such as Trametinib and U0126, were performed. 
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6.2 Results 
6.2.1 RNA Sequencing data validation 
RNA Sequencing was conducted on Parental (four replicates), Selected (two 
independent cell populations – Sel1 and Sel2, in triplicates each), Flow sorted 
(two independent cell populations – FS1 and FS2, in triplicates each) MDA MB 231 
cells and Parental (four replicates), Selected (two independent cell populations – 
Sel1 and Sel2, in quadruplicate each) MDA MB 435 cells. RNA quality was 
confirmed using the Agilent RNA Screen Tape assay and the Aligent 2200 
TapeStation system which revealed RNA Integrity Number (RIN) values of around 
10 for both cell lines (Table 6-1). The library was run on the Illumina NextSeq 
platform using High Output 75 cycles kit.  
For validation purposes, fold changes in gene expression derived from the 
number of sequence reads identified by RNA - Seq were compared with fold 
changes determined by quantitative reverse transcription PCR (RT-qPCR). In 
order to validate RNA - Seq data from MDA MB 231 cells, I selected the following 
genes for RT-qPCR, MXRA8, ENPP1, LILRB1, TNFSF15, PTPRU, HBEGF and 
compared Selected MDA MB 231 vs Parental MDA MB 231 and Selected MDA MB 
231 vs Flow sorted MDA MB 231. For Selected MDA MB 231 vs Parental MDA MB 
231, the fold changes from both experiments fell on a single fitted straight line 
with R2 = 0.9044, P = 0.0035. For the Selected MDA MB 231 vs Flow sorted MDA 
MB 231, the fold changes from both experiments also fell on a single fitted 
straight line with R2 = 0.9971, P < 0.0001 (Figure 6-1). In order to validate RNA - 
Seq data obtained for MDA MB 435, I chose the following genes PLAU, PLAT, 
PTPRU, MXRA8, HBEGF and HSD11B1 and compared Selected vs Parental MDA MB 
435. In this case, the fold changes from both experiments fell on a single fitted 
straight line with R2 = 0.97, P = 0.0003 (Figure 6-2). 
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Table 6-1 RIN values for MDA MB 231 and MDA MB 435 cell lines. 
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Figure 6-1 Data validation of RNA - Seq for MDA MB 231 cells. 
Linear regression plots of fold change for Selected MDA MB 231 vs Parental MDA MB 231 (top) 
and Selected MDA MB 231 vs Flow sorted MDA MBA 231 (bottom) obtained by RNA - Seq 
compared to RT-qPCR (relative to GAPDH). 
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Figure 6-2 Data validation of RNA - Seq for MDA MB 435 cells. 
Linear regression plots of fold change for Selected MDA MB 435 vs Parental MDA MB 435 
obtained by RNA - Seq compared to RT-qPCR (relative to GAPDH). 
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6.2.2 RNA Sequencing analysis of Parental, Selected and Flow 
sorted MDA MB 231 cells 
To obtain an overview of the differences and similarities between samples 
obtained from Parental, Selected and Flow sorted MDA MB 231 cells, Principle 
Component Analysis (PCA) was performed (Figure 6-3). 
RNA sequencing data analysis revealed that the expression of 1817 genes were 
significantly different (p < 0.05) by greater than 1.5 fold change (FC) in Selected 
MDA MB 231 cells relative to Parental MDA MB 231 cells. Whereas, by comparing 
genes identified in Selected MDA MB 231 cells to Flow sorted MDA MB 231 cells, 
1632 genes were significantly different (p < 0.05, FC > 1.5), of which 615 genes 
were common changes between the two pairwise comparisons (Figure 6-4). 
Bonferroni correction was not applied.  
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Figure 6-3 Principal component plot of RNA - Seq data obtained for Parental, Selected and 
Flow sorted MDA MB 231 cells. 
Principal component plot of RNA - Seq data indicating the clustering together of samples obtained 
from Parental and Flow sorted MDA MB 231 cells, which separated from samples obtained from 
Selected MDA MB 231 cells.  
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Figure 6-4 Gene expression profile of Parental, Selected and Flow sorted MDA MB 231 cells. 
A) Comparison of global gene expression profile of Parental MDA MB 231 and Selected MDA MB 
231 cells (threshold FC > 1.5; p < 0.05). B) Comparison of global gene expression profile of Flow 
sorted MDA MB 231 and Selected MDA MB 231 cells (threshold FC > 1.5; p < 0.05). C) Venn 
diagram of gene expression changes for Selected MDA MB 231 vs Parental MDA MB 231, and 
Selected MDA MB 231 vs Flow sorted MDA MB 231 (thresholds of p < 0.05 and FC > 1.5). 
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6.2.3  RNA Sequencing analysis of Parental and Selected MDA 
MB 435 cells 
To compare RNA Sequencing samples obtained for Parental and Selected MDA MB 
435 cells, PCA was performed (Figure 6-5).  
RNA sequencing data analysis of global gene expression profile revealed that the 
expression of 23,423 genes were identified, of which 10,876 genes were 
significantly changed (p < 0.05, FC > 1.5) (Figure 6-6). Bonferroni correction was 
not applied. 
6.2.4 Comparison of gene expression data sets obtained for MDA 
MB 231 and MDA MB 435 cells 
In order to find common genes associated with cytoskeleton and elasticity 
changes, the two data sets for MDA MB 231 and MDA MB 435 cells were 
compared. Thresholds of p < 0.05 and FC > 1.5 were used. By comparing genes 
changed in Selected MDA MB 231 vs Parental MDA MB 231 to genes changed in 
Selected MDA MB 435 vs Parental MDA MB 435, 562 genes were found to be in 
common, while comparison of genes sets of Selected MDA MB 231 vs Flow sorted 
MDA MB 231 to genes changed in Selected MDA MB 435 vs Parental MDA MB 435, 
427 genes were found to be in common. More stringent comparison of three data 
sets, Parental MDA MB 231 vs Selected MDA MB 231 to Flow sorted MDA MB 231 vs 
Selected MDA MB 231 to Parental MDA MB 435 vs Selected MDA MB 435, revealed 
214 genes that were common changes for pore-selected MDA MB 231 and MDA MB 
435 cells (Figure 6-7). 
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Figure 6-5 Principle component plot of RNA - Seq data obtained for Parental and Selected 
MDA MB 435 cells. 
Principal component plot of RNA - Seq data indicating the clustering together samples obtained 
from Parental MDA MB 435 cells separated from samples obtained from Selected MDA MB 435 
cells. 
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Figure 6-6 Gene expression profile showed for Parental and Selected MDA MB 435 cells. 
A) Comparison of global gene expression profile of Parental MDA MB 435 and Selected MDA MB 
435 cells (threshold FC > 1.5; p < 0.05). B) Venn diagram of gene expression changes for Parental 
and Selected MDA MB 435 cells, 10,876 genes were found to be significantly changed (thresholds 
of p < 0.05 and FC > 1.5). 
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Figure 6-7 Comparison of number of overlapped genes for three data sets: Parental vs 
Selected MDA MB 231, Flow sorted vs Selected MDA MB 231 and Parental vs Selected MDA 
MB 435. 
Venn diagram depicts the number of overlapping genes for three data sets, Parental vs Selected 
MDA MB231, Flow sorted vs Selected MDA MB 231 and Parental vs Selected MDA MB 435. 
Thresholds of p < 0.05 and FC >1.5 were used.  
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6.2.5 GSEA data analysis of common genes reveals increased 
signalling through the Ras-Raf-MEK-ERK mitogen-activated 
protein kinase (MAPK) pathway 
The Broad Institute’s Gene Set Enrichment Analysis (GSEA) algorithm was 
employed to identify functional patterns or pathways associated with the 
cytoskeleton and elasticity changes of Selected MDA MB 231 and MDA MB 435 
cells. In order to identify oncogenic signatures of Selected MDA MB 231 cells, 615 
genes that were identified as common genes associated with the invasive 
behaviour of Selected MDA MB 231 cells by comparing two data sets, (Parental vs 
Selected with Flow sorted vs Selected) were used as data input. GSEA of 
oncogenic signatures allowed identification of the 10 most significantly changed 
Gene Sets, of which 5 (in fact, 5 of the top 6) were associated with increased 
signalling through KRAS, (Figure 6-8) (Table 6-2). 
In order to find common gene sets from invasive pore-selected MDA MB 231 and 
MDA MB 435, the 214 genes that were identified as common genes by comparing 
615 genes identified in invasive MDA MB 231 cells were compared to the 10,678 
genes identified as significantly changed genes in Selected MDA MB 435 cells, 
were used as a data input for GSEA. GSEA revealed the 10 most significantly 
changed Gene Sets, of which KRAS signalling alterations were commonly 
associated in 5 (and 4 of the top 5) (Figure 6-8) (Table 6-3). These results 
suggested that the identified genes in the KRAS signatures were indicative of 
changes in Ras/MAPK signalling being involved in the invasive behaviour of pore-
selected MDA MB 231 and MDA MB 435 cells. 
KRAS “signature” genes identified in the significantly changed Gene Sets 
associated with KRAS, Raf and MAPK signalling were used for heatmaps to depict 
patterns of gene expression for MDA MB 231 (Figure 6-9) and MDA MB 435 data 
(Figure 6-10).  
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Figure 6-8 GSEA analysis reveals KRAS signalling gene signatures in pore-selected cells. 
Top graph depicts the 10 most significantly changed Gene Sets identified by GSEA in Selected 
MDA MB 231. The bottom graph depicts the 10 most common significantly changed Gene Sets 
identified for pore-selected MDA MB 231 and MDA MB 435 cells.  
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Table 6-2 GSEA identified Gene Sets. 
The table represents the 20 most significantly changed Gene Sets identified for Selected MDA MB 
231 cells. Data analysis was performed with GESA. 
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Table 6-3 GSEA identified Gene Sets. 
The bottom graph represents the 20 most significantly changed Gene Sets identified for pore-
selected MDA MB 231 and MDA MB 435 cells. Data analysis was performed with GESA. 
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Figure 6-9 Genes identified in KRAS “signatures” for MDA MB 231 cells. 
The heatmap represents 49 genes that were associated with KRAS, Raf and MAPK signalling 
identified by GSEA for MDA MB 231 sub-populations.
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Figure 6-10 Genes identified in “KRAS signatures” for MDA MB 435 cells. 
The heatmap represents 49 genes that were associated with KRAS, Raf and MAPK signalling 
identified by GSEA for MDA MB 435 sub-populations. 
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6.2.6 Trametinib treatment affects the expression of genes 
associated with the Ras-Raf-MEK-ERK pathway  
Having revealed increased signalling through the Ras-Raf-MEK-ERK mitogen-
activated protein kinase (MAPK) pathway by GSEA of RNA sequencing data, next I 
wanted to investigate whether the MAPK/ERK pathway was responsible for the 
observed changes in pore-selected MDA MB 231 and MDA MB 435 cells, such as 
enhanced confined migration, increased motility, disrupted cytoskeleton and 
decreased stiffness. In order to validate the effect of MAPK/ERK pathway 
inhibition on observed changes, I decided to use two pharmacologically distinct 
MEK inhibitors, Trametinib and U0126.  
I started the investigation by checking whether the expression of genes that 
were associated with the KRAS “signature” identified by GSEA, were dependent 
on the activity of MAPK/ERK pathway. For this purpose, I chose several genes for 
MDA MB 231 cells, including: ENPP1, HBEGF, PTPRU, MXRA8, HSD11B1 and 
TNFSF15, and the following genes for MDA MB 435 cells: PLAU, PLAT, HBEGF, 
PTPRU, MXRA8, HDS11B1, and assessed their expression following Trametinib 
treatment. In brief, the experiment was performed as follows; cells were seeded 
in a well of 6-well plate. Next day, cells were treated with 0.5 µM of Trametinib 
or DMSO for 24 hours and kept in standard tissue culture conditions. 
Subsequently RNA was extracted, cDNA synthesized and qRT-PCR was performed. 
The expression of genes was normalized to GAPDH. In order to assess the 
percentage inhibition of gene expression upon Trametinib treatment, gene 
expression levels were normalized to DMSO controls. The analysis revealed that 
the expression of genes that were upregulated in Parental, Selected and Flow 
sorted MDA MB 231 cells and Parental, Selected MDA MB 435 cells were 
decreased after Trametinib treatment. Additionally, genes that were 
downregulated in Selected MDA MB 231 and MDA MB 435 cells were upregulated 
following MEK inhibitor treatment (Figure 6-11), consistent with genes identified 
in the KRAS “signature” were dependent on the activity of MAPK/ERK pathway. 
These genes could be, through direct or indirect means, responsible for the 
observed disorganisation of cytoskeletal structures and cell plasticity changes in 
pore-selected cell lines, which would subsequently affect their confined 
migratory and invasive capabilities.   
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Figure 6-11 Trametinib treatment affects expression of genes associated with the Ras-Raf-
MEK-ERK pathway. 
The top graph depicts mean percentage (± SEM) of gene expression inhibition upon Trametinib 
treatment for Parental, Selected and Flow sorted MDA MB 231 cells. Data pooled from n = 3 
independent experiments. The bottom graph depicts mean percentage (± SEM) of gene expression 
inhibition upon Trametinib treatment for Parental and Selected MDA MB 435 cells. Data pooled 
from n = 3 independent experiments.  
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6.2.7 MEK inhibition restores actin organisation and focal 
adhesions in Selected MDA MB 231 and MDA MB 435 cells 
Having identified decreased actin cytoskeleton anisotropy and cell rigidity 
(Young’s modulus), as well as an increased signalling through the Ras-Raf-MEK-
ERK mitogen-activated protein kinase (MAPK) pathway in pore-selected cells, I 
decided to inhibit the MAPK pathway to determine whether MAPK signalling 
contributed to the observed loss of stress fibres and focal contacts in Selected 
MDA MB 231 and MDA MB 435 cells. In order to evaluate the input of MAPK/ERK 
pathway on actin organisation, I used two pharmacologically distinct MEK 
inhibitors, Trametinib or U0126.  
In order to image actin by confocal microscopy, samples were prepared as 
follows. In brief, cells were seeded on coverslips and grown overnight. The next 
day, they were treated with 0.5 µM Trametinib, 10 µM U0126 or DMSO, and 
incubated for 24 hours in standard issue culture conditions. After incubation, 
cells were fixed and stained with phalloidin and anti-pFAK antibody in order to 
detect focal adhesions. Subsequently, cells were imaged on the Zeiss 710 
confocal. The obtained confocal images revealed that following Trametinib or 
U0126 treatment, Selected MDA MB 231 (Figure 6-12) (Figure 6-13) and MDA MB 
435 (Figure 6-16) (Figure 6-17) cells changed their actin organisation from 
primarily cortical to cytoplasmic fibrillary structures.  
In order to quantify actin alignment, the ImageJ plug-in Fibril Tool was utilised. 
In order to be consistent with the image plane of stained F-actin taken for the 
anisotropy analysis, Total Internal Reflection Fluorescence microscopy (TIRF) 
images were used. TIRF microscopy allowed visualisation of fluorescent 
molecules less than 200 nm from the coverslip surface. Such location 
corresponded to the ventral cortical actin position. TIRF images revealed 
diffused actin staining in DMSO-treated pore-selected MDA MB 231 and MDA MB 
435 cells, while in Trametinib or U0126-treated pore-selected MDA MB 231 
(Figure 6-12) (Figure 6-13) and MDA MB 435 (Figure 6-16) (Figure 6-17) cells, long 
actin filaments were observed. F-actin anisotropy analysis revealed a significant 
increase of F-actin anisotropy in Trametinib and U0126-treated pore-selected 
MDA MB 231 (Figure 6-12) (Figure 6-13) and MDA MB 435 (Figure 6-16) (Figure 
6-17) cells relative to DMSO-treated control cells.  
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Immunofluorescence labelling with anti-pFAK antibody, of Trametinib or U0126-
treated pore-selected MDA MB 231 and MDA MB 435 cells revealed assembly of 
focal adhesions in comparison to DMSO-treated control cells. The pFAK-stained 
cells images revealed that DMSO-treated pore-selected MDA MB 231 and MDA MB 
435 cells had fewer and less pronounced focal complexes, while Trametinib or 
U0126-treated cells were characterized by more mature and larger focal 
assemblies. The number of focal adhesions complexes was counted using ImageJ. 
Number of FA was counted per cell. The average number of focal adhesions per 
group was counted per cell and then normalized to the cell area, which was 
determined from Operetta High Content Imaging System. The analysis revealed 
that DMSO-treated Selected MDA MB 231 (Figure 6-14) (Figure 6-15) and MDA MB 
435 (Figure 6-18) (Figure 6-19) cells had fewer focal adhesions per cell and per 
cell area compared to Trametinib or U0126-treated cells. 
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Figure 6-12 Trametinib treatment restores actin structures in Selected MDA MB 231 cells. 
Top panel – representative maximal projection images of phalloidin-stained Selected MDA MB 231 
cells treated with DMSO or Trametinib. Images were acquired on a Zeiss 710 confocal microscope. 
Bottom panel - representative images of phalloidin-stained Selected MDA MB 231 cells treated with 
DMSO or Trametinib. Images were acquired on a TIRF microscope. Scale bar = 10 µm. The 
bottom graph depicts mean (± SD) F-actin anisotropy for DMSO and Trametinib-treated Selected 
MDA MB 231 cells. Data represent individual cells pooled from n = 3 independent experiments. 
Statistical significance determined by Mann - Whitney test. 
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Figure 6-13 U0126 treatment restores actin structures in Selected MDA MB 231 cells. 
Top panel – representative maximal projection images of phalloidin-stained Selected MDA MB 231 
cells treated with DMSO or U0126. Images were acquired on a Zeiss 710 confocal microscope. 
Bottom panel - representative images of phalloidin-stained Selected MDA MB 231 cells treated with 
DMSO or U0126. Images were acquired on a TIRF microscope. Scale bar = 10 µm. The bottom 
graph depicts mean (± SD) F-actin anisotropy for DMSO and U0126-treated Selected MDA MB 231 
cells. Data represent individual cells pooled from n = 3 independent experiments. Statistical 
significance determined by Mann - Whitney test. 
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Figure 6-14 Trametinib treatment restores focal adhesions in Selected MDA MB 231 cells. 
Representative images of pFAK-stained Selected MDA MB 231 cells treated with Trametinib or 
DMSO. The images were acquired on a Zeiss 710 confocal microscope. Scale bar = 10 µm. A) 
Graph depicts focal adhesions per individual cell. Data depicts individual cells pooled from n = 3 
independent experiments, with mean (± SD) indicated. B) Graph depicts mean (± SEM) focal 
adhesions per cell (n = 12 – 15 cells per experiment). Data from n = 3 independent experiments.  
C)  Mean (± SEM) focal adhesions per cell per mean cell area (n = 12 – 15 cells per experiment). 
Data pooled from n = 3 independent experiments. Statistical significance determined by Mann - 
Whitney test. 
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Figure 6-15 U0126 treatment restores focal adhesions in Selected MDA MB 231 cells. 
Representative images of pFAK-stained Selected MDA MB 231 cells treated with U0126 or DMSO. 
The images were acquired on a Zeiss 710 confocal microscope. Scale bar = 10 µm. A) Graph 
depicts focal adhesions per individual cell. Data depicts individual cells pooled from n = 3 
independent experiments, with mean (± SD) indicated. B) Graph depicts mean (± SEM) focal 
adhesions per cell (n = 12 – 15 cells per experiment). Data from n = 3 independent experiments.  
C)  Mean (± SEM) focal adhesions per cell per mean cell area (n = 12 – 15 cells per experiment). 
Data pooled from n = 3 independent experiments. Statistical significance determined by Mann - 
Whitney test. 
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Figure 6-16 Trametinib treatment restores actin structures in Selected MDA MB 435 cells. 
Top panel – representative maximal projection images of phalloidin-stained Selected MDA MB 435 
cells treated with DMSO or Trametinib. Images were acquired on a Zeiss 710 confocal microscope. 
Bottom panel - representative images of phalloidin-stained Selected MDA MB 435 cells treated with 
DMSO or Trametinib. Images were acquired on a TIRF microscope. Scale bar = 10 µm. The 
bottom graph depicts mean (± SD) F-actin anisotropy for DMSO and Trametinib-treated Selected 
MDA MB 435 cells. Data represent individual cells pooled from n = 3 independent experiments. 
Statistical significance determined by Mann - Whitney test. 
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Figure 6-17 U0126 treatment restores actin structure in Selected MDA MB 435 cells. 
Top panel – representative maximal projection images of phalloidin-stained Selected MDA MB 435 
cells treated with DMSO or U0126. Images were acquired on a Zeiss 710 confocal microscope. 
Bottom panel - representative images of phalloidin-stained Selected MDA MB 435 cells treated with 
DMSO or U0126. Images acquired on a TIRF microscope. Scale bar = 10 µm. The bottom graph 
depicts mean (± SD) F-actin anisotropy for DMSO and U0126-treated Selected MDA MB 435 cells. 
Data represent individual cells pooled from n = 3 independent experiments. Statistical significance 
determined by Mann - Whitney test. 
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Figure 6-18 Trametinib treatment restores focal adhesions in Selected MDA MB 435 cells. 
Representative images of pFAK-stained Selected MDA MB 435 cells treated with Trametinib or 
DMSO. The images were acquired on a Zeiss 710 confocal microscope. Scale bar = 10 µm. A) 
Graph depicts focal adhesions per individual cell. Data depicts individual cells pooled from n = 3 
independent experiments, with mean (± SD) indicated. B) Graph depicts mean (± SEM) focal 
adhesions per cell (n = 12 – 15 cells per experiment). Data from n = 3 independent experiments.  
C)  Mean (± SEM) focal adhesions per cell per mean cell area (n = 12 – 15 cells per experiment). 
Data pooled from n = 3 independent experiments. Statistical significance determined by Mann - 
Whitney test. 
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Figure 6-19 U0126 treatment restores focal adhesions in Selected MDA MB 435 cells. 
Representative images of pFAK-stained Selected MDA MB 435 cells treated with U0126 or DMSO. 
The images were acquired on a Zeiss 710 confocal microscope. Scale bar = 10 µm. A) Graph 
depicts focal adhesions per individual cell. Data depicts individual cells pooled from n = 3 
independent experiments, with mean (± SD) indicated. B) Graph depicts mean (± SEM) focal 
adhesions per cell (n = 12 – 15 cells per experiment). Data from n = 3 independent experiments.  
C)  Mean (± SEM) focal adhesions per cell per mean cell area (n = 12 – 15 cells per experiment). 
Data pooled from n = 3 independent experiments. Statistical significance determined by Mann - 
Whitney test.  
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6.2.8 MEK inhibition leads to increased cell stiffness  
After establishing that inhibition of the Ras-RAF-MEK-ERK pathway with two MEK 
inhibitors, Trametinib and U0126, led to F-actin restoration in pore-selected 
MDA MB 231 and MDA MB 435 cells, next I wanted to investigate whether the 
MAPK/ERK pathway was involved in cell rigidity modulation. In order to evaluate 
this relationship, AFM measurements were performed on Trametinib-treated 
MDA MB 231 and MDA MB 435 cells. AFM measurements were performed in 
collaboration with the Engineering Department at University of Glasgow. In 
brief, cells were seeded in 3 cm petri dishes and incubated 24 hours in standard 
tissue culture conditions. After incubation, cells were treated with 0.5 µM 
Trametinib or control cells with DMSO, and incubated for 24 hours prior to AFM 
measurements. During the experiment, cells were kept in culture conditions and 
1% HEPES was added to the media to maintain pH levels. Cells were probed with 
a 4.74 µm diameter spherical bead and force of 3 nN. Five measurements were 
taken over the nuclear area and an average value of Young’s modulus was 
determined per cell. The analysis revealed that MEK inhibition led to an increase 
of cell stiffness in all sub-populations of MDA MB 231 and MDA MB 435 cells 
(Figure 6-20). These results suggested that the MAPK/ERK pathway is not only 
involved in the regulation of cell cytoskeleton organisation but also in the 
modulation of cell elasticity. 
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Figure 6-20 MEK inhibition leads to increased cell stiffness. 
The top graph represents mean (± SD) Young’s modulus of Parental, Selected and Flow sorted 
MDA MB 231 cells treated with Trametinib or DMSO. Data represent individual cells pooled from n 
= 2 independent experiments. Statistical significance of multiple comparisons was determined by 
Kruskal – Wallis followed by Dunn’s multiple comparison test. DMSO vs Trametinib-treated cells 
were compared by Mann - Whitney test. The bottom graph represents mean (± SD) Young’s 
modulus of Parental and Selected MDA MB 435 cells treated with Trametinib or DMSO. Data 
represent individual cells from n = 1 experiment. Statistical significance determined by Mann - 
Whitney test. 
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6.2.9 MEK inhibition restrains invasion by pore-selected MDA MB 
231 and MDA MB 435 cells 
Having shown that MEK inhibition led to restoration of actin cytoskeleton 
structures, and increased cell stiffness in pore-selected MDA MB 231 and MDA MB 
435 cells, the effect on the collagen invasion assay was next investigated 
following U0126 treatment. In order to prepare collagen plugs, human primary 
fibroblasts were mixed with rat tail collagen1 and left for a week to allow 
conditioning of the collagen. The fibroblasts were then removed by treating the 
collagen disks with puromycin for 48 hours and subsequently washed twice with 
PBS. Once the matrices were prepared, cells were seeded on top and allowed to 
invade the collagen for 8 days. MEM/EBSS complete media containing 10 µM 
U0126 or DMSO was added to the dishes as indicated. Media was changed every 
other day. After 8 days of invasion, collagen disks were fixed, paraffin-
embedded and stained with H&E, and individual cell invasion distances were 
quantified using ImageJ. The analysis revealed that upon U0126 treatment, 
pore-selected MDA MB 231 (Figure 6-21) and MDA MB 435 (Figure 6-22) cells 
invaded less deeply into the collagen relative to DSMO-treated control cells, 
suggesting that the rebuilding of actin cytoskeleton structures and increased cell 
stiffness dictated the invasive ability of pore-selected cells.  
 
184 
 
 
Figure 6-21 U0126 treatment of pore-selected MDA MB 231 cells restrains invasion. 
Representative images of invading cells into the collagen matrix for pore-selected MDA MB 231 
cells treated with DMSO or U0126. Scale bar = 100 µm. Graph depicts mean (± SEM) travelled 
distance for Selected MDA MB 231 cells treated with DMSO or U0126. Data pooled from n = 3 
independent experiments. Statistical significance determined by Mann - Whitney test.  
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Figure 6-22 U0126 treatment of pore-selected MDA MB 435 cells restrains cell invasion. 
Representative images of invading cells into the collagen matrix for pore-selected MDA MB 435 
cells treated with DMSO or U0126. Scale bar = 100 µm. Graph depicts mean (± SEM) travelled 
distance for Selected MDA MB 435 cells treated with DMSO or U0126. Data pooled from n = 3 
independent experiments. Statistical significance determined by Mann - Whitney test. 
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6.2.10 Trametinib treated cells migrate slower and shorter 
distances 
Having identified enhanced cell motility of Selected MDA MB 231 and MDA MB 
435 cells with an individual cell migration assay, I next wanted to investigate 
whether MEK inhibition had an effect on cell motility. In order to perform an 
individual cell migration assay, 5,000 cells were seeded per well in a 24-well 
plate and subsequently incubated overnight in standard tissue culture 
conditions. The next day, cells were treated with 0.5 µM Trametinib or 10 µM 
U0126, control cells with DMSO, for 24 hours and subsequently placed in a Nikon 
TE 2000 Time Lapse Microscope in which images were acquired every 15 minutes 
for 22 hours. Individual cells were tracked for 45 frames excluding dividing cells 
using a Manual tracking tool in ImageJ. Migration velocity, accumulated distance 
and Euclidean distance were measured using the Chemotaxis plug-in in ImageJ. 
From this experiment I found that, Trametinib or U0126-treated Parental, 
Selected and Flow sorted MDA MB 231 cells (Figure 6-23) (Figure 6-24), and 
Parental and Selected MDA MB 435 cells (Figure 6-25) (Figure 6-26) migrated 
slower and shorter distance relative to DMSO-treated control cells. 
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Figure 6-23 MDA MB 231 cells treated with Trametinib migrate slower and shorter distance. 
A) Graphs represent mean (± SEM) velocity, accumulated distance and Euclidean distance for 
Parental, Selected and Flow sorted MDA MB 231 cells treated with DMSO. Statistical significance 
determined by Kruskal – Wallis followed by Dunn’s multiple comparison test. B) Graphs represent 
mean (± SEM) velocity, accumulated distance and Euclidean distance for Parental MDA MB 231 
cells treated with 0.5 µM of Trametinib or DMSO. C) Graphs represent mean (± SEM) velocity, 
accumulated distance and Euclidean distance for Selected MDA MB 231 cells treated with 0.5 µM 
of Trametinib or DMSO. D) Graphs represent mean (± SEM) velocity, accumulated distance and 
Euclidean distance for Flow sorted MDA MB 231 cells treated with 0.5 µM of Trametinib or DMSO. 
Each dot represents a mean of n ≥ 8 tracked cells. Data pooled from n = 3 independent 
experiments. Statistical significance determined by Mann - Whitney test. 
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Figure 6-24 MDA MB 231 cells treated with U0126 migrate slower and shorter distance. 
A) Graphs represent mean (± SEM) velocity, accumulated distance and Euclidean distance for 
Parental, Selected and Flow sorted MDA MB 231 cells treated with DMSO. Statistical significance 
determined by Kruskal – Wallis followed by Dunn’s multiple comparison test. B) Graphs represent 
mean (± SEM) velocity, accumulated distance and Euclidean distance for Parental MDA MB 231 
cells treated with 10 µM of U0126 or DMSO. C) Graphs represent mean (± SEM) velocity, 
accumulated distance and Euclidean distance for Selected MDA MB 231 cells treated with 10 µM 
of U0126 or DMSO. D) Graphs represent mean (± SEM) velocity, accumulated distance and 
Euclidean distance for Flow sorted MDA MB 231 cells treated with 10 µM of U0126 or DMSO. Each 
dot represents a mean of n ≥ 8 tracked cells. Data pooled from n = 3 independent experiments. 
Statistical significance determined by Mann - Whitney test. 
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Figure 6-25 MDA MB 435 cells treated with Trametinib migrate slower and shorter distance. 
A) Graphs represent mean (± SEM) velocity, accumulated distance and Euclidean distance for 
Parental and Selected MDA MB 435 cells treated with DMSO. B) Graphs represent mean (± SEM) 
velocity, accumulated distance and Euclidean distance for Parental MDA MB 435 cells treated with 
0.5 µM of Trametinib or DMSO. C) Graphs represent mean (± SEM) velocity, accumulated distance 
and Euclidean distance for Selected MDA MB 435 cells treated with 0.5 µM of Trametinib or 
DMSO. Data pooled from n = 2 independent experiments. Statistical significance determined by 
Mann - Whitney test. 
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Figure 6-26 MDA MB 435 cells treated with U0126 migrate slower and shorter distance. 
A) Graphs represent mean (± SEM) velocity, accumulated distance and Euclidean distance for 
Parental and Selected MDA MB 435 cells treated with DMSO. B) Graphs represent mean (± SEM) 
velocity, accumulated distance and Euclidean distance for Parental MDA MB 435 cells treated with 
10 µM of U0126 or DMSO. C) Graphs represent mean (± SEM) velocity, accumulated distance and 
Euclidean distance for Selected MDA MB 435 cells treated with 10 µM of U0126 or DMSO. Data 
pooled from n = 3 independent experiments. Statistical significance determined by Mann - Whitney 
test. 
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6.2.11 Trametinib treated Selected MDA MB 231 spread more 
relative to Parental and Flow sorted MDA MB 231 cells 
Having identified decreased cell spreading of pore-selected MDA MB 231 relative 
to Parental MDA MB 231 cells, I next wanted to find out whether MEK inhibition 
had an effect on cell spreading. In order to evaluate this behaviour, I utilised 
two different approaches. First, I used Operetta High Content Imaging System to 
quantify the areas of cells treated with Trametinib or DMSO. In the second 
approach, spreading properties, with and without Trametinib treatment, was 
investigated using the xCelligence Real-Time Cell Analyzer (RTCA) system.  
In order to measure cell area with the Operetta System, 10,000 cells were 
seeded in black 96-well plates. Following 24-hour incubation, cells were treated 
with 10 µM Trametinib, or control cells with DMSO, and subsequently incubated 
for 24 hours in standard tissue culture conditions. After incubation, cells were 
fixed and stained with DAPI and Whole Cell Stain (WCS). The analysis of cell 
areas revealed that DMSO-treated Selected MDA MB 231 had smaller cell areas 
compared to DSMO-treated Parental and Flow sorted MDA MB 231 cells. Upon 
Trametinib treatment, Selected and Flow sorted MDA MB 231 cells spread 
significantly more than Parental MDA MB 231 cells (Figure 6-27).  
The RTCA system is impendence-based and allows monitoring of cell spreading in 
real-time. Special plates called E-plates that were used in this assay have micro 
electrodes integrated at the bottom of the plate which allow measurement of 
changes in electrical impendence across the plate due to cell spreading. In order 
to perform the experiment, 10,000 cells were seeded per well, the plates were 
placed in the machine and scanned every 5 minutes for 5 hours. After 5 hours, 
0.5 µM Trametinib was added and scanning was continued for the next 7 hours. 
The results revealed that DMSO-treated Selected MDA MB 231 cells have 
decreased spreading relative to DMSO-treated Parental and Flow sorted MDA MB 
231 cells, while Trametinib treatment led to an increase of cell spreading only in 
Selected MDA MB 231 cells (Figure 6-28).  
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Figure 6-27 Trametinib-treated Selected MDA MB 231 cells spread more relative to Parental 
and Flow sorted MDA MB 231 cells. 
A) Graph depicts mean (± SEM) cell area for Parental, Selected and Flow sorted MDA MB 231 
cells treated with DMSO. Statistical significance determined by Kruskal – Wallis followed by Dunn’s 
multiple comparison test. B) Graphs depict mean (± SEM) cell area for Parental, Selected and Flow 
sorted MDA MB 231 cells treated with DMSO or Trametinib. Each dot represents an average from 
n = 6 fields per well, from at least 200 cells per field. Data pooled from n = 3 independent 
experiments. Statistical significance determined by Mann - Whitney test. 
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Figure 6-28 Trametinib-treated Selected MDA MB 231 cells spread more than Parental and 
Flow sorted MDA MB 231 cells. 
A) Graph depicts cell spreading for Parental, Selected and Flow sorted MDA MB 231 cells treated 
with DMSO or Trametinib. B) Graph depicts mean (± SD) cell spreading at 12 hrs for Parental, 
Selected and Flow sorted MDA MB 231 cells treated with DMSO. Statistical significance 
determined by Kruskal – Wallis followed by Dunn’s multiple comparison test. C) Graphs depict 
mean (± SD) cell spreading at 12 hrs for Parental, Selected and Flow sorted MDA MB 231 cells 
treated with DMSO or Trametinib. Data pooled from n = 2 independent experiments. Statistical 
significance determined by Mann - Whitney test. 
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6.2.12 Trametinib treated Parental and Selected MDA MB 435 
cells spread more relative to DMSO  
In order to investigate MDA MB 435 cell spreading properties upon Trametinib 
treatment, I utilised two different methods as detailed for MDA MB 231 cells. 
First, I used Operetta High Content Imaging System to quantify cell areas of cells 
treated with Trametinib or DMSO. In the second approach, spreading properties 
investigated using xCelligence Real-Time Cell Analyzer (RTCA) system.  
Cell area analysis revealed that DMSO-treated Selected MDA MB 231 cells had 
decreased cell areas in comparison to DMSO-treated Parental cells. Trametinib 
treatment led to significantly increased cell areas of both Parental and Selected 
cells MDA MB 435 cells (Figure 6-29).  
The analysis of cell spreading from using xCelligence Real-Time Cell Analyzer 
(RTCA) revealed that DSMO-treated Selected MDA MB 435 cells have decreased 
spreading relative to DMSO-treated Parental MDA MB 435 cells, while Trametinib 
treatment led to increased cell spreading of both Parental and Selected MDA MB 
435 cells (Figure 6-30). 
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Figure 6-29 Parental and Selected MDA MB 435 cells treated with Trametinib spread more. 
A) Graph depicts mean (± SEM) of cell area for Parental and Selected MDA MB 435 cells treated 
with DMSO. B) Graph depicts mean (± SEM) of cell area for Parental MDA MB 435 cells treated 
with DMSO or Trametinib. C) Graph depicts mean (± SEM) of cell area for Selected MDA MB 435 
cells treated with DMSO or Trametinib. Each dot represents an average from n = 6 fields per well, 
from at least 200 cells per field. Data pooled from n = 3 independent experiments. Statistical 
significance determined by Mann - Whitney test. 
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Figure 6-30 Trametinib-treated Parental and Selected MDA MB 435 cells spread more. 
A) Graph depicts cell spreading for Parental and Selected MDA MB 435 cells treated with DMSO or 
Trametinib. B) Graph depicts mean (± SD) cell spreading at 12 hrs for Parental and Selected MDA 
MB 435 cells treated with DMSO. C) Graphs depicts mean (± SD) cell spreading at 12 hrs for 
Parental and Selected MDA MB 435 cells treated with DMSO or Trametinib. Data from n = 1 
experiment. Statistical significance determined by Mann - Whitney test (ns = not significant). 
 
 
6.3 Conclusions 
To identify signalling pathways that influenced cytoskeletal and cell stiffness 
changes observed in pore-selected MDA MB 231 and MDA MB 435 cells, an RNA 
Sequencing experiment was performed. In this chapter, I have presented data 
showing that analysis of RNA - Seq by utilising Gene Set Enrichment Analysis 
(GSEA) allowed me to identify increased signalling through the Ras-Raf-MEK-ERK 
mitogen-activated protein kinase (MAPK) pathway in pore-selected MDA MB 231 
and MDA MB 435 cells. Due to the fact that this pathway plays an important role 
in controlling many fundamental cellular processes, I decided to interrogate 
whether the observed alterations in the activity of the MAPK/ERK pathway were 
causally related to the cytoskeletal and stiffness changes in pore-selected cell 
lines. For this purpose, I decided to block the MAPK/ERK pathway by applying 
two different MEK inhibitors, Trametinib and U0126. I found that upon 
Trametinib or U0126 treatment, the actin organisation changed from primarily 
cortical to cytoplasmic fibrillary structures in pore-selected MDA MB 231 and 
MDA MB 435 cells. Additionally, pore-selected MDA MB 231 and MDA MB 435 cells 
were characterized by more mature and larger focal adhesion assemblies after 
MEK inhibitor treatment. Moreover, I found that MEK inhibition led to increased 
cell stiffness of all sub-populations of MDA MB 231 and MDA MB 435 cells. By 
utilising the collagen invasion assay, I found that blocking MEK restrained pore-
selected cell invasion into the collagen. Furthermore, I found that MEK inhibition 
diminished cell motility and altered spreading of all sub-populations of MDA MB 
231 and MDA MB 435 cells in vitro. 
The results described above showed that MEK inhibition had an effect on all sub-
populations of MDA MB 231 and MDA MB 435 cells in various experimental assays. 
Such an effect was not unexpected due to the fact that signalling through the 
MAPK/ERK pathway is maintained at a basal level in Parental and Flow sorted 
MDA MB 231, and Parental MDA MB 435 cells. Therefore blocking it with 
Trametinib or U0126 completely abolished its activity in all treated cell lines, as 
a consequence changes in different cell properties were observed.  
 
 
7 Discussion 
Cancer metastasis is a major problem in cancer. It is responsible for 90% of 
patient mortality, and yet it remains an incompletely understood process. The 
metastatic cascade involves multiple steps, such as invasion of surrounding 
tissue, intravasation, transit through blood or lymphatic vessels and 
extravasation to secondary organs (Mehlen and Puisieux 2006). Within primary 
tumours, due to highly selective processes, sub-populations of cancer cells gain 
traits which enable them to invade the tumour associated stroma through 
confined spaces, and subsequently survive the complex “journey” from the 
primary neoplasm to foreign tissues (Vanharanta and Massague 2013; Nguyen, 
Yoshida et al. 2016). During the metastatic “journey”, cancer cells must invade 
through epithelial cell layers and dense extracellular matrix which, as detailed 
in the introduction, is composed of tunnel-like tracks or pores which range in 
size from 0.1 - 30 µm. Hence, a common feature of some of the steps in the 
metastatic cascade is the ability of cancer cells to squeeze through confined 
spaces. It is known that some cancer cells are more deformable than other cells, 
and have the ability to squeeze through available spaces, move to secondary 
sites and colonize the foreign tissue. However the pathways/factors leading to 
such phenotypes are still unknown. Therefore, acquiring detailed understanding 
of the molecular mechanisms that contribute to cancer cell constrained 
migration will help to identify potential drug targets to block tumour cell 
dissemination and improve patient outcomes. In order to identify factors 
associated with cytoskeletal and elasticity changes that subsequently contribute 
to enhanced constrained cell migration and invasive abilities, I utilized an in 
vitro selection strategy through 3 µm pores. I was able to select for cells with 
enhanced confined migration ability in vitro. Properties that were unique to 
both pore-selected cell lines were disorganized cell cytoskeleton and decreased 
cell stiffness. To pinpoint factors or signalling pathways responsible for such 
phenotypes, I applied an unbiased method - RNA Sequencing and was able to 
identify, for the first time, that Ras-Raf-MEK-ERK mitogen-activated protein 
kinase (MAPK) pathway was the modulator of cytoskeleton organization and 
stiffness, and subsequently involved in the enhanced invasive phenotype. 
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7.1 In vitro selection of cancer cells through 3 µm pores 
using cell culture inserts 
The purpose of this part of the project was to separate invasive cancer cells with 
constrained migration capabilities from the parental tumour cell lines, and to 
apply a holistic approach to identify potential confined migration contributors. I 
chose the breast cancer (MDA MB 231-luc-D3H2LN) and melanoma cancer (MDA 
MB 435) cell lines as they are known to be highly heterogeneous, and because 
breast and melanoma tumours may be highly metastatic. In order to enrich for 
such cell sub-populations, I adopted a stringent selection strategy in which 
invasive cells were selected from MDA MB 231-luc-D3H2LN or MDA MB 435 cell 
populations based on their passage through 3 µm diameter constrictions in cell 
culture inserts that mimic gaps in dense extracellular matrix (ECM) or between 
cells. After three rounds, populations were selected that were significantly more 
migratory through 3 µm pores in vitro relative to Parental cells. Keeping in mind 
that cell size might have an impact on cell migration in 3D environments, I 
decided to test the hypothesis that cells with smaller volumes might have 
enhanced ability to migrate through physical hindrances. Having observed the 
smaller relative cell size of pore-selected cells, an additional selection strategy 
was employed. Using flow cytometry sorting, I was able to enrich Parental MDA 
MB 231 cells for as equivalently small as pore-selected MDA MB 231 cells. Having 
obtained the necessary control for cell size, I found that pore-selected MDA MB 
231 cells were significantly more migratory in vitro through 3 µm pores relative 
to Parental and Flow sorted MDA MB 231 cells. This experimental set up allowed 
me to make an important conclusion that constrained migration capability was 
not entirely dependent on cell size. In fact, this finding can be supported by 
Lautscham et al. (Lautscham, Kammerer et al. 2015). They reported that cells’ 
ability to migrate through narrow pores did not depend on cytoplasmic volume 
(total cell volume with subtracted nuclear volume). By utilising microfluidic 
devices with decreasing microchannels cross sections with an average pore size 
of 3 µm pores, they tested four different cancer cell lines of varying cell size, 
stiffness and adhesiveness on their ability to migrate through narrow channels 
and found that nuclear volume and cell adhesiveness were the main factors 
influencing constrained migration, but not cell size. 
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The next step was to find out whether the sub-populations of pore-selected cells 
exhibited invasive properties in more physiological relevant environments. It was 
first tested by using an in vitro 3D collagen invasion assay, and secondly, their 
growth and metastatic abilities were assessed in vivo. From these experiments, I 
found that pore-selected cells were not only characterized with constrained 
migration abilities but also they were more invasive in the 3D collagen assay in 
vitro. They were also more aggressive in vivo as shown by increased tumour 
volumes and weights for pore-selected MDA MB 231 cells, and by increased 
number of lung tumours in mice injected with pore-selected MDA MB 435 cells. 
These results revealed that the selection strategy enabled me to successfully 
separate invasive cancer cells with constrained migration ability, which is the 
key finding of this chapter, and to my knowledge this is the first described in 
vitro 3 µm pore selection strategy for invasive cancer cells. In the literature, 
there are studies describing in vitro selection of invasive sub-clones from varying 
cancer cell lines such as human breast cancer, human lung adenocarcinoma, 
primary human melanoma, human glioblastoma and human gastric cancer cell 
lines (Jacob, Bosserhoff et al. 1995; Chu, Yang et al. 1997; Peng, Ran et al. 
2009; Abdelkarim, Vintonenko et al. 2011; Koo, Martin et al. 2012) using the 
Transwell invasion (also referred as Boyden chamber) method to study cancer 
cell metastatic process. However, these studies were focused on investigating 
different aspects of the metastatic cascade, typically the contribution of the 
extracellular matrix on the cancer progression. Therefore, researchers used 
Transwell membrane inserts with 8 µm pores coated with the basement-
membrane gels, such as laminin-2, matrigel or basement membrane type-IV 
collagen. The investigators were able to successfully select invasive sub-cell 
lines from parental cells. In addition, these selected cell-lines also exhibited 
enhanced metastatic potential in vivo, consistent with my own results. This 
indicated that Transwell assay can be used as an in vitro strategy for selection of 
more invasive cancer cells.  
There are numerous studies employing in vivo selection of highly metastatic cells 
from cancer cell lines, such as human pancreatic adenocarcinoma, human breast 
cancer, human melanoma and human lung adenocarcinoma (Bruns, Harbison et 
al. 1999; Clark, Golub et al. 2000; Gumireddy, Sun et al. 2007; Cai, Luo et al. 
2015). In these studies, the investigators injected parental cancer cells into 
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immune-compromised mice subcutaneously, orthotopically or into the tail vein. 
The metastases were harvested and the tumour cells were re-injected into mice. 
After several rounds of selection, highly metastatic cells were obtained and their 
gene expression profiles were compared to parental cells. Such an in vivo 
selection model constitutes a relevant selection strategy due to the fact that it 
resembles the human situation. Moreover, the orthotopic injection of cancer 
cells necessitates the entire metastatic process for distant lesions to occur, 
consequently it provides a good approach for identifying genes associated with 
metastatic tropism. Nonetheless, due to the lack of a fully functional immune 
system in immune-compromised mice, the input of the immune system to 
metastatic progression cannot be evaluated. Moreover, such a selection strategy 
does not allow for studying a particular step of the metastatic cascade. This 
demonstrates that a variety of approaches can be useful for answering distinct 
scientific questions about different aspects of the metastatic process. 
7.1.1 Nuclear properties in constrained cell migration 
There are many in vivo studies demonstrating that nuclear deformation plays an 
important role during cancer cell dissemination (Yamauchi, Yang et al. 2005; 
Alexander, Koehl et al. 2008; Beadle, Assanah et al. 2008) as well as 
transendothelial migration (Voisin, Woodfin et al. 2009). Nuclear properties such 
as size, shape, and rigidity may impact the cells’ ability to migrate through 
confined spaces in the extracellular environment. Wolf et al. (Wolf, Te Lindert 
et al. 2013) demonstrated that cells which size exceeded the diameter of the 
pore cross-section, and which were not able to proteolytically widen the pore 
size, experienced nuclear arrest and immobilization in the pore opening. 
Lautscham et al. (Lautscham, Kammerer et al. 2015) reported that the main 
obstacle for cancer cells to overcome the physical hindrance is the large nuclear 
volume, by comparing different cancer cell lines with varying nuclear size. In 
contrast to these papers, I found that the equivalently smaller nuclei size of 
pore-selected and flow sorted cells did not explain the enhanced confined 
migratory ability of pore-selected cells, which suggested that there were 
additional factors contributing to the confined migration capability of Selected 
MDA MB 231 cells.  
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The ability of the nucleus to deform depends on nuclear rigidity, which can be 
dictated by lamin A/C expression, chromatin content or chromatin condensation. 
Mutation in the LMNA gene coding for lamin A cause more than 300 diseases, 
referred to as laminopathies (Worman, Fong et al. 2009). Additionally, lamin A/C 
expression has been observed to be deregulated in many cancer types (Hutchison 
2014). Cells derived from mice deficient for lamin A/C (lamina-/-) had 
significantly softer and fragile nuclei (Lammerding, Schulze et al. 2004). Many 
studies have reported that the deregulation of lamin A/C expression impaired 
cell migration in 2D environments. Furthermore low levels of lamin A/C 
facilitated 3 µm pore migration (Harada, Swift et al. 2014), while increased 
lamin A/C expression resulted in cell migration impairment (Rowat, Jaalouk et 
al. 2013). In order to reveal potential determinants of enhanced confined 
migration capability of pore-selected cells, the mechanical properties of the 
nucleus were investigated. The results revealed that pore-selected and flow-
sorted MDA MB 231 cells had stiffer nuclei compared to Parental MDA MB 231 
cells, in spite of the fact that lamin A/C expression was diminished in those cell-
types. First, it revealed that the augmented nuclear stiffness of pore-selected 
cells did not explain its enhanced confined migration. Second, the possible 
explanation for the discrepancy between enhanced nuclei stiffness and 
decreased lamin A/C expression could be that lamin A/C are not the only 
determinants of nuclear rigidity. In fact, it is unclear whether lamin A/C or 
chromatin content/condensation is most responsible for changes in nuclei 
stiffness. In the study conducted by Pajerowski et al. (Pajerowski, Dahl et al. 
2007), they showed that the nucleus of embryonic stem cells is more pliable due 
to an open and less condensed chromatin structure than nuclei of differentiated 
cells in which chromatin is more compacted. However, during cell 
differentiation not only does the compaction level of chromatin increase, but 
also the expression of lamins A and C. Besides lamins, chromatin content may 
also impact nuclear rigidity. As an example, the nuclear interior increases in 
stiffness when it becomes compressed exhibiting sponge-like properties (Dahl, 
Engler et al. 2005; Rowat, Lammerding et al. 2008). Cells aspirated into narrow 
micropipettes first showed decreases in nuclear size, but then reached a plateau 
where chromatin could be no longer shrunk. Chromatin in the nucleus exists in 
two states; heterochromatin, which is the more condensed form; and 
euchromatin, which is the lightly condensed and transcriptionally active form. 
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The level of chromatin compaction may depend on post-translational histone 
modifications. 
Chromatin compaction may have a big impact on nuclear stiffness and 
translocation. For example, some studies reported that alterations of chromatin, 
by divalent cations or upregulation of heterochromatin proteins, led to enhanced 
chromatin compaction and nuclear stiffness, while treatment of nuclei with 
chelating agents resulted in chromatin decondensation and reduction in nuclear 
rigidity (Dahl, Engler et al. 2005). Furthermore, condensed forms of chromatin 
may facilitate directed cell migration. With this in mind, I speculated whether 
chromatin condensation was altered and may have facilitated the confined 
migration ability of pore-selected MDA MB 231 cells. In order to assess it, I first 
investigated the chromatin content which revealed that Parental cells had 
significantly more chromatin relative to Selected and Flow sorted MDA MB 231 
cells. In order to assess chromatin condensation, I stained cells for the 
heterochromatin marker H3K27me3 as a starting point. Immunostaining revealed 
larger patches in pore-selected and Flow sorted MDA MB 231 cells, suggesting 
enhanced chromatin compaction in comparison to Parental cells. Next, to use a 
more quantitative approach of chromatin condensation detection, I utilised a 
method described by Lleres et al. (Lleres, James et al. 2009). They presented a 
quantitative analysis of chromatin compaction in live cells using a FLIM-FRET-
based assay. As a control experiment, to validate whether differences in 
chromatin compaction could be detected, I treated cells with 2-deoxyglucose (2-
DG) and sodium azide, and observed chromatin compaction in pore-selected and 
Parental MDA MB 231 cells regardless of differences in DNA content. This was 
consistent with the data reported by Lleres et al. who also showed that 
treatment of cells with 2-DG and sodium azide led to extensive chromatin 
compaction. Having validated the method, I continued with the assay and 
revealed that pore-selected and flow sorted cells had more compacted 
chromatin relative to Parental cells, which may explain the increased nuclear 
stiffness of these cell lines.  
Together, my findings revealed that nuclear size, stiffness and chromatin 
condensation did not determine the pore-selected cells’ ability to migrate 
through confined pores. However, the findings of this chapter indicated that the 
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reduction in chromosome number correlated with decreased nuclear and cell 
volume; additionally the decreased chromosome number correlated with more 
condensed chromatin.  
7.2 Cell mechanical properties 
There is a plethora of studies showing that malignant cancer cells are softer than 
corresponding normal cells, and that such plasticity may facilitate cancer cell 
invasion and metastasis (Cross, Jin et al. 2008; Faria, Ma et al. 2008; Li, Lee et 
al. 2008). These reports are supported by my own experimental data showing 
that pore-selected MDA MB 231 and MDA MB 435 cells, which were more 
migratory through confined spaces as well as more invasive in vivo, had reduced 
cell stiffness that might have facilitated their confined migration ability. As 
detailed in the introduction, the main determinant of cellular mechanics is the 
network of cytoplasmic actin filaments that bestow individual cells with the 
ability to overcome external mechanical forces (Moeendarbary and Harris 2014). 
Moreover, it has been shown that mechanical properties of purified cytoskeletal 
components such as actin, microtubules and intermediate filaments exhibited 
viscoelastic properties similar to whole cells (Gittes, Mickey et al. 1993; Janmey, 
Hvidt et al. 1994). Actin filaments, together with actin crosslinkers and 
polymerizing factors, create a mesh of 200 nm thickness located below the 
apical plasma membrane called actin cortex which shapes and provides a 
structural support for cancer cells, and which contributes to cell mechanical 
rigidity (Kumar, Maxwell et al. 2006). In addition, Gupta et al. (Gupta, Sarangi 
et al. 2015) reported that cells with well-developed stress fibres (nematic 
organization) were characterized with solid-like mechanical properties, while 
cells with more disorganized, (orthoradial) pattern of actin filaments around the 
nucleus (isotropic organization) were characterized with fluid like mechanical 
properties. To address the question of what might be responsible for the 
observed differences in cell stiffness between Parental, Selected and Flow 
sorted MDA MB 231 and Parental and Selected MDA MB 435, the organization of 
the actin cytoskeleton was investigated. Confocal, as well as TIRF, imaging of 
phalloidin-stained cytoplasmic and cortical F-actin revealed that pore-selected 
MDA MB 231 and MDA MB 435 cells had more ruffled actin organization, marked 
by fewer distinct cytoplasmic and cortical F-actin fibres compared to Parental or 
Flow sorted MDA MB 231, as well as Parental MDA MB 435. Quantification of actin 
205 
 
fibre alignment revealed a significant decrease in F-actin anisotropy in both 
pore-selected cell lines relative to other sub-populations from each cell line. 
Furthermore, when I disrupted F-actin by treating cells with Cytochalasin D, I 
observed a marked decrease of cortical stiffness in Parental MDA MB 231 cells, 
which can be supported by (Rotsch and Radmacher 2000; Wakatsuki, Schwab et 
al. 2001), suggesting that the cell mechanical properties are dependent on 
organization of the cortical F-actin. These results are consistent with a role of 
cytoskeleton mechanical properties in confined cell migration.  
The cell cytoskeleton connects with the ECM via membrane-associated 
macromolecular assemblies called focal adhesions. Despite the fact that cells 
can utilize different migration modes that are more or less dependent on 
integrin–mediated adhesion, the general picture of cell migration points out that 
focal adhesions play an important role in the cell migration process by helping 
cells to convert contractile forces into traction forces to move cells forward and 
retract the cell body tail. Focal adhesions are assembled during stress fibre 
polymerization, which drives the formation of extending protrusions (filopodia, 
lamellipodia) (Nagano, Hoshino et al. 2012). Nonetheless, there is conflicting 
data in the literature describing the role of increased adhesion as supporting 
(Rolli, Fransvea et al. 2003) or preventing tumour cell migration (Rodriguez 
Fernandez, Geiger et al. 1992). Due to observed changes in cytoskeleton 
organization between Parental and pore-selected MDA MB 231 and MDA MB 435 
cells, I decided to interrogate whether the observed cytoskeleton organization in 
pore-selected cells had an effect on focal adhesion assembly and subsequently 
on cell adhesiveness and motility. By staining cells with anti pFAK antibody, I 
found that pore-selected cells had a significantly reduced number of focal 
adhesions relative to Parental cells. However, despite the difference in number 
of focal complexes, the MDA MB 231 sub-populations did not differ in substrate 
adhesiveness. To determine whether the observed disparity in focal adhesion 
had an effect on cell motility, I utilized a random motility assay. The results 
revealed that pore-selected MDA MB 231 and MDA MB 435 cells migrated with 
increased speed and further distance. These results supported previously 
reported data showing that rapidly moving cells such as neutrophils and 
Dictyostelium discoideum (Nagasaki, Kanada et al. 2009) exhibit very small focal 
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adhesions while cells with pronounced focal complexes such as fibroblasts move 
slowly.  
Apart from the cytoskeleton being a known cell rigidity determinant, it has also 
been reported that lipid bilayers possess bending and compression elasticity. 
Plasma membrane stiffness and fluidity depend on the plasma membrane 
composition of lipids and proteins, as well as cholesterol content (Byfield, 
Aranda-Espinoza et al. 2004; Zhao, Prijic et al. 2016). Membrane fluidity is an 
indication of the movement of molecules in the membrane. Some studies have 
reported that decreased membrane fluidity correlated with increased metastatic 
potential of breast cancer cells, and such effect could be reversed by depletion 
of cholesterol upon antimetastatic drug treatment (Sherbet 1989; Sok, Sentjurc 
et al. 2002). In order to inspect whether the observed changes in cell rigidity 
might have been due to changes in membrane fluidity, I utilized a previously 
described method (Klein, Pillot et al. 2003). The lateral membrane diffusion of 
NBD-C6-sphingomyelin-treated cells was measured using a Fluorescence 
Recovery after Photobleaching method (FRAP). The results revealed that there 
were no differences in t1/2 and mobile fraction between all the sub-populations 
of MDA MB 231 and MDA MB 435, suggesting that there was no difference in 
membrane fluidity. As a result, membrane fluidity did not appear to be a cell 
property that dictated the ability of pore-selected cells to migrate through 
constrained pores, again pinpointing a significant role of cytoskeleton 
mechanical properties in confined cell migration.  
Altogether, these results indicated that cytoskeletal rigidity plays a significant 
role in confined cell migration of pore-selected MDA MB 231 and MDA MB 435 
cells. Moreover, dysregulated cytoskeletal organization in both pore-selected 
cell lines imposed less pronounced focal adhesion assembly, which was reflected 
in their increased motility.  
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7.3 RNA Sequencing analysis reveals increased 
signalling through the Ras-Raf-MEK-ERK mitogen-
activated protein kinase (MAPK) pathway in pore-
selected MDA MB 231 and MDA MB 435 cells 
The purpose of this part of the project was to identify factors or signalling 
pathways associated with the observed changes in pore-selected MDA MB 231 
and MDA MB 435 cells. For this reason, RNA Sequencing experiments were 
conducted. In order to unveil factors or signalling pathways, Gene Set 
Enrichment Analysis (GSEA) algorithms were applied. GSEA allows for the 
identification of enriched sets of genes based on previously published data. The 
GSEA analysis revealed increased signalling through the Ras-Raf-MEK-ERK 
mitogen-activated protein kinase (MAPK) pathway in pore-selected cells. The 
MAPK/ERK pathway plays important roles in the regulation of many fundamental 
cellular processes, such as proliferation, migration, angiogenesis and survival 
(Chong, Vikis et al. 2003; Wellbrock, Karasarides et al. 2004; Meloche and 
Pouyssegur 2007; Mebratu and Tesfaigzi 2009). Due to the fact that many 
components of this pathway have been found to be either mutated or 
overexpressed in many human cancers, it has been a subject of intense research, 
therefore there have been already many inhibitors developed to block some of 
the cascade’s kinases. For example, Vemurafenib and Sorafenib block the 
activity of B-Raf kinase, and Trametinib and U0126 block MEK1/2 kinases 
(Roberts and Der 2007; Burotto, Chiou et al. 2014; Holderfield, Nagel et al. 
2014; Tran, Cheng et al. 2016).  
In order to assess the impact of the MAPK/ERK pathway on the observed changes 
in pore-selected cells, I decided to block this pathway by applying two selective 
MEK inhibitors, Trametinib or U0126. I started the investigation by assessing 
whether expression of genes that were associated with the KRAS “signature”, 
identified by GSEA, was dependent on the activity of the MAPK/ERK pathway. To 
address this, I treated MDA MB 231 and MDA MB 435 cells with Trametinib and 
performed qRT-PCR. From this experiment, I determined that expression of the 
chosen genes was dependent on MAPK/ERK pathway activity, suggesting that 
these genes could be responsible for the observed disorganisation of cytoskeletal 
structures and cell plasticity changes in pore-selected cell lines and 
subsequently affect their confined migratory and invasive capabilities. 
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In order to validate an effect of MAPK/ERK pathway inhibition on actin 
organisation and focal adhesion assembly, I treated pore-selected MDA MB 231 
and MDA MB 435 cells with Trametinib or U0126. I found that MEK inhibitor 
treatment led to the appearance of long actin filaments and more focal 
adhesions in comparison to the more disorganised actin organisation and fewer 
focal complexes in DMSO-treated control cells. These results suggested that the 
MAPK/ERK pathway played an important role in stress fibre assembly. These 
results can be supported by Choi and Helfman (Choi and Helfman 2014). They 
showed that MDA MB 231 LM2 cells, which were selected based on their ability to 
metastasise to the lungs, had poorly organized stress fibres in comparison to 
their Parental cells, and interestingly LM2 cells had higher level of K-Ras 
expression and increased levels of pERK. Additionally, they showed that knock-
down of K-Ras or inhibition of MAPK/ERK pathway with U0126 inhibitor led to 
actin fibre restoration. 
In the next step of the project, I wanted to interrogate whether inhibition of the 
MAPK/ERK pathway had an effect on cell stiffness. Cell stiffness was significantly 
decreased in pore-selected cells, and following treatment with Trametinib cells 
became stiffer in comparison to DMSO-treated cells. In order to assess how 
MAPK/ERK pathway inhibition affected cell invasion and motility in vitro, 
collagen invasion and individual cell migration assays were conducted. I found 
that upon U0126 treatment invasion of pore-selected MDA MB 231 and MDA MB 
435 cells through fibroblast-conditioned collagen was restrained. Additionally, 
all the sub-populations of MDA MB 231 and MDA MB 435 cells migrated more 
slowly and moved shorter distances upon MEK inhibition, again suggesting that 
elevated signalling through the MAPK/ERK pathway in pore-selected MDA MB 231 
and MDA MB 435 cells was responsible for the enhanced invasive capabilities and 
motility in vitro.  
These results suggested that elevated signalling through the MAPK/ERK pathway 
was responsible for actin disruption and cell stiffness determination in pore-
selected MDA MB 231 and MDA MB 435 cells, and to my knowledge, this is the 
first time that the MAPK/ERK pathway has been shown to be involved in the cell 
elasticity modulation. 
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Before going into the possible mechanisms of how the MAPK/ERK pathway might 
alter actin filament organization, I will briefly describe how actin filaments and 
stress fibres are formed. F-actin filaments are formed by polymerization of 
globular monomeric actin (G-actin) subunits in a process called actin 
treadmilling, as described in the introduction. Moreover, the assembly and 
disassembly of actin filaments is regulated by many actin binding proteins, at 
least 100 (Dominguez and Holmes 2011). Bundled actin filaments, together with 
myosin II and the actin cross-linking protein α-actinin create structures called 
stress fibres (Burridge and Wittchen 2013). Stress fibre formation is dependent 
on actomyosin contractility, which can be regulated by several kinases that have 
the potential to phosphorylate myosin regulatory light chain 2 and cofilin. 
Initiation of stress fibre and focal adhesion formation is regulated by the well-
characterized small GTPase RhoA (Hanna and El-Sibai 2013). RhoA, when bound 
to GTP, has the ability to activate Rho-associated coiled-coil kinases (ROCK). 
ROCK kinases phosphorylate many downstream substrates, such as myosin light 
chain (MLC), regulatory subunit of MLC phosphatase (MYPT1) and LIM kinases. 
Phosphorylation of MLC activates it and increases its interaction with actin, 
which results in cell contractility. Phosphorylation of MYPT1 inhibits its activity 
and increases levels of phosphorylated MLC. Phosphorylation of LIM kinases 
activates them, which in turn leads to the phosphorylation and inhibition of the 
F-actin depolymerizing activity of cofilin (Rath and Olson 2012). There have 
been many studies showing that the Ras/ERK pathway has the capacity to 
modulate cell cytoskeletal organisation, and one mechanism by which Ras 
modifies actin filament assembly is by altering RhoA/ROCK pathway. For 
example, active ERK diminished the activity of ROCK by post translational 
modification (Pawlak and Helfman 2002), or through regulation of p21Cip1 which 
is involved in Ras-induced inhibition of the ROCK/LIMK/Cofilin pathway (Besson, 
Gurian-West et al. 2004). Furthermore, RhoA activity could be diminished by ERK 
via regulation of Fra-1 (Vial, Sahai et al. 2003). Based on the above, it is valid to 
speculate that the increased signalling through the MAPK/ERK pathway in pore-
selected cells might affect the activity of RhoA/ROCK signalling directly by 
decreasing the activity of RhoA, ROCK or LIMK, or by affecting their activity 
through an uncharacterized indirect mechanism.  
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An additional possibility for how the MAPK/ERK pathway might be involved in the 
dysregulation of actin cytoskeleton and cell elasticity changes in pore-selected 
cells is through the action of KRAS “signature” genes. By applying GSEA analysis, 
I was able to pinpoint some genes that were described by being activated by 
oncogenic KRAS based on previously published data. Therefore, it is possible to 
speculate that the coordinated action of some of the products of these genes, or 
a product of a single gene, might affect the activity of proteins involved in the 
complex mechanisms of the actin polymerization/depolymerization process, 
leading to cytoskeleton disorganisation. One of the genes which would require 
further investigation is Trangelin 3 (also called NP22). Transgelins are actin-
binding proteins belonging to the calponin protein family and have been shown 
to gel and stabilise actin gels in vitro (Assinder, Stanton et al. 2009). The precise 
role of these proteins is unknown, however it has been reported that they play 
roles in many biological activities, including regulating muscle fibre 
contractility, cell differentiation, tissue invasion, and tumour suppression 
(Assinder, Stanton et al. 2009). Expression of transgelins has been found to be 
decreased in breast, colon and prostate cancers (Shields, Rogers-Graham et al. 
2002; Wulfkuhle, Sgroi et al. 2002; Yang, Chang et al. 2007). In terms of the role 
of transgelins in stress fibre formation, it has been reported that depletion of 
Transgelin 2 (also known as SM22β) in REF52 fibroblasts led to disrupted cell 
cytoskeleton and changes in cell motility (Thompson, Moghraby et al. 2012). 
Additionally, Na at al. showed that Transgelin 2 stabilized cortical F-actin at the 
immunological synapse by blocking the activity of cofilin (Na, Kim et al. 2015). 
In addition, Mori et al. reported that Transgelin 3 co-localized with F-actin on 
stress fibres (Mori, Muto et al. 2004). Therefore, due to the increased expression 
of Translegin 3 in pore-selected cells and its ability to bind to actin, it is 
reasonable to speculate that it might play a significant role in the regulation of 
actin polymerization/depolymerization machinery or the stress fibre formation 
process leading to actin filament disruption and consequently decreased cell 
stiffness.  
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7.4 Final conclusions and future directions 
In conclusion, I showed that using Transwell assay with 3 µm pore membranes I 
was able to select for cells with enhanced constrained migration properties, 
enhanced motility and upregulated invasion capabilities in vitro. Additionally, I 
demonstrated that confined migration did not solely depend on cell or nuclei 
size, or nuclear rigidity. By investigating cell mechanical features, I found that 
pore-selected cells were significantly softer, which was due to disrupted actin 
cytoskeletal organization. Pore-selected MDA MB 231 and MDA MB 435 cells had 
more ruffled-like F-actin with short actin filaments in comparison to longer and 
more aligned actin stress fibre organisation in Parental cells. Moreover, by 
applying RNA Sequencing, I was able to identify that increased signalling through 
the MAPK/ERK pathway was responsible for the disrupted actin cytoskeleton and 
decreased cell stiffness, and consequently for increased cell motility and 
invasive capacity in vitro and in vivo.  
I therefore propose that increased signalling through the MAPK/ERK pathway 
leads to an upregulation of genes, which in turn, through a direct or indirect 
manner, contribute to altered cell cytoskeletal organization and focal adhesions, 
and subsequently diminished cell stiffness. Changes in cell elasticity facilitate 
cancer cell confined migration and invasion capabilities, and finally support their 
metastatic capabilities in vivo. Blocking the MAPK/ERK pathway with Trametinib 
or U0126 led to changes in gene expression, which might have contributed to 
actin cytoskeleton stabilization. Restoration of the actin cytoskeleton made cells 
stiffer and in consequence contributed to a reduction in cancer cell invasion and 
motility (Figure 7-1).    
There are still some questions that should be addressed; whether activating the 
MAPK/ERK pathway in Parental cells, for example through overexpressing 
oncogenic Ras or B-Raf, would disrupt actin organisation, reduce cell stiffness 
and subsequently promote their confined migration and invasion abilities in vitro 
and in vivo. In addition to that, it would be interesting to characterize whether 
the effect of the Ras/MAPK pathway on actin structures is due to acute or 
sustained signalling.  To address this question, Parental MDA MB 231 and MDA MB 
435 cells could be transfected/transduced with estrogen-receptor hormone 
binding domain fusions with Ras (ER-Ras) or B-Raf (BRaf-ER), which allow for the 
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specific and conditional activation of these proteins upon the addition of 
estrogen analogues such as 4-hdroxytamoxifen (4-HT). Cells could be stimulated 
with 4-HT to activate Ras or B-Raf, and the time course of MAPK activation 
monitored by western blotting of MAPK component phosphorylation. F-actin 
structures could be examined in fixed cells over time. In parallel, Selected MDA 
MB 231 and MDA MB 435 cells could be treated with the MEK inhibitors U0126 or 
Trametinib, which restored actin structures and increased F-actin anisotropy, at 
intervals ranging from minutes to hours to determine the time course of 
cytoskeleton recovery. In addition, cells could be transfected with GFP-tagged 
LifeAct, which is a 17 amino acid peptide that enables F-actin visualization in 
live cells (Riedl, Crevenna et al. 2008), and the effects of MEK inhibition and 
Ras/B-Raf overexpression on F-actin structures monitored by time-lapse 
fluorescence microscopy. AFM measurements of cell elasticity would determine 
the temporal relationships between MAPK activation, cytoskeleton disruption 
and mechanical properties. Moreover, it would be interesting to interrogate 
which of the genes that were identified by GSEA could be directly involved in 
the alteration of actin organisation and cell stiffness modulation. Such 
candidates could be potential drug targets.  
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Figure 7-1 Proposed model for the MAPK/ERK pathway in actin cytoskeleton and cell 
stiffness regulation. 
(Left panel) Increased signalling through the MAPK/ERK pathway leads to changes in gene 
expression, which in turn contribute to cell cytoskeleton disorganisation and changes in cell 
stiffness. Subsequently, decreased cell stiffness facilitates cancer cell constrained and invasive 
capabilities. (Right panel) Inhibition of the MAPK/ERK pathway leads to decreased expression of 
genes associated with cytoskeletal alteration and contributes to stress fibre and focal adhesion 
restoration. The rebuilt cell cytoskeleton recovers cell stiffness and diminishes constrained cell 
migration and invasion abilities.  
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